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Neisseria gonorrhoeae has been on the rise in the State of Florida since 2013. Florida 
currently follows the Centers for Disease Control and Prevention guidelines for 
identifying those at-risk for gonorrhea and drug resistant gonorrhea infections. These 
groups are narrowly defined and do not consider the different population dynamics 
throughout the State. This study examined the question of who is at-risk for contracting 
drug resistant strains of gonorrhea in the eight different regions of Florida based on the 
prescribed use of last-line-of-antibiotic-defense. Florida’s Surveillance Tools and 
Reporting System provided 12 years of secondary data from 2007 to 2018.  The data 
included 34 risk and demographic variables equaling over 9.5 million data points. The 
data were analyzed through chi-square, cross tabulation, and multiple logistic regression 
calculations. The findings indicated that each region had statistically significant unique 
risk and demographic factors as predictors of drug-resistance. Some of the regions shared 
similar risk and demographic factors such as age, condom use, and oral sex, with age 
being the most common factor across most of the regions. Conclusively, the regional 
findings were not identical to each other, indicating that a uniform application of a 
statewide intervention is not applicable. These varying factors, most of which are 
behavioral risk factors, are indicative of the Health Belief Model and the Theory of 
Reasoned Action. Intervention strategies will need to target specific demographics and 
risk factors in each region to institute social change and prevent the spread of drug-
resistant gonorrhea.   
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Chapter 1: Introduction to the Study  
Introduction 
Neisseria gonorrhoeae, or more commonly known as gonorrhea, is a pathogenic 
bacterium that is generally transmitted sexually, but can also be transmitted by other 
means (Giguère & Alary, 2015). Gonorrhea has been well documented for centuries and 
was first described by the Greeks in 130 A.D. (Black & Black, 2016). The term 
gonorrhea in Greek means “flow of seed,” indicating that the common form of 
transmission was sexual (Black & Black, 2016). It was not until 1916, when Albert 
Ludwig Sigesmund Neisser was able to identify the pathogenic bacterium that caused 
gonorrhea, hence creating the taxonomic name Neisseria (after himself) gonorrhoeae 
(supporting and giving credit to the original Greek name; Black & Black, 2016).  
 In the United States alone, there are over 800,000 identified cases per year 
(United States Centers for Disease Control and Prevention (CDC), 2017). Many more 
cases are not recognized due to the asymptomatic infectious behavior of the bacteria. 
Most individuals are asymptomatic; thus, they do not seek medical treatment (Maraynes 
et al., 2017). There are significant risks associated with this infection, including but not 
limited to, sterility, ectopic pregnancy, increased risk of contracting HIV, and necrosis 
(CDC, 2017).  
Background 
 There are many publications on the behavior of Neisseria gonorrhoeae but no 
current peer reviewed works on at-risk groups in Florida were identified. This 
dissertation studied the relationship between the use of last-line-of-antibiotic-defense 
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treatment as a method of predicting at-risk groups for drug resistant variants of 
gonorrhea. The following articles support this study. Alirol et al. (2017) published 
information on the history of drug-resistant gonorrhea and noted that there has been little 
to no research on the at-risk groups. They discussed the need for more research in this 
area as well as their anticipation that gonorrhea would become completely drug-resistant 
in the very near future. Tuite et al. (2017) examined ciprofloxacin, azithromycin, and 
ceftriaxone antibiotics and their effectiveness on resistant strains of gonorrhea. They 
claimed that interventions were necessary or else there would soon be incurable strains of 
gonorrhea. Maraynes et al. (2017) discussed the difficulties of diagnosing cases of 
gonorrhea due its asymptomatic behavior. Their work supported the position of this 
dissertation: that the CDC only narrowly and limitedly focuses on at-risk groups on a 
national level and does not take into consideration regional differences. They supported a 
more targeted approach and the identification of the regional at-risk groups for effective 
interventions.  
Kirkcaldy (2016) published the most current surveillance information on 
gonorrhea from limited locations. There are only 27 clinical sites across the United States 
that monitor for drug-resistant strains of gonorrhea and, due to financial restraints, not 
every individual is tested for drug resistance. Only those who fall under the CDC criteria 
are tested. This indicates that regional data collection is not occurring, and thus creating a 
gap in data as well as potentially misdirecting intervention strategies. The sites were 
chosen to detect changes in antimicrobial sensitivity across a wide range of national 
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geographies and was not designed to be nationally representative. This suggests a need 
for more targeted regional approaches.  
Whiley et al. (2012) placed emphasis on the concern that it is only a matter of 
time before gonorrhea becomes completely drug resistant. They also emphasized the need 
for more research, and that a targeted approach will be necessary to intervene in the 
evolution of drug resistance. Giguère and Alary (2015) and Grad et al. (2015) discussed 
the importance of identifying and targeting specific groups. They sought to stop the 
spread of drug-resistant gonorrhea. In their publications, they referred to these at-risk 
groups as core groups, but on a worldwide scale. These core groups, as they have defined 
are risky behavior, repeatedly infected, and sex workers. There was no identification or 
discussion how to identify at-risk groups on a localized scale. National demographics 
may vary from localized demographics; identifying at-risk groups at the local scale would 
be of greater benefit and significantly more effective.  
Problem Statement 
 Over the last 50 years there have been a variety of ever-changing medications to 
treat gonorrhea (CDC, 2017). Unfortunately, due to the organism’s ability to adapt, all 
but one of those treatment plans are now useless (Alirol et al., 2017; CDC, 2017; 
Kirkcaldy, 2016). This bacterium is rapidly evolving to become drug-resistant and the 
CDC stated in 2017 that this last drug treatment option will not last (CDC, 2017). The 
CDC has stated that drug-resistant gonorrhea is now an urgent public health issue (CDC, 
2017). There were many predictions beginning in 2015, that it would become drug-
resistant within as little time as this decade (Grad et al., 2015). Unfortunately, those 
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predictions were correct and in March 2018, the first identified case of completely drug-
resistant gonorrhea appeared in a British male in the United Kingdom (Bello, 2018). 
Although not completely drug resistant, in January 2019 two unrelated British women, 
contracted variants that are resistant to the current prescribed recommended antimicrobial 
treatments, indicating the progression to full drug resistance is nearing (Gallagher, 2019).  
Although proclaimed as a major public health issue by the CDC, Florida has done 
little to bring it to the attention of its citizens. Currently, Florida’s at-risk groups are the 
same as those recommended by the CDC: men having sex with men, sex workers, and 
pregnant women (CDC, 2017; 2018). Considering the vast variation in Florida’s 
demographics, these three groups are too narrow ranging and do not take into 
consideration regional demographics. Florida’s demographics are not evenly distributed 
across the state. The demographical groups are concentrated in the different regions, 
primarily due to historical events, immigration, and migration patterns. The details of the 
demographic variations within Florida, is discussed in detail in Chapter 2.  
Purpose of the Study 
 The purpose of this quantitative study was to identify the at-risk groups per 
Florida region that are most likely to contract drug-resistant gonorrhea. Within the eight 
Florida regions, there is a significant informational gap on those who are at-risk for 
contracting gonorrhea and drug-resistant gonorrhea. Florida and CDC identify narrow 
ranging at-risk groups that are vulnerable for contracting gonorrhea and drug-resistant 
gonorrhea. The state does not focus on the regional demographics. In Florida, the 
demographics vary by county and region. These vast cultural differences can contribute 
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to the progression of sexually transmitted diseases because varying cultures view sexual 
behaviors differently (Trecker & Dillon, 2014; Trecker et al., 2015). This dissertation 
expands the currently limited demographical knowledge of infected groups, predicts 
potential at-risk groups for drug-resistant gonorrhea, and creates a knowledge foundation 
with which to develop targeted interventions.  
Research Questions and Hypotheses 
This study identified the at-risk groups for contracting drug-resistant gonorrhea on 
a regional basis in Florida by evaluating (a) the currently prescribed last line of antibiotic 
treatments and (b) the gonococcal infection risk factors. To fulfill the intention of this 
study, the following questions were answered using secondary data provided by the State 
of Florida. 
Research Question 1: Are there differences in using last-line-of-antibiotic-defense 
between Florida as a whole and each of the eight regions?   
Research Question 2: Are there differences in using last-line-of-antibiotic-defense 
among the eight Florida regions?  
Research Question 3: What are the statistically significant factors associated with 
being treated with last-line-of-antibiotic-defense in each of the eight regions 
and the state of Florida? 
Theoretical Framework 
 This dissertation fits well within the 1966 health belief model (HBM) and the 
1975 theory of reasoned action (TRA). The HBM is based on four basic principles: (1) 
perceived susceptibility, which means how a person perceives how much at risk there is 
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for contracting the infection; (2) perceived severity, or how serious the consequences are; 
(3) perceived barriers, such as what would interfere with or facilitate adoption; and (4) 
perceived cost of dealing with an intervention (Rosenstock, 1974). With TRA, the 
individual considers the consequences of their behavior before engaging in that behavior 
(Ajzen, 1985). Currently the World Health Organization (WHO) and the CDC identify 
the at-risk groups as sex workers, pregnant women, and men who have sex with men 
(CDC, 2018). This leaves out a large number of other demographic groups, such as 
heterosexuals, bisexuals, age ranges, and ethnic. Based on the HBM and TRA models, 
many other groups may be at-risk because they do not believe they fit into one of the 
proposed categories. Considering the many different demographics across the regions of 
Florida, there are individuals who do not fit into the narrower reaching categories as 
currently defined. Thus, the individuals may continue risky behavior, thinking they are 
not at risk. This means it is necessary to identify the at-risk groups on a directed scale, so 
that targeted interventions can be created.  
Giguère and Alary (2015) and Grad et al. (2015) established models for 
identifying at-risk groups on a global scale, based on behavior or antibiotic resistance. 
They used existing large-scale data to focus their model on targeted core groups. Their 
core groups have some similarities to the identified core groups, which the CDC have 
also identified. All of the current models look at global or national applications. The 
models created by Giguère and Alary (2015) and Grad et al. (2015) could be modified for 
use on a more regionalized scale, as this dissertation sought to do.  
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Nature of the Study 
This study examined the relationship between gonorrhea infections and causes. A 
quantitative study using government-provided secondary data was conducted. Florida and 
the Federal government collect gonorrhea infection data, because gonorrhea infections 
are mandated as a reportable disease (CDC, 2012). Using secondary data from a 
government source indicated that the information has already been vetted and passed at 
least one institutional review board (IRB) prior to collection. Use of the secondary data 
required further IRB approvals. Additionally, to collect the amount of data that was 
needed to complete this dissertation as primary data, was cost prohibitive. There was no 
guarantee that grant monies would be successfully obtained at all or within the timeframe 
to conduct this study. Thus, using existing government data was the most logical 
approach. To successfully predict which risk and demographic factors by region were 
most likely to acquire drug-resistant gonorrhea infections, statistical evaluations were 
conducted. Thus, a quantitative approach was the strongest method to generate the 
findings.  
Types and Sources of Data 
 There were limited databases available for demographic factors, risk factors, and 
prescribed last-line-of-antibiotic-defense treatments for Florida.  To obtain this 
information, the following two databases were used: 
1. Florida’s Surveillance Tools and Reporting System (STARS) is a 20-year 
database consisting of 78 risk-behavior data entries, additional associated 
demographics, and prescribed modes of treatment with the infection. As a 
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reportable disease, gonorrhea was in the database. However, such cases are 
reported only if the individual has been medically diagnosed as positively infected 
with the bacterium. Access to this database was provided upon execution of a 
signed data use agreement (agreement number 2019-082).  
2. Within the Florida Community Health Assessment Resource Tool Set (CHARTS) 
system, information was limited to ethnic, sex, age, and location.  This 
information was used as a basis for targeted data mining.  
Definitions 
Age-range: Age group that an individual fall within (CDC, 2016b and FDOH, 2018). 
Always used condoms: Individual always used a condom during a sexual act (FDOH, 
2018). 
Anonymous partner: Sex with and unknown individual (FDOH, 2018). 
Condom use with main partner: Using a condom with the partner who is considered the 
primary individual in the relationship (FDOH, 2018).  
Condom use with other partner: Using a condom with an individual not considered as the 
primary individual in the relationship (FDOH, 2018). 
Drug use: Using legal or illegal drugs or medicine (FDOH, 2018). 
Ethnic: Cultural factors including local culture, ancestry, nationality, and language (CDC, 
1993). 
Gender: The gender that an individual identifies themselves as (CDC, 2017).  




Had an STD in the last 12 months: The individual had a STD in the 12 months prior to 
the current infection (FDOH, 2018). 
Incarcerated in the last 12 months: Has been incarcerated within the 12 months prior to 
the current infection (FDOH, 2018).  
Initial antibiotic treatment: Medical intervention utilized by licensed medical doctors to 
treat gonococcal infections (Hook III, Shafer, Deal, Kirkcaldy, & Iskande, 2013).  
Intoxicated Alcohol or Drugs: Individual was either using alcohol or drugs at the time of 
being infected (FDOH, 2018). 
Knew self-HIV status: Individual who knows their HIV status at the time of the infection 
(FDOH, 2018). 
Meet through the internet: Individual meet sex partner through the internet (FDOH, 
2018). 
Men having sex with men: Biological male having sex with another biological male 
regardless of their sexual orientation (FDOH, 2018).  
Met partner in bar: Individual meet sex partner in a bar (FDOH, 2018). 
Meet partner in bath: Individual meet sex partner in a bathhouse (FDOH, 2018). 
Never used condom: Individual who never uses a condom during a sex act (FDOH, 
2018). 
New Partner in last 90 days: Individual has sex with a new partner that they have know 
for 90 day or less (FDOH, 2018). 




Oral sex with a man: Individual had oral sex with a man regardless of sexual orientation 
(FDOH, 2018). 
Oral sex with a woman: Individual had oral sex with a woman regardless of sexual 
orientation (FDOH, 2018). 
Paid for sex: Individual gave drugs, money, or something in exchange for sex (FDOH, 
2018). 
Pregnancy: A pregnant female at the time of the infection (FDOH, 2018). 
Race: An individual’s physical characteristics such as skin color, hair color, eye color, 
and bone structure (CDC, 1993).  
Region: Area of Florida consisting of a group of counties (Gaglioti et al., 2018).  
Risk factor: A condition, behavior, or other factor that increases the risk of contracting 
gonococcal infections (CDC, 2017; Kirkcaldy, 2016). 
Self-reported gender: The gender that an individual identifies themselves as (CDC, 
2017).  
Sexual Assault: An individual who was a victim of sexual assault (FDOH, 2018). 
Sexual orientation: A person’s sexual identity in relation to the gender in which they are 
attracted to (CDC, 2017).  
Sometimes used condoms: Individual who did not regularly use condoms (FDOH, 2018).  
State: Refers to the state of Florida. 




Unprotected sex with woman: Sex with a female without protective barriers (Giguère, 
K.et al., 2019). 
Vaginal or anal sex with man: Sex with a male either vaginally or anally regardless of 
sexual orientation (FDOH, 2018). 
Vaginal or anal sex with woman: Sex with a female either vaginally or anally regardless 
of the sexual orientation (FDOH, 2018).  
Was paid for sex: Individual who received drugs, money, or something in exchange for 
sex (FDOH, 2018). 
Assumptions 
Within this study it was assumed that the secondary data were collected correctly, 
and that the data were true and complete. Gonorrhea is a reportable disease in Florida and 
at the Federal level (CDC, 2012). The information originates from the health care 
provider or a designee. Due to the many different individuals who may be entering the 
information there is no guarantee that the data were entered correctly or completely.  
It is also assumed that not all cases of gonorrhea in Florida were reported. It was 
assumed that in some instances, a medical professional, in protecting the interests of their 
patients, may have omitted information or not reported the infection at all. Even if some 
medical professionals failed to report, the information reported was considered a 
representative group of identified cases in each region. Another reason for this 
assumption was that gonorrhea has asymptomatic behavior characteristics (Maraynes et 
al., 2017). Thus, many cases remain undetected and unreported. The number of 
unreported cases is unknown, although there have been many estimates that the actual 
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cases are significantly higher than what has been reported (CDC, 2017). It was assumed 
that the unreported cases would follow the same demographic infectious trends as the 
reported cases, thus the data that was available was considered representative of all cases.  
Scope and Delimitations 
 Although the HBM and TRA fits this study well, there is still a lack of regional 
specific information to the public. This lack of information inhibits individuals from 
making informed health related choices. It was conjectured that the level of behavioral 
driven susceptibility is associated to an appropriate level of knowledge base. This study 
was not intended to answer all the possible questions that may arise, but it was intended 
to gain a better understanding of at-risk groups on a regional basis. This then established 
a foundation for future interventions and continued research in the areas of disease 
prevention.  
Limitations 
 This study used the guiding tenets of the HBM and TRA with a focus on those 
perceived at-risk for drug resistant gonorrhea. The data for this study were secondary and 
provided by FDOH. The study was limited to the data available and the methods by 
which the data were collected. The information was collected from many sites across 
Florida and it is unknown if all health professionals entering the information were 
properly trained in the data collection process. This limited the ability to effectively 
measure or mediate the potential for reporting bias. The secondary data were secured 
data; there were no identifiers linking to the infected individual. Thus, it was impossible 
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to return to question the individual or medical professional for further clarification of 
information, if deemed relevant for this study.  
Significance 
There is a significant gap in the literature on any identified at-risk groups for 
drug-resistant gonorrhea, on a per region basis, in the state of Florida. All gonorrhea 
infections in Florida are reported through STARS and limited data is made available to 
the public through CHARTS. Within CHARTS, gonorrhea infection data is limited to the 
number of gonorrhea infections that occur per county per year along with basic 
demographics. Florida’s reporting structure does not group counties into regions and has 
no regional reporting. There is extremely limited data on gonococcal drug-resistant 
infections in Florida, and there is no predictive reporting. Drug-resistant reporting for 
Florida is provided by the Gonococcal Isolate Surveillance System (GISP), which is not 
part of Florida’s monitoring program (CDC, 2016a). Also, GISP reported on only one 
Florida county, Miami-Dade, for which reporting ceased in 2013. In addition, GISP only 
requires sampling for drug resistance from select demographic groups and not all 
identified cases (CDC, 2016a). Florida has not published any work on attempts to 
identify at-risk groups for drug-resistant strains at either a state, regional, or county level. 
Florida has currently failed to obtain a position or pursue further major research in this 
area.  
This particular bacterium has been rapidly evolving drug resistance. The first 
drug-resistant case was identified in March of 2018 (Welch, 2018). The infected 
heterosexual male did not fit into the current high-risk group categories of WHO or the 
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CDC. This means that the generalized identified at-risk groups, such as homosexual 
males, sex workers, and pregnant women, may be too narrow ranging. For the state of 
Florida, each region needed to be evaluated for gonorrhea patterns that could lead to drug 
resistance. This then set a foundation for prevention initiatives that could be customized 
for each region. If effective interventions are implemented, there will be less of a need for 
treating gonorrhea with medications and thus, slow down or even stop the increasing 
foothold of drug-resistant strains.  
Summary 
Gonorrhea has been recorded since 130 A.D. and has most likely been in 
existence for a much longer time. Not only is it one of the oldest recorded sexually 
transmitted diseases, but it may also be even be one of, if not, the first. There is no 
legitimate information beyond herbal remedy speculations on how gonorrhea was treated 
prior to modern medicine. It was not until the first antibiotic was discovered in 1928 by 
Alexander Fleming and came to market in 1942 with the onset of World War II that an 
actual effective treatment for gonorrhea became available. Gonorrhea was first treated 
with antibiotics in 1943. In just over 70 years, society has gone from being able to simply 
and effectively treat gonorrhea to uncurable strains. This supports the concept that 
gonorrhea is an extremely resilient and highly adaptable pathogen. As a society we 
cannot continue to assume that science will be able to continuously find effective 
treatments for gonorrhea. The ability to cure gonorrhea is additionally compounded by 
the fact that it has asymptomatic behaviors that effectively camouflages it from detection 
by the host.  
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Public health professionals need to investigate non-drug treatment methods to 
stop the spread of this infection. Like any pathogen, if one can interrupt the lifecycle by 
not providing future hosts, then eradication and extinction is possible. Instead of 
continuously creating more medications that eventually become ineffective, interventions 
and safe sex practices would be of greater benefit. This study identified at-risk groups for 
drug-resistant strains of gonorrhea at regional levels and at the statewide level for future 
focused interventions. Many factors such as ethnic, age, culture, and the like can affect 
sexual behaviors. These can vary from state to state and region to region within the states. 
This study identified regional-based trends within Florida so that future effective 
interventions beyond drug treatments can be developed and more clearly focused on the 
regional populations.  
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Chapter 2: Literature Review 
Introduction  
The purpose of this quantitative study was to identify the groups that are most 
likely to contract drug-resistant gonorrhea in a given Florida region. Florida follows the 
guidelines recommended by the CDC for intervention strategies. Florida is diverse and 
has regional demographic variations. The recommended target groups do not uniformly 
match the demographics of each region. Drug resistance is driven by misuse or overuse 
of antimicrobial agents. This study compares the-last-line-of-defense treatments to the 
different demographic and risk factor characteristics in order to develop a predictive 
model for those who most likely will be at risk to contract drug-resistant variants of 
gonorrhea in each region and the state.  
The pathogenic sexually transmitted bacterium Neisseria gonorrhoeae has been 
well documented for centuries and was first described by the Greeks in 130 A.D. (Black 
& Black, 2016). The term gonorrhea in Greek means “flow of seed” indicating that the 
common form of transmission was sexual (Black & Black, 2016). In the United States 
alone, there are over 800,000 identified cases per year (CDC, 2017). There are many 
more cases that are not recognized due to the asymptomatic behavior of the bacteria; the 
overall numbers may be much higher than what is being reported (Maraynes et al., 2017).  
 Over the last 50 years there have been a variety of ever-changing medications to 
treat gonorrhea (CDC, 2017). Due to the organism’s ability to adapt, all but one of those 
antibiotic treatment plans are now useless (Alirol et al., 2017; CDC 2017; Kirkcaldy, 
2016). The CDC stated in 2017 that cefixime and ceftriaxone together or in combination 
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with azithromycin is last drug treatment option. The CDC stated that this will not last, 
which makes drug-resistant gonorrhea an immediate and urgent public health issue 
(CDC, 2017).  
Literature Review Methodology 
 The literature for this review was collected through various media. The initial 
review began with the CDC website on gonorrhea. The CDC is the leading authority in 
the United States for all reportable infectious diseases in the United States (U.S.) and its 
territories. Information on gonorrhea and gonococcal infections outside of the U.S. was 
also taken into consideration. The CDC site was reviewed extensively to gain a better 
understand of the core nature of gonorrhea and its drug-resistant behavior. The CDC site 
provided access to other published works. This “chain referencing” was a beneficial tool 
in identifying relevant works.  
The second area of review evaluated the WHO’s website for additional 
information and trends. Although this work focused on Florida, since gonorrhea is 
becoming a global crisis, it was considered a significant source to investigate. It is also 
important to understand that global transportation is relatively quick and affordable. 
Diseases can be transported in a matter of only a few hours through mechanisms such as 
air travel and longer for travel by sea. Florida, especially Disney World, is a common 
vacation destination for visitors from all over the world (Fyall, 2019). Thus, 
asymptomatic gonococcal infections can be easily transported into Florida. The other 
aspect is the sex trade, which is legal in other countries such as Germany and Canada 
(Weitzer, 2017). The chances of gonorrhea being brought back to the United States 
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through American sex tourists is significant (Weitzer, 2017). This also means there is a 
potential for introduction of new strains into the United States. The third area of review 
was the Florida Department of Health (FDOH) website on gonorrhea. This study focuses 
on gonococcal infections in Florida, thus the FDOH was an excellent site of information 
as well as another source of “chain referencing.”  
 Upon complete review of the aforementioned websites, the literature search 
commenced. There were two different approaches to identify applicable literature. The 
first approach was to use Google Scholar. Google Scholar is not a complete database of 
information and it often presented irrelevant literature, but it is a useful tool that aided in 
“chain referencing.” The second source of literature was to search through Walden 
University’s database subscriptions such as Walden University’s database PubMed, 
ProQuest, and Science Direct.  These were cross-discipline databases in medicine, public 
health, and science providing a comprehensive search.  
 The literature review for the majority of this study was intentionally limited to 
literary works published in the last 5-years from the start of this dissertation and 
pertaining directly to the dissertation topic. The key terms used were gonorrhea, 
gonorrhea infections, drug resistance, drug-resistant gonorrhea, Florida and history of 
Florida. The phrase drug-resistant gonorrhea revealed the most direct and compelling 
research; gonorrhea, drug resistant, and gonorrhea infections were too broad. The 
acquisition of general gonorrhea knowledge used the term phrase history of gonorrhea. 
This provided literary works discussing the core epidemiology and etiology of gonorrhea. 
These literary works established foundational information for this dissertation. Literary 
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works that did not discuss drug-resistant gonorrhea or the history of gonorrhea were 
reviewed for pertinent information, but often were excluded.  
Theoretical Framework 
 The purpose of theories in health is to provide a comprehensive understanding of 
factors that need to be considered for the designing, implementation, and evaluation of a 
health promotion program (Rimer & Glanz, 2015). Human behavior is complicated, and a 
theoretical understanding can be beneficial to the health professional. A health 
professional who has a working and grounded understanding in human behavior allows 
that professional to better support a person, family, group, or large community to improve 
their health status (Rimer & Glanz, 2015). The theories in health are designed as a guide 
in the understanding of why and how people and communities make health related 
choices (Rimer & Glanz, 2015). The theories in health offer an organized mechanism of 
grasping situations, appraising relationships, and forecasting outcomes (Rimer & Glanz, 
2015). Theories in health will also explain the need for interventions, the best prescribed 
course of an intervention, and how to assess the successes or failures of an intervention 
(Rimer & Glanz, 2015). In the works of Rimer and Glanz (2015) they stated that theories 
help practitioners to interpret the findings of the research and make the jump from facts 
written on a piece of paper to comprehending the dynamic interactions between the 
environmental context and human behavior. Where theories provide a broad roadmap that 
aid in the explanation of the dynamics of human health behavior, identifying effective 
interventions, selecting suitable target audiences, and evaluating; outcome models narrow 
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down the approach and provide specific targeted structure for the health professional 
(Rimer & Glanz, 2015).  
Health Belief Model (1966) 
The foundation of the HBM of 1966 still holds true today. A review of literary 
works indicated that there is a considerable lack of knowledge within the public in regard 
to the transmission of gonorrhea, transmission of drug-resistant gonorrhea, and the reality 
of that everyone is susceptible to this infection. Current interventions are only targeting 
men who have sex with men, individuals in the sex trade industry, and pregnant women. 
In the eyes of the general public, the majority of individuals do not fall into these 
categories. This perpetuates the notation that most individuals are unlikely to contract 
gonococcal infections. In contrast to individual beliefs, a number of literary works 
indicate that there is a growing number of groups exclusive of the aforementioned three 
that are being infected by this bacterium. From a health theory standpoint this problem 
fits ideally with the 1966 HBM.  
The 1966 HBM is based on four constructs (Hayden, 2017; McWhirter & 
Hoffman-Goetz, 2016). The first construct is perceived susceptibility (Hayden, 2017; 
McWhirter & Hoffman-Goetz, 2016). Perception is an influential mechanism directing 
individual behaviors. As mentioned, it is plausible that many individuals may think that 
since they do not fall within one of the three aforementioned identified categories, they 
are not susceptible to gonococcal infections. Unfortunately, this is a blind interpretation. 
Although they as an individual may not fall into one of these categories, their partner 
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could have been and still be, an unknowing asymptomatic carrier. Open relationships and 
relationships where one or more partners are unfaithful can also be problematic.  
The second construct is perceived severity (Hayden, 2017; McWhirter & 
Hoffman-Goetz, 2016). Humans in this world have become reliant on the notion that 
medicine can cure all. This creates the false sense of health safety for individuals. It 
perpetuates the belief that even if they do acquire a gonococcal infection it will be easily 
cured through medical invention. This generates an appearance that a gonococcal 
infection is no more than a minor inconvenience. Perceptions as these, are extremely 
disconcerting and can perpetuate the spread infections.  
The third construct is perceived barriers (Hayden, 2017; McWhirter & Hoffman-
Goetz, 2016). Barriers, in relationship to gonococcal infections, are that gonorrhea is 
becoming drug resistant. There is a significant lack of information to the public educating 
them that gonococcal infections are not only on the verge of being completely drug 
resistant, but there has now been at least one documented case. The lack of information to 
the public, may cloak the perception that there are barriers of incurable gonococcal 
infections. The greatest unseen current barrier is the actual lack of public knowledge 
regarding this bacterium.  
The final construct is the perceived cost of adhering to the propose intervention 
(Hayden, 2017; McWhirter & Hoffman-Goetz, 2016). There is a perception that most 
antibiotics are relatively inexpensive. This can lead to a false interpretation that it is 
relatively inexpensive to treat a gonococcal infection. The medications currently being 
used cost insurance and government-based insurance approximately $162 million per 
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year or $202 per person per year (Chesson et al., 2014). Overall, this is not too great of a 
financial burden on an individual. Leading them to be unconcerned if they contract a 
gonococcal infection.  
Theory of Reasoned Action (1975)  
 The (TRA) the is based on the assumption that an individual considers the 
consequences of their behavior before engaging in that particular behavior (Ajzen, 1985). 
Within this model there are three constructs. The first is behavioral attitude (Ajzen, 
1985). This construct states that the behavior intention is a function of that individual’s 
attitude about the behavior and subjective norms (Ajzen, 1985). The second is attitude 
and it can be understood as the decision of one’s behavior based on how others would 
perceive that individual if the behavior is or is not conducted (Ajzen, 1985). The third is 
the subjective norm and is based on the perceived expectations by key individuals in that 
individual’s life.  
 TRA can be influential in the decision-making process of and for sexual activity 
associated with the risk of contracting a gonococcal infection. The WHO and the CDC 
have currently identified the at-risk groups for contracting gonorrhea as pregnant women, 
sex workers, and men who have sex with men (CDC, 2018). Under the TRA model an 
individual who does not fall within any one of these categories would not consider 
themselves at risk. The perception would then be that they would not need to worry how 
others perceive them since they would not be subject to contracting the pathogen. From a 
TRA standpoint there would be no judgement and they would most likely proceed 
forward with the risk behavior. If the at-risk groups can be narrowed down to a regional 
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level, this may then change the perception of who is at-risk. This in turn changes how an 
individual evaluates the outcome of their action in conjunction of how others perceive 
them based on their actions.  
Basics about Gonorrhea 
History 
 Neisseria gonorrhoeae, or gonorrhea, is considered one of the earliest known 
human pathogenic bacteria (Morgan & Decker, 2016). It is not known how long 
gonorrhea has been plaguing humankind. It is safe to state, that it has been known for at 
least 2000 years. The historical roots of this bacterium are vastly deep and impactful on 
human health, so much so that it has even been documented within the biblical scriptures 
(Morgan & Decker, 2016). Circa 130-200AD, the Greek physician Galan was the first to 
name and describe gonorrhea. The term is based in the ancient Greek language and 
translates as an “unwanted excretion of seamen” (Morgan & Decker, 2016). Other 
scholars have translated it literally from Latin as “flow of seed” (Black & Black, 2016). 
Regardless of which translation is used, both the ancient Greek and Latin languages 
indicate that N. gonorrhoeae has an association with sexual transmission.  
 Gonorrhea has a secondary name that is believed to have arisen from geographical 
origins. It for centuries has been referred to as “the clap” (Black & Black, 2016). Circa 
1378 there was an area of Paris known for prostitution as Les Clapiers (Black & Black, 
2016). It is believed this geographical location supported the spread of gonorrhea and 
originated the street term the “clap.” For centuries gonorrhea was only identified by its 
symptoms. It was not until the invention of the microscope that Albert Ludwig 
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Sigesmund Neisser in 1916 was able to successfully taxonomically describe gonorrhea as 
gram-negative diplococci (Black & Black, 2016). It was from a combination of Neisser’s 
work and the symptomatic description from ancient Greece, that gonorrhea has earned its 
modern taxonomic binomial name Neisseria gonorrhoeae.  
Etiology 
 Gonorrhea is a gram-negative diplococcus bacterium. It has an affinity for, and 
infects the mucosal surfaces of the genital tract (Sherrard, 2014). Gonorrhea will infect 
the urethra as well as the genital glands, uterine cervix, fallopian tubes, epididymites, 
anal canal, distal rectum, oropharynx, and eyes (Sherrard, 2014). Under specific 
conditions or anatomical position, a female with an active vaginal gonorrhea infection 
can then become anally infected (Morgan & Decker, 2016). This cross contamination is 
due in part to the close proximity of the vagina and anus, and that gonorrhea can cause 
fluid discharge from the vaginal cavity (Morgan & Decker, 2016). Although gonorrhea 
can be a discomforting and an irritating infection, it also has the ability to be extremely 
dangerous. There are a multitude of associated risks. It has been documented that an 
individual infected with gonorrhea may eventually acquire pelvic inflammatory disease, 
sterility, septicemia, and necrosis as well as having a greater chance of contracting HIV 
infections (CDC, 2017).  
There is also a 30% risk of vertical transmission from infected mothers to babies 
during the birthing process (Sherrard, 2014). Within a few weeks of birth, babies will 
exhibit ophthalmia neonatorum and if left untreated, will cause blindness (Sherrard, 
2014). There are instances of neonatal sepsis infection occurring specifically in cases 
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when there has been prolonged rupture of membranes or preterm delivery (Sherrard, 
2014). Neonatal sepsis can lead to infant death. If an infant (non-newborn) or a child 
contracts gonorrhea, experts advise that it may be related to sexual abuse and will require 
authoritative and legal intervention (Sherrard, 2014). 
Antimicrobial History 
The sulfonamides were considered the first antimicrobial agents affective against 
gonorrhea and were discovered by Gerhard Domagk in 1935 (Unemo & Shafer, 2014). 
The sulfonamides had an 80% to 90% success rate (Unemo & Shafer, 2014). By 1944 the 
sulfonamides were no longer effective. Luckily in 1928 Alexander Fleming discovered 
penicillin (Black & Black, 2016). Due to production costs, it was not affordably produced 
until 1942. In 1943 the medical community was able to begin using it on gonorrhea. The 
effectiveness did not last long. Only three years later in 1946 gonorrhea became resistant 
to penicillin (Unemo & Shafer, 2014). Tetracycline discovered by Benjamin Dugger was 
the next antimicrobial used to treat gonorrhea infections. By 1986 gonorrhea was 
resistant to that antimicrobial. Within the same time-period, around 1967 spectinomycin 
was also rendered useless (Unemo & Shafer, 2014). As time passed, each antimicrobial 
for gonorrhea became obsolete. Macrolide (azithromycin) in 1999, Cephalosporins in 
2003, and Quinolones in 2007 (Black & Black, 2016).  
Treatment 
The treatment of gonorrhea has been complicated due to its ability to develop 
antibiotic resistance quite quickly (Morgan & Decker, 2016). There is a growing concern 
in the medical community over this issue. Gonorrhea is now resistant to multiple classes 
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of antimicrobial drugs including sulfonamides, penicillins, tetracyclines, macrolides, 
fluoroquinolones, and just recently cephalosporins (Morgan & Decker, 2016). Only in the 
last few years gonococcal antibiotic resistance has become a worldwide problem 
(Morgan & Decker, 2016; Sherrad, 2014). Pharmaceutical companies are scrambling for 
new chemical controls. A review (2018) of the Federal Drug Administration Clinical 
Trials website indicated that there are at minimum 60 clinical trials being conducted to 
find antibiotic treatments for gonorrhea. Over the last 50 years there have been a variety 
of medications to treat gonorrhea (CDC, 2017). The constant changing of drug treatment 
protocols are a direct result of the resilience of gonorrhea (CDC, 2017). The treatment 
medicines and modes of treatments are changing every few years (CDC, 2017).  
Gonorrhea as a survival tactic, has evolved to become drug resistant over and 
over. Every time a new antibiotic is introduced, the bacterium becomes resistant in as 
little as one decade to that drug or treatment plan (CDC, 2017). Gonorrhea has been so 
successful that all but one of the many drug treatment plans are now useless (Alirol et al., 
2017; CDC, 2017; Kirkcaldy, 2016). Cefixime and ceftriaxone in combination or in 
combination with azithromycin is considered the last treatment left to combat gonorrhea 
(Morgan & Decker, 2016). These antibiotics are used in series as a combined treatment 
because they are not effective enough to be used as standalones (Kirkcaldy, 2016) 
Unfortunately, gonorrhea is showing signs of resistance to these treatments (Morgan & 
Decker, 2016). In March 2018, the first case of complete drug-resistant gonorrhea or 
“super gonorrhea” was documented (Ducharme, 2018). Additionally, although not 
completely drug resistant as in the March 2018 case, in January 2019 two unrelated 
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British women contracted variants that are resistant to the current prescribe recommended 
treatments (Gallagher, 2019). 
Current Issues 
Neisseria gonorrhoeae ranks second as the most common notifiable sexually 
transmitted disease in the United States (Morgan & Decker, 2016). In the United States 
alone, there are over 800,000 identified cases of any strain of gonorrhea per year (CDC, 
2017). The estimated medical cost is $162 million per year (Chesson et al., 2014). 
Worldwide there are approximately 62 million cases diagnosed (Sherrad, 2014). 
Researchers believe that this is too low of an estimate, that the current numbers are 
grossly inaccurate, and the actual rates are significantly higher (Maraynes et al., 2017).  
The belief that the information is inaccurate is based in part within the unique 
behavior of the bacterium. In adults, gonorrhea is almost always transmitted sexually 
(Sherrard, 2014). The classical presentation of a gonococcal infection for a male is white 
to yellow discharge from the urethra (Kerani et al., 2015).  In more advanced cases, green 
discharge from the urethra (Kerani et al., 2015). The male individual will at times have 
painful and burning sensations in the urethra and glans during urination (Kerani et al., 
2015). Females also exhibit white to yellow and in some cases green discharge, but it will 
come from the cervix and not the urethra (Kerani et al., 2015). The female infected with 
gonorrhea will also have abdominal pain and in some cases leading toward Pelvic 
Inflammatory Disease (PID) (Kerani et al., 2015). Gonorrhea has a dark side where it can 
also exhibit asymptomatic behavior in 40% of the infected males and 60%-80% of the 
infected females (CDC, 2017). The literature indicates that up to 60% of all individuals 
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infected with gonorrhea are unaware of their infection (CDC, 2017). Gonorrhea 
transmission is more efficient from male to female due to anatomical characteristics 
(Sherrard, 2014). The risk of acquiring gonorrhea from an infected partner, only having a 
single unprotected sexual intercourse act, is estimated at 30% to 70% regardless of 
anatomical sex (Morgan & Decker, 2016; Sherrard, 2014). The physiological design of 
females versus males coupled with the bacterium’s behavior, is why females will be more 
asymptomatic than males (Kerani et al., 2015). Gonorrhea’s asymptomatic behavior 
makes it very difficult to diagnose (CDC, 2017). Characteristically if an individual is not 
presenting signs or symptoms, they will not seek out medical intervention (CDC, 2017). 
They will instead become a biological vector for this bacterium (CDC, 2017). Based on 
these percentages alone, it could be elucidated that the true number of infected 
individuals globally are in the hundreds of millions.  
There may be some hope on the horizon. There are times during the drug-resistant 
evolution of a bacterium they lose resistance to earlier historical treatments. There have 
been some studies indicating that azithromycin is having an increased effectiveness 
against gonorrhea (Martin et al., 2016). Although this may be a positive indication, 
gonorrhea, at one time became fully resistant to azithromycin. This then leaves the 
possibility of gonorrhea becoming resistant again and in a much shorter time period than 
before.  
 The issue of drug-resistant gonorrhea could be overcome by simple interventions. 
Regrettably, currently there is little discussion outside of the medical community 
regarding gonococcal drug resistance. An uninformed public will fuel this growing issue. 
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Adding to the lack of information, or more so of isolating the general public’s mind set, 
the targeted groups as recommended by the CDC and the WHO for gonococcal infection 
interventions are men who have sex with men, individuals who work in the sex trade such 
as escorts, exotic dancers, and prostitutes, and pregnant women (CDC, 2017). This 
creates an ideological thought with the common public, perpetuating the behavior 
because the mindset is; that if a person does not fall into one of these categories, they are 
not at risk for contracting this infection. Unfortunately, this is may not be the case and the 
current recommendations for targeted intervention may in fact be exasperating the spread 
of the infection through basic unawareness and misinforming of the general public. 
Recent Research on Drug-Resistant Gonorrhea 
There are currently different methods being implemented to combat drug-resistant 
gonorrhea. The works that approach from a surveillance and intervention standpoint are 
Barbee (2014), Chesson, Kirkcaldy, Gift, Owusu-Edusel Jr., and Weinstock (2014); 
Fingerhuth, Bonhoffer, Low, and Althaus (2016); Golparian, and Shafer (2014); 
Kirkcaldy et al. (2016); Mackenzie and Decker (2016); Martin et al. (2016); Sherrard 
(2014); Town et al. (2015); Unemo and Shafer (2014); Unemo (2014); Wi et al. (2017); 
and Ventola (2015).  The works that are confronting this issue from the molecular and 
cellular viewpoint in order to gain a better understanding of the genomic complexities of 
why the bacterium is drug resistant and how it becomes drug resistant are Alm et al. 
(2014); Allan-Blitz et al. (2017); Allan-Blitz et al. (2018); Basarab et al. (2015); Baym, 
Stone, and Kishony (2016); Buono et al. (2014); Jacobsson et al. (2014); Unemo, del Rio, 
and Shafer (2016); Unemo (2015); and Goparian, Shafer, Ohnishi, and the Unemo (2015)  
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The surveillance researchers are studying gonococcal infection rates. The work of 
Ventola (2015) identifies nationwide gonococcal infections basing those infections on the 
number of prescriptions written on a state-by-state basis. They are also studying over 
prescribing of antibiotics for both individual and commercial purposes with the 
expectations of detecting potential zones of drug resistance. Unemo and Shafer (2014) 
take a different approach. Their surveillance program collects information based on 
positive laboratory identification of drug-resistant strains of gonorrhea. The Gonococcal 
Isolate Surveillance Project (GISP) is utilized by Chesson et al. (2014), Fingerhuth et al. 
(2016) and Kirkcaldy et al. (2016). They collect their information through GISP which in 
turn gathers its data from participating clinics and laboratories. The information provided 
directly to GISP has been vetted through the CDC for accuracy in reporting. Kirkcaldy et 
al. (2016) compile this data and track the evolution of drug-resistant strains. Kirkcaldy et 
al. (2016) have stated that currently, GISP is the only source of national and regional 
gonococcal antimicrobial susceptibility data in the United States. Unemo (2015) and 
Unemo and Shafer (2014), are using data collected from other literary works to develop a 
complete comprehensive overview of the extent of gonorrhea drug resistance.  
The understanding of where these infections are happening, how extensive the 
prevalence rates are, and the number of drug-resistant strains is invaluable. It is unlikely 
that a gonococcal infection can be stopped without some form of medical or public health 
intervention. Unless the mechanisms of how drug resistance and susceptibility are 
understood there may be no future medicinal options. Jacobsson et al. (2014); Allan-Blitz 
et al. (2017); Allan-Blitz et al. (2018); Basarab et al. (2015); Buono et al. (2014); and 
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Unemo et al. (2016) are investigating the mechanism in which the gonococcal bacterium 
uptakes or blocks antimicrobial medicines. The main research focus targets the 
mechanism(s) in which the antimicrobial drugs pass through the cellular membrane. 
These researchers are also investigating what happens when the medications enter the 
cellular matrices. Jacobsson et al. (2014) has elucidated that there is a significant genetic 
link to antimicrobial resistance. The team investigated the DNA Gyrase Inhibitor 
AZD0914 and manipulated it to have the ability to activate or deactivate it. The motive 
was to determine if this genome has a role in gonococcal drug resistance. Similarly, Alm 
et al. (2015) studied the same genome but used a different approach. Instead of 
controlling the genome which could add bias to the study. They used strains of gonorrhea 
which already have both active and inactive AZD0914 genomes. This was then used as a 
comparison for antimicrobial effectiveness.  
Genetics 
From the studies it is been found that N. gonorrhoeae has an extraordinary 
capacity to alter its genetic material (Golparian & Shafer 2014). Other species within the 
Neisseria genera share this ability (Golparian & Shafer 2014). Gonorrhea has the ability 
to transfer partial or whole genes during its entire life cycle. This means it can effectively 
change its genome through all types of mutations. It incorporates these mechanisms to 
quickly adapt and survive to changing environmental factors. This rapid evolutionary 
ability has allowed gonorrhea to survive in the most hostile environments of the human 
body such as the mucosa of the urinary tract or the vaginal cavity (Golparian & Shafer 
2014). Its abilities to rapidly mutate through genomic exchange indicates it has either 
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mutated, acquired, or developed all of its known physiological mechanisms for 
antimicrobial resistance. The findings in the literary works elucidate that gonorrhea’s 
antimicrobial resistance is imbedded in its chromosomes. It has been directly identified as 
chromosomes blaTEM gene and the tetM gene (Unemo & Shafer, 2014). It is these genes 
that have resulted in a high level of resistance for penicillin and tetracycline. Within the 
bacterial cell this drug-resistant genetic material is found in the plasmid. There is 
significance in where this critical information is housed in the cell. It is being and has 
been well documented and known that bacteria as well as all cells participate in 
molecular level cellular communication (Black & Black, 2016). It is not been known 
until recently what the is the significance of this ability. In the works of Unemo and 
Shafer (2014) they have reported that gonococcal antibiotic resistance can be passed 
through gene transfer. Bacteria conduct genomic transfer by interlocking to each other’s 
plasmids. Thus, the storage of critical genomic information within the plasmid means a 
more rapid transfer of the genomic code. The other significance of this molecular level 
communication is that if there is at minimum of one bacterium within the genus Neisseria 
caring antibiotic resistant genetic mutations, that bacterium can then pass that specific 
genetic code onto another Neisseria sp. including the gonorrhea bacterium. There is two-
fold significant concern with this behavior. First, if someone is carrying any drug-
resistant Neisseria sp., even those that are commensal; if that individual is exposed to a 
drug susceptible gonorrhea strain, once that drug susceptible strain exchanges genomic 
information in situ it becomes instantaneously drug resistant. The other concern, to put it 
simply, if you have just one bacterium per antimicrobial drug that carries resistance, each 
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of those bacteria can then transfer those antimicrobial drug genetic codes to a common 
colony; developing a strain of “super bugs” that are resistant to all antimicrobial drugs. 
 There is thought that gonorrhea may soon be classified as a genetic a reservoir of 
the antimicrobial resistant genes (Golparian & Shafer 2014; Unemo & Shafer, 2014). It 
has been found that there is an entire group of commensal bacteria in the Neisseria 
genera that frequently inhabit human anatomical sites including but not limited to the 
pharynx (Neisseria spp.) (Unemo, 2015). These areas are often exposed to antimicrobial 
medication for the treatment of other infections. Because Neisseria has such an affinity 
for survival, these commensal bacteria may also be creating drug-resistant variants to 
antimicrobial medications that have not yet been tested or evaluated for curing 
gonococcal infections (Unemo, 2015). Studies also indicate Neisseria spp. through 
transformation (transfer of genetic material from one bacterium to another) pass these 
drug-resistant genes to other species in their same genera (Black & Black, 2016). It is 
believed that this horizontal gene transfer is what may have plausibly played a pivotal 
role in the transfer of and spread of the mosaic penA allele creating cephalosporin 
resistance (Baym, Stone, & Kishony, 2016). The transfer and uptake of DNA between 
species within the same genera is quite rapid (Golparian & Shafer 2014). These 
antimicrobial resistant gonococcal strains spread rapidly and quickly within their 
geographical region and eventually establish an international presence (Unemo & Shafer, 
2014). There has been cause for concern but has yet to be proven that gonococcal strains 
could share antimicrobial resistant genes with other non-like genera and species 
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(Golparian & Shafer 2014). Currently there is no proven cause for concern, but it may 
become problematic in the future.  
Antimicrobial Defense 
 Antimicrobials medications attack bacteria by binding to specific targets that are 
critical for the vitality and function of the bacterium (Unemo & Shafer, 2014). Through 
this molecular binding the bacterium’s functions are interrupted, and death occurs 
(Unemo & Shafer, 2014). The bacterium overcomes this issue is by altering its binding 
sites through genomic mutation (Unemo & Shafer, 2014). This renders the antimicrobial 
chemical ineffective. Cleverly the changing of the antimicrobial binding side is only 
enough to stop the antimicrobial chemical but not enough to interfere with the ongoing 
functions of the bacterium cell. This does not affect or lower the overall physiological 
fitness of the bacterium (Unemo & Shafer, 2014). It has also been found that in some 
variants of N. gonorrhoeae, it instead enhanced the biological fitness of the bacterium 
(Unemo & Shafer, 2014). Interpretively, not only have antimicrobial medications been 
rendered ineffective, but they have also strengthened the bacteria.  
Fitness 
 There is evidence in the research that in the absence of antimicrobial medications, 
gonorrhoeae may become less fit. This indicates that the resilience and fitness of 
gonorrhea coincides with environmental pressures (Golparian & Shafer 2014). The 
greater the environmental pressure, the greater its fitness. Gonorrhea has also derived 
mechanisms of self-preservation regardless of the presence of antimicrobial chemicals. 
During the infection, the human body is bombarding the bacteria with antibodies and 
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other antimicrobial attacks (Black & Black, 2016). The bacterium will mutate to 
strengthen and protect itself from the immune system (Unemo, del Rio & Shafer, 2016). 
As part of its defensive strategy, gonorrhea will incorporate host-derived compounds to 
protect itself from antimicrobial attacks (Unemo et al., 2016). One of the best examples 
of this, is gonorrhea using polyamines that are found in the male genitalia tract as a 
coating for itself (Unemo et al., 2016). Thus, the bacteria will camouflage itself from the 
host’s immune system (Unemo et al., 2016). The coating also inhibits complement-
mediated killing from the hosts immune system (Unemo et al., 2016). Gonococci have 
been documented in laboratory conditions creating biofilms that help make it resistant to 
antimicrobials (Unemo et al., 2016). This only emphasizes that gonorrhea is an extremely 
resilient, highly fit, bacteria and why it has survived thousands of years.  
History and Geography of Florida 
 Florida Historical Origins 
 Florida was once Spanish owned. Juan Ponce de Leon was the first to lead a 
European expedition to Florida in 1513 (Arnade, 1961; Greenberger, 2005; Worth, 2014). 
It is believed and has been historically documented, that he made landfall just south of 
Cape Canaveral Florida (Worth, 2014). He originally named the state “Pascua Florida” or 
feast of flowers as a tribute to Spain’s Easter celebration (Worth, 2014). Over time, 
Spanish influenced increased with other explores such as Lucas Vázquez de Ayllón in 
1526, Pánfilo de Narváez, in 1527, Hernado De Soto in 1539, and Tristán de Luna y 
Arellano in 1559 all bringing European diseases and decimating upwards of 90% of the 
native population (Moore, 2013).  
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In 1565 the Spanish created the first permanent European settlement in North 
America in Saint Augustine Florida (Moore, 2013; Worth, 2014). To this day Saint 
Augustine is a thriving successful city. In 1562 the French attempted to explore and settle 
parts of Florida under Jean Ribault, bringing French culture into the mix (Broussard, 
2003). By 1581 African slaves were being introduced into Florida through the city of St. 
Augustine (Johnson, 2002). In 1586 the British began to see value in Florida and Sir 
Francis Drake attacked and burned down Saint Augustine in an attempt to establish an 
English settlement (Keeler, 2017). The Spanish continued for the next hundred years to 
colonize Florida as a Spanish territory and spreading religion by establishing over 100 
missions throughout the northern region of Florida up and into Georgia (Moore, 2013; 
Worth, 2014). In 1702 the British again made a move to out the Spanish from Florida by 
destroying all the Spanish missions (Childers, 2004). Again in 1740 the English General 
James Oglethorpe invades Saint Augustine (Childers, 2004). By 1763 England is now the 
ruling faction over Florida (Halbirt, 2004). But this role did not last long and the Spanish 
in 1783 took back Florida (Childers, 2004). During this time, the United States was 
establishing itself as a strength to be reckoned with.  
At one time Florida’s panhandle stretched from the Savanna River to the 
Mississippi. Over time the boundaries were pushed back due to battles and skirmishes 
until it is reached its present boundaries (Cusick, 2007). Finally, in 1819 the Spanish 
realized they could no longer hold Florida and relinquished it to the United States by 
leaving the state (Cusick, 2007). Thus, handing control over to the United States. Once 
the United States gained control of Florida, many southern Americans began to migrate 
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into its northern sections. It was sometime before the southern part of Florida became 
populated. Florida was approved on March 3, 1845 to enter the union. It was officially 
designated as the 27th state (Weitz & Sheppard, 2018). Not long after statehood, Florida 
in 1851, established two colleges which to this date are still some of the most recognized 
institutions in the country. They are the now Florida state University (formerly West 
Florida Seminary) and the University of Florida (formally East Florida Seminary) (Weitz 
& Sheppard, 2018). Although Florida was the only southern state who avoided its capital, 
Tallahassee, from being captured by the Union, the suicidal death of Governor John 
Milton force Florida to become Federally controlled and no longer a Confederate state in 
1865 (Weitz & Sheppard, 2018).  
Florida Demographical History 
From a demographic standpoint one can say that the northern part of Florida has a 
southern personality whereas the southern part of Florida has a northern personality. 
Florida could be considered a patchwork of cultures. The early Spanish around 1500 to 
1600 settled primarily in the panhandle and along the northern coast (Arnade, 1961; 
Greenberger, 2005; Worth, 2014). The central part of Florida around 1800 was settled by 
a collage of individuals such as native Americans, farmers, escaped slaves, and ranchers 
who to this day are commonly referred to as crackers (Otto, 1987). The farming industry 
became an important cultural draw to the State. To meet the growing demands for 
farmland, in 1901 the Everglade drainage projects began (Light & Dineen, 1994). 
Besides dramatically changing the landscape negatively from an environmental 
standpoint, it dried a significant number of wetlands to the south (Light & Dineen, 1994). 
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This then created more inhabitable land for both the farmer and entrepreneur. This new 
organically rich and now inhabitable land was an attraction for more people to move to 
the southern parts of the State.  
Starting in the mid-1900s until present Southern Florida has seen an influx of the 
modern pioneer. Americans from all over the country, different states, and different 
cultures have established themselves in many parts of the southern areas of Florida. The 
primary demographics of south Florida consisted of mixed Europeans moving down from 
the northern States. Then in 1980 there was a dramatic cultural shift to the southernmost 
part of Florida (Hause, 2016). In an effort to aid political refugees from communist Cuba, 
the Mariel boatlift occurred. This caused a major influx of Latin culture into the 
southernmost part of Florida (Alberts, 2016). It created a dramatic change in the 
demographics and behaviors. With the Cuban influx and primarily Spanish speaking 
population, the southern part of Florida, principally Miami-Dade, began attracting more 
Spanish speaking individuals from other nations (Alberts, 2016). It became an area where 
English speaking was not needed to thrive. This created a very unique demographic 
population in the Miami-Dade area with cultural beliefs that are very different than the 
rest of the state (Alberts, 2016). The movement to Florida in the 1900’s was exponential. 
It is estimated that since 1950 the population of Florida has grown over 700% (U.S. 
Census, 2018).  
Florida Geography 
Florida is the Southernmost state in the continental United States. It is located 
along the eastern seaboard and is a peninsula (Cooke, 1945; Sellards, 1919). It is 
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surrounded by the Atlantic Ocean to the East and the Gulf of Mexico to the West. It is 
58,560 square miles and it is 447 miles long by 361 miles wide (Cooke, 1945; Sellards, 
1919). The highest natural point is only 345 feet above sea level. It hosts 1,197 statute 
miles of coastline, 663 miles of beaches, over 7,700 lakes, and over 4,500 islands (Cooke, 
1945; Sellards, 1919). The largest lake in the state which is also the drinking water 
reserve for Central Florida, Lake Okeechobee is 700 square miles connected to the 
longest river in the State, the St. Johns River as 273 miles in length (Corrales, Naja, Bhat, 
& Miralles-Wilhelm, 2017).  
There are three primary geographical land formations in the state which define in 
part how individuals settled within Florida attracted by areas to settle for farming, 
mining, and other commercial interests (Odum, 2018). The South Atlantic Coastal Plain 
(SACP) includes northeastern Florida's coast. It extends from Florida's northern border 
on the Atlantic seaboard, southward about 150 miles to the area around Cape Canaveral. 
It then turns and runs northwesterly and inland toward the New York-Alabama 
Lineament, the suspected slip-strike fault on the eastern edge of the Mississippi Valley. 
The SACP features barrier islands with both sand dunes and maritime forests of southern 
sugar maple and white ash. These areas are backed by salt marshes. The bays support 
forested wetlands, such as mangroves and mangrove swamps (Ramos-Fregonezi, et al, 
2015). 
The Atlantic Coastal Plain (ACP) is divided by the South Atlantic Coastal Plain. 
The ACP extends from the south shore of Long Island, New York, all the way to the 
southern tip of Florida in the Dry Tortugas which are a chain of five islands west of the 
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Florida Keys. The plain then runs northward along the state's Gulf coast to Apalachicola, 
where it is bounded by the East Gulf Coastal Plain. The ACP lacks the hilly upland areas 
that characterize the SACP, but it includes the beaches found on both coasts of the 
peninsula and the Everglades. The Everglades is also well known as the "river of grass" 
due to its high content of wetland grasses that eventually lead out to seagrasses in the 
saltier marshes. The Everglades constitutes much of the southern tip of the state (Rovere 
et al., 2015).  
The East Gulf Coast Plain (EGCP) is another coastal plain with the same general 
geographic characteristics as the SACP and the ACP. Unlike the SACP and the ACP it 
includes much of the coastal areas of the Gulf of Mexico as far north as Panama City. 
The geology is very unique on side of the state and the EGCP. Most of the coastal side of 
the EGCP hosts white-sand beaches from as far south as Tampa Bay to the panhandle of 
Florida. This is due to erosion from the high calcium carbonates found sediments of the 
area (Sluijs et al., 2014).  
Florida Statewide Demographics 
There is no doubt that Florida has experienced historical immigration and 
emigration of many different ethnic and cultural groups over the centuries. From the 
earliest of settlers to the present, Florida continues to be an ever-expanding melting pot of 
genetic diversity. Florida hosts approximately 20.984 million residents (U.S. Census, 
2018). The key demographics of the state breaks down and are estimated as the 
following: 54.9% of the population is White alone, 16.8% Black alone, and 24.9% 
Hispanic alone; 51.1% female gender with 54.3% of the total female population being 
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employed; 53.1% of the population is between the ages of 18 and 65; over 80% of the 
population is American born (U.S. Census, 2018); and the median income for the state is 
$48,900 per year, with 64.8% of the houses owner occupied (U.S. Census, 2018). Only 
14.7% of the total population is living in poverty. The population per square mile is 350.6 
persons. It is important to realize that these are estimates. The last census was conducted 
in 2010 and the ethnic demographics were the following: 57.9% White alone, 15.2% 
Black alone, 0.3% Native alone, 2.4% Asian alone, 0.1% native Hawaiian alone, 1.5% 
two races, 22.5% Latino or Hispanic, and 0.3% other race (U.S. Census, 2018). Based on 
that same census the total population at the time was 18,801,310 persons and is currently 
estimated at 20,984,400 (U.S. Census, 2018).  
Florida Regional Demographics 
Florida’s demographics are not evenly distributed across the state for some of the 
ethnic groups. It is concentrated into the different regions primarily influenced by 
historical events and immigration and migration pattern. Florida itself is divided into 67 
counties (U.S. Census, 2018). For this study Florida was divided into eight regions 
(Figure 1). The Northwest which includes Escambia, Santa Rosas, Okaloosa, Walton, 
Holmes, Washington, Jackson, Bay, Calhoun, Gulf, Liberty, and Franklin counites. The 
North Central hosts Gadsden, Leon, Wakulla, Jefferson, Madison, Taylor, Lafayette, 
Hamilton, Suwanee, Dixie, Columbia, Gilchrist, Union, Bradford, Alachua, Levy, 
Marion, and Citrus counties. The Northeast consists of Nassau, Baker, Duval, Clay, 
Putnam, and St. Johns county. The East Central includes Sumter, Lake, Flagler, Volusia, 
Seminole, Orange, Osceola, and Brevard counties. West Central has Hernando, Pasco, 
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Pinellas, Hillsborough, Polk, Manatee, Sarasota, Hardee, Desoto, and Highlands. The 
Southwest hosts Charlotte, Glades, Lee, Hendry, and Collier. The Southeast is home to 
Indian River, Okeechobee, Saint Lucie, Martin, and Palm Beach. The Southern hosted. 
Broward, Monroe, and Miami-Dade. When evaluating Florida at a region by region level 
it has vast differences in the demographic distribution in relationship to the state as a 
whole. 
Figure 1  
 
The Eight Regions of Florida 
 
Note. Depicts the eight regions of Florida and counties within. Image adopted and 
modified from 
https://www.flcenterfornursing.org/RegionalData/FCNRegionalWorkforceReports.aspx. 
and the FDOH http://www.flhealthsource.gov/bgs-providers 2018. Florida Center for 
Nursing and the FDOH.  
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Using the known census data and not estimates, the Northwest region has the following 
demographics: 77.7% White alone, 13.6% Black alone, 0.7% Native alone, 1.1% Asian 
alone, 0.1% native Hawaiian alone, 2.1% two races, 4.6% Latino or Hispanic, and 0.1% 
other race (Figure 2). Total population was 1,039,053 persons and 5.5% of the total 
population of the state (U.S. Census, 2018). 
Figure 2  
 
Demographic Distribution of the Northwest Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the Northwest region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The North Central region has the following demographics: 70.7% White alone, 20.3% 
Black alone, 0.4% Native alone, 0.8% Asian alone, 0.0% native Hawaiian alone, 1.3% 
two races, 6.4% Latino or Hispanic, and 0.1% other race (Figure 3) (U.S. Census, 2018). 
Total population was 1,504,399 persons and 8% of the total population of the state (U. S. 
Census, 2018).  
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Figure 3  
 
Demographic Distribution of the North Central Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the North Central region of Florida. 
The data were provided by the U.S. Census Bureau (2018).  
The Northeast region has the following demographics: 77.7% White alone, 13.3% Black 
alone, 0.3% Native alone, 1.8% Asian alone, 0.1% native Hawaiian alone, 1.6% two 
races, 5.8% Latino or Hispanic, and 0.1% other race (Figure 4) (U. S. Census, 2018). 
Total population was 1,419,960 persons and 7.5% of the total population of the state 








Figure 4  
Demographic Distribution of the Northeast Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the Northeast region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The East Central region has the following demographics: 67.4% White alone, 11.1% 
Black alone, 0.3% Native alone, 2.4% Asian alone, 0.1% native Hawaiian alone, 1.6% 
two races, 16.9% Latino or Hispanic, and 0.3% other race (Figure 5) (U.S. Census, 2018). 
Total population was 3,361,496 persons and 17.9% of the total population of the state 












Figure 5  
 
Demographic Distribution of the East Central Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the East Central region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The West Central region has the following demographics: 69.0% White alone, 9.0% 
Black alone, 0.3% Native alone, 1.7% Asian alone, 0.0% native Hawaiian alone, 1.3% 
two races, 18.6% Latino or Hispanic, and 0.1% other race (Figure 6) (U.S. Census, 2018). 
Total population was 4,248,998 persons and 22.6% of the total population of the state 







Figure 6  
 
Demographic Distribution of the West Central Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the West Central region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The Southwest region has the following demographics: 61.5% White alone, 13.3% Black 
alone, 1.2% Native alone, 1.2% Asian alone, 0.0% native Hawaiian alone, 1.1% two 
races, 21.5% Latino or Hispanic, and 0.1% other race (Figure 7) (U.S. Census, 2018). 
Total population was 809,009 persons and 4.3% of the total population of the state (U.S. 









Figure 7  
 
Demographic Distribution of the Southwest Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the Southwest region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The Southeast region has the following demographics: 68.9% White alone, 11.4% Black 
alone, 0.3% Native alone, 1.4% Asian alone, 0.0% native Hawaiian alone, 1.2% two 
races, 16.6% Latino or Hispanic, and 2.1% other race (Figure 8) (U.S. Census, 2018). 
Total population was 1,922,265 persons and 10.2% of the total population of the state 








Figure 8  
 
Demographic Distribution of the Southeast Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the Southeast region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
The Southern region has the following demographics: 43.38% White alone, 16.01% 
Black alone, 0.2% Native alone, 1.9% Asian alone, 0.05% native Hawaiian alone, 1.26% 
two races, 36.91% Latino or Hispanic, and 0.28% other race (Figure 9) (U.S. Census, 
2018). Total population was 4,317,591 persons and 23% of the total population of the 










Figure 9  
 
Demographic Distribution of the Southern Region Based on U.S. Census Data 
 
Note. Pie chart of the demographic distribution of the Southern region of Florida. The 
data were provided by the U.S. Census Bureau (2018).  
From the census data there is a significant trend that shows an inclination towards ethnic 
diversity with significant increases in Latino populations and decrease in White 
populations towards the southern end of the state with less ethnic diversity and decrease 
in Latino populations towards the northern end of the state (Figure 10). Black, Native 








Figure 10  
 

















Each of the ethnic groups have ethnic sub-groups within them increasing the cultural 
diversity within the census. For example, those who identify as Latino may have cultural 
origins from Spain, Brazil, Puerto Rico, Colombia, Peru, Cuba, Mexico and the like. 
Each of these ethnic subgroups has its own unique culture and heritage (Molina, Phillips, 
& Sidanius, 2015). Their approach to topics such as family, health habits, sexual 
behaviors, and sexual knowledge can vary dramatically (Jackson, Karasek, Dehlendorf, 
& Foster, 2016). Florida in the near future, will have to delve a bit deeper with the 
approach on sexual health in relationship to sexually transmitted diseases (STD) as it 
pertains to the different populations per region across the State.  
Gonorrhea in Florida 
 Florida has seen an increasing trend in gonorrhea infections. In 2017 there were 
31,710 cases with a rate of 154.3 per 100,000 population (FL Health CHARTS, 2018). 
Six years earlier in 2011 there were 19,704 cases with a rate of 104.0 per 100,000 
population. Over this six-year time frame Florida has seen a 60.9% increase in gonorrhea 
infections and a 48.4% increase in rates (FL Health CHARTS, 2018). Nationally in 2011 
there were 321,849 reported cases of gonorrhea at a rate of 103.3 per 100,000 population 
and in 2017 there were 555,608 cases at a rate of 171.9 per 100,000 population. Over the 
six-year term the nation saw a 72.6% increase in cases and a 66.4% rate increase 
(Braxton et al., 2018). Although Florida is below the national trends none the less this is 
still a significant increase overall. In this same time frame, as a comparison (Figure 11), 
in Florida infectious syphilis had 1,257 cases in 2011 at a rate of 6.6 per 100,000 
population and 2,391 cases in 2017 at a rate of 11.6 per 100,00 population (FL Health 
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CHARTS, 2018). This is a 90.2% increase in syphilis cases and a 75.8% increase in rates 
in the six-year period. Nationally there were 46,040 cases of infectious syphilis in 2011 at 
a rate of 14.8 per 100,000 population and in 2017 101,567 cases at a rate of 31.4 per 
100,000 population (Braxton et al., 2018). There was a 120.6% increase in cases 
nationally and 112.2% increase in rate over the six-year period. Florida cases of 
Chlamydia in 2011 were at 76,050 at a rate of 407.3 per 100,000 and in 2017 there were 
100,057 cases at a rate of 486.8 per 100,000 (FL Health CHARTS, 2018). This is a 
31.6% increase in cases and a 19.5% increase in rates in the six-year time frame. 
Nationally in 2011 there were 1,412,791 cases of Chlamydia at a rate of 453.4 per 
100,000 population and in 2017 there were 1,708,569 at a rate of 528.8 per 100,000 
population (Braxton et al., 2018). Over the six-year period nationally there was a 20.9% 
increase in Chlamydia cases with a 16.6% increase in the rate.  
Overall, Florida has been below the national levels for bacterial STD infection 
rates, but it has still seen a significant increase in cases and rates (Figure 12). The 
increases are large percentage jumps, which is disconcerting. In regard to gonorrhea this 
is an alarming trend. This trend can lead to the rapid evolution of completely drug-
resistant gonorrhea strains. There is also been a greater increase of male infections vs. 
female infections in the same six-year period. Gonorrhea infections in males has 
increased 95.1% whereas in females the increase has only been 27.9% (FL Health 
CHARTS, 2018). The cause of this increase dramatically slanting towards the male 




Figure 11  
 
Comparison of the 2017 Bacterial STI Rates per 100,000 Population: Florida VS. USA 
 
Note. Bar graph comparing Florida to the USA regarding bacterial STI rates. The data 





















Figure 12  
 
Graph of the Increase in Gonorrhea Rates in Florida Between 2011 to 2017 
 
Note. Line graph demonstrating an increasing trend in gonorrhea rates in Florida between 
2011 to 2017. The data were provided by the Florida Department of Health (2018).  
 Florida states that any sexually active person can contract gonorrhea through 
unprotected sex vaginally, anally, or orally (CDC, 2017). This is a generalized blanket 
statement that protects the state from any liabilities of not protecting the public. Although 
it is true that anyone can contract a gonorrhea infection, the state focuses primarily on 
sexually active men who are gay, bisexual, or have sex with men. The state also states 
that women who are sexually active under the age of 25 years or older women with 
certain risk factors such as multiple sex partners are also at risk (FL Health CHARTS, 
2018). There is no focus on those who may be at risk for drug-resistant variants.  
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Drug-Resistant Variants and the state of Florida 
 The CDC monitors drug resistance through the Gonococcal Isolate Surveillance 
Program (GISP) (Kirkcaldy, 2016). As of 2016 there are 27 participating clinical sites 
that collect gonorrhea samples to be sent off for drug-resistant analysis (Kirkcaldy, 2016). 
The clinical sites cater to the local demographics of the area. After 2013 there are no 
more participating clinical sites in Florida (Kirkcaldy, 2016). Prior to 2013 there were 
two participating clinical sites, and they were Miami-Dade from 1998 to 2013 and West 
Palm Beach from 1987 to 1998 (Kirkcaldy, 2016). There is no current data for any area 
of Florida. The lack of participation of Florida in the monitoring of drug resistance is 
problematic. This means that Florida will have to rely on data from other monitoring 
locations to develop statewide interventions. The other option, is to utilize the mode of 
treatment as a determinate of who would be most likely to contract a drug-resistant 
variant and build a predictive model from mode of treatment in conjunction with most 
dominate group of infected individuals. Considering Florida is demographically diverse, 
the monitoring needs to come from within and not be based on other areas of the United 
States. Additionally, full drug resistance has occurred in March 2018. After 2013 and 
later, has been some of the most critically important years for the evolution of gonorrhea 
drug resistance (CDC, 2017). 
Summary 
It was aforementioned that there are two core approaches for studying Neisseria 
gonorrhoeae, its increasing antimicrobial resistance, and the way it is spreading through 
the population by human behavior. The surveillance approach is necessary to maintain 
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and gain the understandings of the origin of the infection; infection rates for past, present, 
and future; the location of the infections for past, present, and future; affected groups; and 
different drug-resistant variants. The findings of those research teams who conducted 
surveillance, all shared a commonality. The common findings in the simplest terms, is 
that cases of gonococcal infections are increasing. They are increasing at the local, 
national, and worldwide levels. Those findings also indicate that gonococcal infections 
are not limited to the three simplified groups of; men who have sex with men, workers in 
the sex trade, and pregnant women as identified by the WHO and the CDC. Gonococcal 
infections are spreading to other groups. The researchers also share findings that indicate 
a correlation between a lack of public education and the perpetuation of an increase in 
antimicrobial drug resistance cases.  
  From the conflicting literary works, it is possible that the CDC could be 
unintentionally misrepresenting the at-risk groups. The literature does clearly state that 
those who have gonococcal infections are at a greater risk for contracting HIV. This 
could possibly be the reason why the CDC has focused on men having sex with men as 
one of the at-risk categories for gonococcal infections. The second at-risk group that the 
CDC discusses are those working in the sex industry. One needs to take into 
consideration that prostitution is illegal in most of the United States. Because of this there 
are no routine health inspections nor sexual health safety training for these individuals. 
The lack of education and medical inspections only aides in the spread of the gonococcal 
bacterium. The final group targeted by the CDC are pregnant women. The CDC may be 
targeting this group because women can be asymptomatic, and that bacterium can easily 
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affect the fetus and a newborn child. The governmental representation of at-risk groups, 
in this instance appears to be contradictory to some of the findings in the literature. 
Unfortunately, the current presented information maybe misdirecting the public.  
 There is another aspect regarding the race to stay ahead of drug-resistant 
gonorrhea. Science needs to evaluate affective approaches that can control or kill the 
bacterium at the molecular level. Gonorrhea just like any other single celled organism has 
the same basic structures. Gonorrhea is diplococcus meaning there always two cells 
grouped together and the cells are round in shape. These cells are surrounded by gram 
negative phospholipid membrane. It is this phospholipid membrane that plays a role in 
drug resistance. Imbedded within the membrane are a series of trans-membrane proteins. 
These proteins control all the materials entering and exiting the cell. Often it is found in 
nature there may be some variances of a species that are naturally resistant. Through 
artificial directional selection those resistant strains survive and are the only strains left to 
reproduce. If a better understanding of the molecular pathways can be identified, a better 
drug delivery at the molecular level can be incorporated.  
Antimicrobial resistant gonorrhea is a rarely publicly discussed sexually 
transmitted infection. This lack of discussion is ironic considering that gonorrhea is the 
second most reported sexually transmitted disease in the United States as well as being 
extremely resilient with amazing adaptability to almost any environment. The aptitude is 
for it to adapt to almost any environment and quickly embed the adaptions within its 
genomic code. It also has the ability to receive and donate different segments of its and 
other’s genomic code. This is conducted between other species within the genera as well 
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as to its own species. The bacterium does not need to go through asexual reproduction 
and hope a mutation occurs, it can just pass segments of its code through the method of 
conjugation and transference. This rapid transfer gives gonorrhea the ability to gain 
antimicrobial resistance almost instantaneously provided the correct genomic code exists. 
 Gonorrhea is becoming a “super bug.” The CDC and WHO have stated that 
gonorrhea may soon become completely drug resistant. If this happens, the United States 
and the world will be facing the next great epidemic. In March 2018 with the emergence 
of the first case of completely drug-resistant gonorrhea may be an indication that this 
epidemic is just around the corner. It is unknown if any new antimicrobials that can fight 
gonorrhea will be entering the market in the very near future. As of now there is only one 
effective treatment and it is believed that there are only a few years left before becomes 
that treatment becomes ineffective. The first instance of this was documented in January 
of 2019 where two unrelated women who contracted gonorrhea were unable to be 
affectively treated with the current recommended treatment protocol. One thing is for 
certain, there are other at-risk groups beyond men having sex with men, individuals who 
work in the sex trade, and pregnant women. Review of the literature indicates that there is 
a significant lack of research at the regional level. These at-risk groups need to be 





Chapter 3: Research Method 
Introduction  
The purpose of the study was to identify which category or categories of 
individuals in each Florida region were most likely to contract drug-resistant strains of N. 
gonorrhoeae. The study used data collected from 2007 to 2018. From this data, infectious 
trends were evaluated and determined. Due to the nature of the bacterium and its ability 
to share genomes, identification of the at-risk groups can be determined based on use of 
last-line-of-antibiotic-defense.  
This quantitative study used secondary data provided by the FDOH Bureau of 
Communicable Diseases. Since gonorrhea infections are mandated as a reportable 
communicable disease, the FDOH independently and continually collects gonococcal 
infection data; the Federal government collects similar data through the Gonococcal 
Isolate Surveillance Project (GISP) (CDC, 2012). The advantage of using secondary data 
is that that the information has already been vetted and passed governmental IRB 
protocols. The use of secondary data significantly lowers the research costs and often 
provides large scale data.  
Research Design and Rationale 
The approach to this study determined what variables were useful from the 
existing secondary data to identify those who are at risk for contracting drug-resistant 
strains of gonococcal bacteria. The outcome is already known. What was not known was 
the variables that caused this outcome. The methodology (discussed later in this chapter) 
was designed to discover the causes of the outcome. Since the demographics in Florida 
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vary regionally, it was assumed that the risk factors (significant variables) in each region 
would also vary. In order to determine which variables were significant, a series of 
questions were answered. From those answers, predictive, regionally focused models 
were constructed. This information can be used to develop applicable and more 
successful preventative interventions. The data were analyzed swiftly. Since this study 
used secondary data, the data points already existed and thus it was completed within a 
short timeframe.  
Methodology 
Florida is divided into 67 counties (U.S. Census, 2017). These counties were 
grouped into eight regions for this study. Grouping the counties into regions provided 
enough data points to be statistically significant. This study utilized existing secondary 
data provided by the state of Florida. Data from the Gonococcal Isolate Surveillance 
System (GISP) from the Federal government was going to be used as a comparison for 
drug-resistant strains. But the GISP data were limited and could not be effectively used as 
a comparison, because Florida closed its only collection site for monitoring drug-resistant 
strains in 2013, and thus was no longer participating in GISP drug-resistant data 
collection.  
Florida uses two systems to house its data. The first is CHARTS, which is open to 
the public with limited accessible data points. The second is STARS, which requires 
permission from the state to access but has a much greater source of data points. 
CHARTS allowed for a general understanding of the need for this study. STARS is a 
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more in-depth data source, which provided a more focused study. Each system has its 
benefits but also has its limitations. These will be discussed later in this chapter.  
CHARTS 
The Florida (CHARTS) system. Within this system there is limited information 
available but there is enough information to use for generalizations. This data set is 
directly available to the public with interactive capabilities. Regarding gonorrhea 
infections, CHARTS provides sex, race, and age for each county and statewide in an 
interactive format. It lacks the necessary detailed information such as mode of treatment, 
religion, sexual behavior, drug use, and the like. It also lacks the raw data for additional 
statistical manipulation, and it limits the user to only building graphs, charts, and rates.  
STARS 
Florida STARS is a database of all reportable diseases and the associated 
demographics with the disease. Gonorrhea is considered a reportable disease and is in the 
data base. STARS host the raw gonorrhea data as well as over 100 different data points 
regarding gonorrhea infections in the State. The system is highly restricted and in order to 
access the information one must either be an employee of the Florida Department of 
Health or be granted permission by the FDOH through a contractual agreement. In prior 
email and phone discussion with representatives of the FDOH it was confirmed that 
access to this data base was available provided a data use agreement is signed, a proposal 
is submitted including Walden’s IRB approval, and FDOH’s IRB equivalent approves. 
The data was provided and as part of the agreement, the FDOH requires all data 




The Gonococcal Isolate Surveillance System (GISP) is the federal system that has 
national information regarding gonococcal infections. The GISP has data regarding only 
one Florida county; of which that data is directly related to drug resistance. Regrettably 
the collection site was closed in 2013 so there is no current data regarding drug resistance 
in Florida. GISP also has data from 27 other national clinics that have been testing for 
drug resistance which could be used for comparison. Unfortunately, GISP clinical sites 
do not test everyone for drug-resistant variants but only test those that have been deemed 
to fall within the at-risk categorization. This limited testing may be driven by cost, but 
also limits the chances of discovery in other potentially at-risk groups. The GISP data 
could not be used for this study.  
Secondary Data from the State of Florida 
Florida has in its data base 20 years of gonococcal surveillance. This study only 
used the last 12 years (2007 to 2018) of data due to what was available and complete 
from the FDOH. Considering there has been an upward trend in infections in the last 5 
years (Figure 12) as well as a strong evolution towards drug resistance in the last decade, 
this provided a historical base to build from. Based on the GPower calculation the 
minimum number of data points required for significance for a two tailed multiple 
logistic regression calculation at a p<0.05 requires a minimum sample size of 89, for a 
comparison among the means; 210, and F test; 279. Using 12 years of data provided 
enough power for statistical significance. It is financially unfeasible to conduct a one-
year study of this magnitude, let alone a 12-year study. Due to the significant cost and 
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IRB concerns, the data provided by the state was cost effective and has already been 
vetted through the State’s equivalent of an IRB for the data collection. The data usage 
required more than one IRB evaluation.  
 Regional Distribution 
Florida itself is divided into 67 counties (U.S. Census, 2017). A Power calculation 
was conducted. Based on that calculation, individual counties did not hold enough data 
points for statistical significance. In order to obtain statistical significance base on the 
GPower calculation, the counties were grouped into the eight regions (Figure 1) and the 
last eleven years of data were compiled for each of those regions. The Northwest region 
included Escambia, Santa Rosas, Okaloosa, Walton, Holmes, Washington, Jackson, Bay, 
Calhoun, Gulf, Liberty, and Franklin counites. The North Central region hosted Gadsden, 
Leon, Wakulla, Jefferson, Madison, Taylor, Lafayette, Hamilton, Suwanee, Dixie, 
Columbia, Gilchrist, Union, Bradford, Alachua, Levy, Marion, and Citrus counties. The 
Northeast region consisted of Nassau, Baker, Duval, Clay, Putnam, and St. Johns county. 
The East Central region included Sumter, Lake, Flagler, Volusia, Seminole, Orange, 
Osceola, and Brevard counties. West Central region has Hernando, Pasco, Pinellas, 
Hillsborough, Polk, Manatee, Sarasota, Hardee, Desoto, and Highlands counties. The 
Southwest region hosted Charlotte, Glades, Lee, Hendry, and Collier. The Southeast 
region included Indian River, Okeechobee, Saint Lucie, Martin, and Palm Beach 
counties. The Southern region has Broward, Monroe, and Miami-Dade counties.  
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 Data Analysis 
  This quantitative study utilized secondary data provided by the FDOH. The 
provided data contained over 37 million data points, 82 risk factors, and 16 demographic 
factors. The majority of the data provided was categorical data and was listed by county. 
When applicable, data that was not categorical such as age was converted into categorical 
data by grouping. For instance, ages were grouped into age ranges. Within the categorical 
data the responses were coded so that IBM SPSS could conduct the statistical 
calculations (see Table 1). Each region was compared to each other region as well as 
being compared to Florida as a whole. The extremely sensitive data, such as addresses, 
was request but denied. Had the data been provided by the FDOH then spatial mapping 
would have been incorporated using ArcView Geographical Information Systems (GIS).  
The data analysis was conducted in a series of methodical stages so as to 
systematically narrow down to the identifiable at-risk and demographic groups per 
region. The data were assessed for missing data points. Any missing data points were 
evaluated individually for inclusion or exclusion in the study. Once the data were 
evaluated for completeness, the data were then evaluated to identify statistically 
significant risk factors in each region and the state overall. Risk and demographic factors 
that were not determined complete or significant were removed from further analysis. 
The FDOH provided the last-line-of-antibiotic-defense data, thus a final analysis was 
conducted comparing the methods of treatment.  
There were 33 independent variables consisting of demographic data and risk 
factor data that was identified as usable (see Table 1). After the variables were identified, 
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they were evaluated for significance at state and regional levels using Chi-square, cross-
tabulation, and multiple logistic regression calculations as applicable. All 33 independent 
variables were used at both the state and regional levels. Because there was only one 
currently recommended prescribed treatment that is considered the last-line-of-antibiotic-
defense against gonococcal infections (variable 34), the reported prescribed mode of 
treatment was evaluated for significance and was used as the dependent variable. The 
evaluation was conducted at the state and regional levels inclusive of a comparison 
between the state and regional levels. The statistically significant reported last-line-of-
antibiotic-defense was then compared to the statically significant risk factors to evaluate 
any relationships. This was conducted at the state and regional levels inclusive of a 
comparison between the state and regional levels. The final narrowed resulting data were 
analyzed using chi-square, cross tabulation, and logistic regression modeling in IBM 
SPSS. The final results were used to predict which factors would contribute to future 
drug-resistant infections. The literature has elucidated that prescribed last-line-of-
antibiotic-defense are a factor in driving drug resistance. The statistically significant 
reported last-line-of-antibiotic-defense was the dependent variable, and the risk and 
demographic factors are the independent variables in the final calculations. 
 
Table 1 








Gender Categorical 1 = Female, 2=Male 
Sexual Orientation Categorical 1 = Heterosexual, 2 = Bisexual, 
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3 = Homosexual 
Race/Ethnics Categorical 1 = Black/African American, 2 = Hispanic,  
3 = White Non-Hispanic, 4 =Asian Non-Hispanic 
Pregnancy Categorical 1 = No, 2 = Yes 
Initial Antibiotic Treatment Categorical 1 = Last-line-of-antibiotic-defense,  
2 = All Other Antibiotics 
Age Range Categorical 1 = 16-19 yrs., 2 = 20-24 yrs., 3 = 25-29 yrs.,  
4 = 30-34 yrs., 5 = 35-39 yrs., 6 =40-44 yrs.,  
7 =45-49 yrs., 8 = 50-54 yrs., 9 = 55-59 yrs.,  
10 = over 60 years   
Number of Sex Partners 
(A.K.A. Multiple Partners) 
Discrete Numerical thus numbers were as reported. 
Drug Use Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Intoxicated; Alcohol or 
Drug 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Always Used Condoms Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Sometimes Used Condoms Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Never Used Condoms Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Condom Use with Main 
Partner 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Condom Use with Other 
Partner 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Anonymous Partner Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Meet Through the Internet Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
New Partner <90 days Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Met Partner in Bar Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Met Partner in Bath Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Knew self-HIV status Categorical 1 = Yes, 2 = No, 3 = Unknown 
Paid for Sex Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
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Was Paid for Sex Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Vaginal or Anal with 
Woman 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Oral Sex with Woman Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Unprotected Sex with 
Woman 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Vaginal or Anal with Man Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Oral Sex with Man Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Unprotected Sex with Man Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Men Having Sex with Men Categorical 1 = Female, 2 = MSM, 3 = Male Heterosexual 
Had a History of STD’s Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Has had an STD in the last 
12 Months 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Incarcerated in the Last 12 
Months 
Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
Sexual Assault Categorical 1 = Yes, 2 = No, 3 = Refused to Answer 
 
Data Analysis per Research Questions 
This study intended to identify the at-risk groups for contracting drug-resistant 
gonorrhea on a per region basis in Florida through the evaluation of current prescribed 
last line of antibiotic treatments and gonococcal infection risk factors. The data were 
normalized to rates, either per 1,000 or 100,000 as appropriate. The data were 
accumulated by the previously defined Florida regions. The GPower calculations 
indicated different minimum sampling sizes depending on the type of statistical 
calculation utilized. The rates were computed for each available classification (see Table 
1). The variables were then used to answer the following research questions.  
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Research Question 1:  Are there differences in using last-line-of-antibiotic-defense 
between Florida as a whole and each of the eight regions?   
Hypothesis 1: 
H0: There is no statistical significance between each of the eight different regions 
and Florida as a whole for the last-line-of-antibiotic-defense associated with 
gonococcal infections. 
Ha: There is a statistical significance between each of the eight different regions 
and Florida as a whole for the last-line-of-antibiotic-defense associated with 
gonococcal infections. 
Data Analysis 1: 
Chi-square and cross tabulations were conducted to compare the last-line-of-
antibiotic-defense between Florida as a whole and the eight different regions.  
Research Question 2:  Are there differences in using last-line-of-antibiotic-defense 
among the eight Florida regions?  
Hypothesis 2: 
 
H0: There is no statistical significance between the eight Florida regions in regard 
to the last-line-of-antibiotic-defense for gonococcal infections.  
Ha: There is a statistical significance between the eight Florida regions in regard 
to the last-line-of-antibiotic-defense for gonococcal infections. 
Data Analysis 2: 
Chi-square and a cross tabulations were conducted to compare the last-line-of-
antibiotic-defense between the eight different regions. 
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Research Question 3: What are the statistically significant factors associated with being 
treated with last-line-of-antibiotic-defense in each of the eight regions and the 
state of Florida? 
Hypothesis 3: 
 
H0: There are no statistically significant factors associated with being treated with 
last-line-of-antibiotic-defense in the eight regions.  
Ha: There are statistically significant factors associated with being treated with 
last-line-of-antibiotic-defense in the eight regions.  
Data Analysis 3: 
Multiple logistic regression models were conducted for all 33 independent 
variables and the one dependent variable for each of the eight regions and Florida 
as a whole. 
Current Gonococcal Infection Distribution 
 Not all gonococcal data for Florida is available without special request. The 
current freely accessible information through the Florida Department of Health CHARTS 
is gender, age, race, ethnicity, and county. The number of infections and rates are only 
stored to the last twenty years from the presence. This study is limited its evaluations 
between 2007 to 2018 which incorporated time before and after 2013 when the gonorrhea 
rates went on the rise. In addition, rates for 2019 were not available at the time of this 
study. As discussed before, Florida follows the current CDC guidelines of identifying at 
risk groups as being men having sex with men, sex workers, and pregnant women. None 
of this data is available on the open access of the CHARTS site. The FDOH data 
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dictionary was made available for this study. Within the dictionary there was evidence of 
more inclusive information such as sexual behavior, sexual orientation, drug use, 
demographic data, and treatment data. The actual data were made available upon written 
request and IRB approval from both Walden University and the Florida Department of 
Health.  
 The data available to the public is limiting. From the CHARTS system, on a 
Statewide basis, there is an upward trend of gonococcal cases. Using the most recent 
available data through CHARTS, the 2017 overall the rates of gonococcal infection vary 
among the regions (Figure 13). This indicates that infected groups are not uniform ally 
diluted throughout the State, which elucidated that there is a definitive demographic 
influence on gonococcal infections. The data also indicated that there appears to be 
significant infection rates within the non-Hispanic Black groups compared to non-
Hispanic White and Hispanic groups (Figure 14). Unfortunately, there is no other public 
data to evaluate if the CDC recommendation are applicable at the regional level for the 
state of Florida. From what publicly available data there is, evidence exists that the at-risk 
groups were not what the CDC is reporting at the national level. This was found to be 
true and Florida will need to change its limited intervention approach to a more targeted 




2017 Gonococcal Infection Rates Per Region 
 
Note. Depicts gonococcal infection rates among the eight regions of Florida and Florida 























2017 Gonococcal Infection Rates Per Region 
 
Note. Depicts gonococcal infection rates among the eight regions of Florida and Florida 
Statewide based on race. Image created from public data proved by FDOH CHARTS 
system.  
Data Criteria 
 The study population was all individuals who have been diagnosed and reported 
as testing positive for Neisseria gonorrhoeae in the state of Florida. The data points that 
were requested and provided included; tested positive for gonococcal infection, sexually 
transmitted disease history (STD), race, ethnics, age, pregnancy, county of residence, 
gender, self-reported gender, sexual orientation, number of sex partners, treatment 
protocol, prescribed last-line-of-antibiotic-defense treatment and risk factors. Data that 








2017 Gonococcal Infection Rates per 100,000 by Region 
and Race
Overall White Black Hispanic
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Florida were city of occurrence, addresses, zip codes, neighborhood codes, and birth 
year.  
Threat to Validity 
External 
As previously discussed, this study used secondary data acquired from the state of 
Florida. Since the data is not directly collected as would be in a primary data study, there 
may have been some unanticipated introduced bias. It is this bias that could threaten the 
validity of this study. The collected data is only as valid as the individual entering the 
information into the system. It was assumed that the process in which the data were 
entered is designed to be simple and easy. At times, the data may contain omissions or 
entered incorrectly. The recording of the data may potentially threaten the validity of the 
study. Although gonorrhea is considered a reportable disease, a medical professional may 
opt to not report the information with the expectation of protecting doctor-patient 
confidentiality. The failure to report all data points as required, creating data gaps 
through omission, may occur and be in part due to lack of time or failure to question the 
infected individual fully. Data that may have omission errors or appear to be collected 
incorrectly was evaluated to determine if the particular omission would affect the 
outcome. If it affected the outcome, that information was omitted from the evaluation and 
was noted in the results and discussion sections of this study.  
Internal 
For this study a data dictionary was acquired. Review of the data dictionary 
indicates that there were significant number of potential points of interest to compare. 
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The information was narrowed down. During the narrowing process confounders may 
have been overlooked. These confounders might be significant and the failure to 
incorporate them could affect the validity of the study. To correct for this potential, all 
data categories were evaluated against each other. Although this may be tedious it was 
necessary so as to confirm the results are valid. Another internal threat to validity was the 
number of data points available creating invalid and non-statistically significant results. 
In order to reduce this threat, counties were grouped into regions and data over the last 12 
years was utilized. This provided enough Power to produce valid results.  
Ethical Procedure 
 The data provided from the FDOH does not contain the names of the individuals. 
The names are coded and held with the FDOH. As per the FDOH data use agreement, the 
data were kept in a protected location and was only accessed by the approved principal 
investigator (PI). The data were not accessible by anyone who had not been approved by 
the FDOH. The data were kept in a locked file by the PI when not in use and any 
computer-based information was encrypted with access by only the PI. Once the study 
was completed the data were destroyed per the FDOH agreement (Agreement No. 2019-
082). The FDOH required an IRB review and approval prior to their IRB review and 
approval. Thus, a Walden University IRB review was conducted, and the approval, 
number 04-24-19-0304414, was submitted to the FDOH along with the FDOH data use 




 This quantitative study used secondary data provide by the state of Florida. The 
data were vetted through the State’s IRB and checked for validity. Although the state 
confirms the validity of its data there was always the chance some data points may have 
been missed. This study also reviewed the data provided and reviewed it for validity. The 
state provided data is broad reaching and provides informational data points that would 
be otherwise impossible to obtain without significant financial investment, years of 
collection, and a massive team of trained researchers to collect the data. Review of the 
data dictionary and subsequence review of the data itself elucidated a comprehensive 
collection of information. This study was limited to the data available and there was no 
mechanism to be able to return to the individual if further questions arise. The GISP data 
were extremely limited and only used for basic referencing since it is not as 
comprehensive as the data provided by the state of Florida. The GISP data were not 
incorporated into this study. The state did not restrict access to any of the non-identifiable 
data that was available such as mode of treatment, location, sexual behavior, drug use, 
sex, race, ethnics, and the like. Through evaluation of the state provided data, patterns 
emerged indicating what regional groups will be at-risk for contracting drug-resistant 







Chapter 4: Results 
Introduction 
 Gonococcal infections have been on the rise in recent years. These increases are 
predicted to lead to an increase in drug-resistant variants. The understanding of who is at 
risk for drug resistance is critical in creating targeted interventions. These interventions 
will lead to a reduction in overall infections, which should also have an effect in reducing 
drug-resistant strains. Florida limits their targeted interventions based on national 
statistics and recommendations from the CDC. Although the CDC does state 
overarchingly that all sexually active individuals are at risk for gonococcal infections, 
they specifically mention three groups: men who have sex with men (homosexual or 
bisexual men), pregnant women, and sex workers. These identified groups are based on 
national statistics, which do not always match Florida findings or Florida regions within 
the state findings. Florida, as a whole, is not an across-the-board representation of the 
demographics of the United States. Florida demographics change dramatically from 
North to South. Each demographic group approaches sexual behavior differently. It is 
necessary to evaluate each region to gain a better understanding of the driving forces for 
gonococcal infections and how antimicrobial treatments are rendered. This information 
can then identify who would be most likely at risk for contracting drug-resistant variant 
of gonorrhea. From these findings, a more targeted regional approach can be created. 




 This quantitative study used secondary data provided by the FDOH through the 
STARS system under a contractual agreement. Over 37 million data points were 
available, spanning 78 FDOH-identified risk factors. The data provided included all 
available demographic data and all available risk factors from 2007 to 2018. This is the 
most recent and complete information available. The FDOH did not provide data for 
individuals under the age of 16 years. A telephone discussion with a representative of the 
FDOH elucidated that under the age of 16 years indicated nonconsensual sexual contact 
with a minor. Such data is considered sensitive and thus was excluded from the data 
provided.  
Data Evaluation 
The over 37 million data points provided were obtained in string text format. The 
data were converted into categorical data in Microsoft Excel and then imported into IBM 
SPSS (Version 25) for analysis. The data were further separated into regions, as outlined 
in Figure 1. Although rare, line segments with missing data were excluded from the 
calculations. Many of the variables presented as FDOH-identified factors had sections of 
“did not ask” or “refused to answer” as a response. Those responses were excluded from 
calculations as necessary and reported as such. Considering the magnitude of the 
available data and that there were very few missing data rows, the rejection of missing 
data or the inclusion or exclusion of “did not ask” or “refused to answer” when necessary 
did not affect the overall results. On the contrary, it provided clarity in the weakness in 
the data collection process. Seventy-eight risk factors were evaluated, repetitive ones 
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were excluded or combined into single groupings. For instance, risk factors such as “used 
heroin” or “used cocaine” were combined into “used drugs.” Risk factors included 
information such as drug use, number of sexual partners, condom use, type of sexual 
contact, and the like. It was found, that quite often within all of the risk factors, the data 
collector “did not ask” or the participant “refused to answer.” Data were evaluated at the 
statewide and regional level. Data that were found to be not statistically significant were 
eliminated from the final analysis and excluded from reporting. Only statistically 
significant data and results of interest were included in this study.  
Dependent Variable 
This study focuses on predicting the at-risk groups anticipated to contract drug-
resistant strains of gonorrhea. Drug resistance occurs through the repetitive exposure of a 
bacterium to an antibiotic. Considering that there are only a select few antibiotics that are 
effective for the treatment of gonococcal infections, it is understood that there is limited 
time until the bacterium becomes resistant to these last-lines-of-antibiotic-defenses. The 
dependent variable for this study is reported gonococcal infections that required the last-
line-of-antibiotic-defense. The antibiotic data were grouped into two categories (Table 1). 
The results of the evaluated data are summarized in the following sections and are based 
on the three proposed research questions. 
Florida Descriptive Statistics 
Statewide more males (52.5%) than females (47.3%) were infected. The 
difference between the sexes overall is only a few percentage points indicating the male 
to female distribution across the state is relatively equal. Of the infected, only 8.6% were 
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males who had sex with males (MSM). Indicating on a statewide level, infections 
affected those males who identified as heterosexuals more than men who have sex with 
men (homosexual or bisexual). In regard to sexual orientation, 71.3% of the cases were 
reported as unknown. Of 28.7% reporting their sexual orientation (81,106 individuals), 
regardless of being female or male, 74.2% considered themselves heterosexual, 22.95% 
homosexual, and 2.84% bisexual. Again, indicating that gonococcal infections are more 
prominent in heterosexual populations. Race/Ethnicity are a factor in gonococcal 
infections (Figure 15). Black/African American Non-Hispanic are 52.9% of the 
gonococcal infections followed by White Non-Hispanic (19%), Hispanic (9.9%), Asian 
Non-Hispanic (0.4%), and unknown Race/Ethnicity (17.8%). 
Figure 15 
 




The results indicate that young adults under the age of 30 years made up the 
majority of infected individuals. The data can be further expanded into the 5-year age 
categories. Ages 20 to 24 years made up 32.1% of all those infected, followed by 16 to 19 
(21.5%), 25 to 29 (19.4%), 30 to 34 (10.2%), 35 to 39 (5.9%), 40 to 44 (3.9%), 45 to 49 
(2.9%), 50 to 54 (2%), 55 to 59 (1.1%), and over 60 years (0.9%) (Figure 16). 
Figure 16 
 
Percentage of Gonococcal Infections Per Age Group Statewide 
 
Pregnancy did not appear to be a determining factor regarding gonococcal infections. Of 
the infected women, only 14.4% of the women infected were pregnant. Although on the 
national level pregnant woman are considered as one of the at-risk groups for gonococcal 
infections, is it apparent that for Florida they are not the majority of women becoming 
infected.  
 Aforementioned in this dissertation, cefixime and ceftriaxone in combination 
together or with azithromycin is considered the last line treatment left to combat 
82 
 
gonorrhea (Morgan & Decker, 2016). Including unreported treatments, the last-line-of-
antibiotic-defense made up 73% of the initial treatments. These were either azithromycin 
and ceftriaxone in combination (35.7%) or ceftriaxone alone (37.3%). Cefixime or 
combinations which is also considered a last-line-of-antibiotic-defense against 
gonococcal infections, were less than 5% of all prescribed treatments (Figure 17).  
Figure 17 
 
Percentage of the Different Types of Last-line-of-antibiotic-defense Prescribed as Initial 
Treatment 
 
Risk Factor Statewide 
 The risk factors elucidated some trends (Table 2). Some of the trends do not fit 
the current CDC recommendations for at-risk individuals. For instance, only 2.2% of the 
individuals acquired gonorrhea from a sex worker and only 3.5% of those who contracted 
gonorrhea were sex workers. Other trends were that 60.2% of the respondents had a 
history of STD’s. A supporting trend was 32.6% stated they contracted gonorrhea 
through men having sex with men. Having multiple sex partners was not a determining 
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factor. At the time of infection 71.6% of the respondents stated they had only one partner; 
13.7% had two partners; 5% had three partners; and 9.7% had four or more partners.  
Table 2  
 
Risk Factors Listed as Percentage Based on Respondents for the state of Florida 
 
Risk Factor 
Percentage Yes Percentage No 
Drug Use 41.6% 58.4% 
Intoxicated; Alcohol or Drug 18.6% 81.4% 
Always Used Condoms 5.3% 94.7% 
Sometimes Used Condoms 78.9% 21.1% 
Never Used Condoms 25.7% 74.3% 
Condom Use with Main Partner 11.8% 88.2% 
Condom Use with Other Partner 38.8% 61.2% 
Anonymous Partner 31.5% 68.5% 
Meet Through the Internet 22.1% 77.9% 
New Partner <90 days 29.1% 70.9% 
Multiple Partners 26.3% 73.7% 
Met Partner in Bar 11.3% 88.7% 
Met Partner in Bath 4.0% 96.0% 
Knew self-HIV status 48.8% 51.2% 
Paid for Sex 2.2% 97.8% 
Was Paid for Sex 3.5% 96.5% 
Vaginal or Anal with Woman 27.1% 72.9% 
Oral Sex with Woman 27.3% 72.7% 
Unprotected Sex with Woman 27.5% 72.5% 
Vaginal or Anal with Man 84.9% 15.1% 
Oral Sex with Man 70.4% 29.6% 
Unprotected Sex with Man 68.9% 31.1% 
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Men Having Sex with Men 32.6% 67.4% 
Had a History of STD’s 60.2% 39.8% 
Has had an STD in the last 12 
Months 
28.0% 72.0% 
Incarcerated in the Last 12 
Months 
7.4% 92.6% 
Sexual Assault 3.6% 96.4% 
 
 There are many risk factors and key demographics that are apparent for 
gonococcal infections statewide. Black/African American non-Hispanic are the highest of 
infected. Age is another key role and the majority of infected are under the age of 30 
years. Initial treatment will be an issue in relationship to drug-resistant strains. The most 
used medication is currently considered the last-line-of-antibiotic-defense by the CDC. 
Lack of condom use and having a previous STD history are also key factors. Men having 
sex with men is a factor but pregnancy and sex with a sex worker were not relevant.  
Regional Descriptive Statistics 
Regional Demographics and Last Line of Antibiotic Treatments 
Each region has differences among and between in regard to the different 
demographics and the prescribe antibiotic treatments. Evaluating the different regions for 
gonococcal infections based on gender alone, the Northwest Region had more females 
(52.1%) than males (47.9%), the Northeast Region had slightly more males (51.5%) than 
females (48.5%), the North Central Region had slightly more females (52.6%) than males 
(47.4%), the West Central Region had slightly more males (52.2%) than females 
(47.3%), the East Central Region had slightly more males (54.1%) than females (45.9%), 
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the Southeast Region had slightly more males (52.3%) than females (47.7%), the 
Southwest Region had almost equal number of males (50.8%) and females (49.2%), and 
the South Region had many more males (63.9%) than females (35.1%) (Figure 18).  
Figure 18 
 
Percentage of Gonococcal Infections of Males versus Females in each Region 
 
Men who have sex with men in general is a small percentage in some regions 
such as the Northwest Region at 5.2%, North Central Region at 7.9%, East Central 
Region at 8%, and the Southwest Region at 8.7%. Other regions were slightly higher with 
the Northeast Region at 10.7%, West Central Region at 12.2%, and Southeast Region at 
11.1%. The highest region was the South Region making up 29% of those reporting 





























Percentage of Gonococcal Infections for Men who Have Sex with Men in each Region 
 
Those who reported sexual orientation also varied among the regions. Of the reporting 
population, in the Northwest Region 8.1% self-reported as homosexual and 2.7% 
bisexual, the Northeast Region 19.1% self-reported as homosexual and 1.8% bisexual, 
the North Central Region 9.0% self-reported as homosexual and 2.3% bisexual, West 
Central 17.0% self-reported as homosexual and 3.6% bisexual, East Central Region 
22.9% self-reported as homosexual and 2.5% bisexual, Southeast Region 10.9% self-
reported as homosexual and 2.3% bisexual, Southwest Region 11.0% self-reported as 
homosexual and 3.3% bisexual and 2.6% bisexual, and the South Region 48.2% self-











Percentage of Gonococcal Infections Based on Sexual Orientation in Each Region 
 
Ethnicity varies among the different regions. Within the Northwest Region 
Black/African American Non-Hispanic are 43.7% of the gonococcal infections followed 
by White Non-Hispanic (22.8%), Hispanic (1.7%), Asian Non-Hispanic (0.3%), and 
unknown Race/Ethnicity (31.3%) (Figure 21). In the Northeast Region Black/African 
American Non-Hispanic are 67.5% of the gonococcal infections followed by White Non-
Hispanic (17.5%), Hispanic (2.5%), Asian Non-Hispanic (0.4%), and 12% were reported 
as unknown Race/Ethnicity. In the North Central Region Black/African American Non-
Hispanic are 59.0% of the gonococcal infections followed by White Non-Hispanic 
(16.1%), Hispanic (2.2%), Asian Non-Hispanic (0.2%), and unknown Race/Ethnicity 
(22.4%). In the West Central Region Black/African American Non-Hispanic are 53.3% 





















Asian Non-Hispanic (0.4%), and unknown Race/Ethnicity (14.6%). In the East Central 
Region Black/African American Non-Hispanic are 47.6% of the gonococcal infections 
followed by White Non-Hispanic (19.1%), Hispanic (10.1%), Asian Non-Hispanic 
(0.4%), and unknown Race/Ethnicity (22.6%). In the Southeast Region Black/African 
American Non-Hispanic are 58.0% of the gonococcal infections followed by White Non-
Hispanic (22.4%), Hispanic (9.6%), Asian Non-Hispanic (0.4%), and unknown 
Race/Ethnicity (9.5%). In the Southwest Region Black/African American Non-Hispanic 
are 45.2% of the gonococcal infections followed by White Non-Hispanic (32.2%), 
Hispanic (16.2%), Asian Non-Hispanic (0.5%), and unknown Race/Ethnicity (5.7%). In 
the South Region Black/African American Non-Hispanic are 47.4% of the gonococcal 
infections followed by White Non-Hispanic (12.9%), Hispanic (20.3%), Asian Non-




Percentage of Gonococcal Infections per Race/Ethnicity per Region 
 
The percentage of women who reported as pregnant versus not pregnant during 
the time of the gonococcal infection was relatively consisted among some of the different 
regions. The Northwest Region was at 14%, Northeast Region at 14.7%, East Central 
Region at 14.8%, Southwest Region at 14.5%, and the South Region at 13.9% were in the 
middle and most closely related among the regions. The West Central Region at 15.4% 
and Southeast Region at 16.3% were the highest. The North Central Region at 10.3% was 














































Percentage of Pregnant Women with Gonorrhea in Each Region 
 
Consistently among all the regions the data indicated that young adults under the age of 
30 years made up the majority of infected individuals. The data were further categorized 
and evaluated in 5-year age increments. In the Northwest Region ages 20 to 24 years 
made up 33.4% of all those infected, followed by 16 to 19 (24%), 25 to 29 (19.4%), 30 to 
34 (9.9%), 35 to 39 (5.5%), 40 to 44 (3%), 45 to 49 (2.1%), 50 to 54 (1.5%), 55 to 59 
(0.8%), and over 60 years (0.5%). In the Northeast Region ages 20 to 24 years made up 
33.2% of all those infected, followed by 16 to 19 (20.3%), 25 to 29 (20.2%), 30 to 34 
(10.7%), 35 to 39 (6.3%), 40 to 44 (4%), 45 to 49 (2.7%), 50 to 54 (1.7%), 55 to 59 
(1.2%), and over 60 years (0.9%). In the North Central Region ages 20 to 24 years made 
up 37.2% of all those infected, followed by 16 to 19 (24.8%), 25 to 29 (28.5%), 30 to 34 

















(0.6%), and over 60 years (0.5%). In the West Central Region ages 20 to 24 years made 
up 32.2% of all those infected, followed by 16 to 19 (22.7%), 25 to 29 (19.2%), 30 to 34 
(9.9%), 35 to 39 (5.8%), 40 to 44 (3.8%), 45 to 49 (2.7%), 50 to 54 (1.8%), 55 to 59 
(1.1%), and over 60 years (0.9%). In the East Central Region ages 20 to 24 years made 
up 32.8% of all those infected, followed by 16 to 19 (21.1%), 25 to 29 (19.8%), 30 to 34 
(10.4%), 35 to 39 (5.9%), 40 to 44 (3.8%), 45 to 49 (2.7%), 50 to 54 (1.8%), 55 to 59 
(1.0%), and over 60 years (0.8%). In the Southeast Region ages 20 to 24 made up 31.9% 
of all those infected, followed by 16 to 19 (21.2%), 25 to 29 (19.3%), 30 to 34 (9.7%), 35 
to 39 (5.7%), 40 to 44 (4.0%), 45 to 49 (3.2%), 50 to 54 (2.3%), 55 to 59 (1.4%), and 
over 60 (1.4%). In the Southwest Region ages 20 to 24 made up 32.4% of all those 
infected, followed by 16 to 19 (25.4%), 25 to 29 (18.0%), 30 to 34 (9.3%), 35 to 39 
(5.2%), 40 to 44 (3.5%), 45 to 49 (2.6%), 50 to 54 (1.3%), 55 to 59 (1.2%), and over 60 
(1.1%). In the South Region Ages 20 to 24 made up 28.8% of all those infected, followed 
by 16 to 19 (18.9%), 25 to 29 (19.5%), 30 to 34 (11.1%), 35 to 39 (6.9%), 40 to 44 

















Percentage of Gonococcal Infections Per Age Group in Each Region 
 
Increasing use of last line of antibiotic treatment drives drug resistance. Each 
region used the last line of antibiotic treatment at a relatively high rate. Including 
unreported treatments, the last-line-of-antibiotic-defense made up 82.1% of the initial 
treatments for the Northwest Region. In the Northeast Region, the last-line-of-antibiotic-
defense made up 90.5% of the initial treatments. Within the North Central Region, the 
last-line-of-antibiotic-defense made up 81.2% of the initial treatments. In the West 
Central Region, the last-line-of-antibiotic-defense made up 84.8% of the initial 
treatments. In the East Central Region, the last-line-of-antibiotic-defense made up 72.9% 
of the initial treatments. Within the Southeast Region, the last-line-of-antibiotic-defense 
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antibiotic-defense made up 90.5% of the initial treatments. Within the South Region, the 
last-line-of-antibiotic-defense made up 74.6% of the initial treatments (Figure 24).  
Figure 24 
Percentage of the Different Last-line-of-antibiotic-defense versus Other Antibiotics 
Prescribed as Initial Treatment in Each Region 
 
 
The last line of antibiotic treatments was further separated into the different last 
line treatments in relationship to all antibiotic treatments. These last line antibiotic 
treatments are azithromycin and ceftriaxone in combination, doxycycline and ceftriaxone 
in combination, ceftriaxone alone, and cefixime alone or in combinations. In the 
Northwest Region last line antibiotic treatments were prescribed as azithromycin and 
ceftriaxone in combination (40.4%), doxycycline and ceftriaxone in combination (3.6%), 
ceftriaxone alone (38.1%), or cefixime or combinations (2.7%). In the Northeast Region 
last line antibiotic treatments were prescribed as azithromycin and ceftriaxone in 
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alone (44%), or cefixime or combinations (2.9%). In the North Central Region last line 
antibiotic treatments were prescribed as azithromycin and ceftriaxone in combination 
(34.0%), doxycycline and ceftriaxone in combination (3.3%), ceftriaxone alone (40.5%) 
or cefixime or combinations (3.6%). Within the West Central Region last line antibiotic 
treatments were prescribed as azithromycin and ceftriaxone in combination (37.3%), 
doxycycline and ceftriaxone in combination (2.5%), ceftriaxone alone (40.7%), or 
cefixime or combinations (4.3%). In the East Central Region last line antibiotic 
treatments were prescribed as azithromycin and ceftriaxone in combination (32.6%), 
doxycycline and ceftriaxone in combination (2.5%), ceftriaxone alone (33.1%), or 
cefixime or combinations (4.7%). In the Southeast Region last line antibiotic treatments 
were prescribed as azithromycin and ceftriaxone in combination (42.3%), doxycycline 
and ceftriaxone in combination (3.6%), ceftriaxone alone (37.4%), or cefixime or 
combinations (2.0%). In the Southwest Region last line antibiotic treatments were 
prescribed as azithromycin and ceftriaxone in combination (29.6%), doxycycline and 
ceftriaxone in combination (3.2%), ceftriaxone alone (52.8%), or cefixime or 
combinations (4.9%). Within the South Region last line antibiotic treatments were 
prescribed as azithromycin and ceftriaxone in combination (37.1%), doxycycline and 
ceftriaxone in combination (2.8%), ceftriaxone alone (29.8%), or cefixime or 








Percentage of the Different Last Line of Antibiotics Prescribed as Initial Treatment in 
Each Region  
 
 
Risk Factors  
Northwest Region 
 The risk factors for the Northwest region can be found in Table 3. The risk factors 
in this region do not fit the current CDC recommendations for at-risk individuals. For 
instance, only 2.4% of the individuals acquired gonorrhea from a sex worker and only 
2.2% of those who contracted gonorrhea were sex workers. Of the respondents 48.9% 
had a history of STD’s and 11.5% stated they contracted gonorrhea through men having 
sex with men which does not follow the CDC recommendations for being at risk for 
contracting gonorrhea. Having multiple sex partners was not a determining factor. At the 
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time of infection 72.3% of the respondents stated they had only one partner; 16.6% had 
two partners; 4% had three partners; and 7.1% had four or more partners.  
Table 3  
Risk Factors Listed as Percentage Based on Respondents for the Northwest Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 37.5% 62.5% 
Intoxicated; Alcohol or Drug 27.4% 72.6% 
Always Used Condoms 8.3% 91.7% 
Sometimes Used Condoms 92.7% 7.3% 
Never Used Condoms 12.6% 74.3% 
Condom Use with Main Partner 13.8% 86.1% 
Condom Use with Other Partner 74.1% 25.8% 
Anonymous Partner 27.7% 72.3% 
Meet Through the Internet 12.6% 87.4% 
New Partner <90 days 23.2% 76.8% 
Multiple Partners 27.7% 72.3% 
Met Partner in Bar 4.9% 95.1% 
Met Partner in Bath 0% 100% 
Knew self-HIV status 48.8% 51.2% 
Paid for Sex 2.4% 97.6% 
Was Paid for Sex 2.2% 97.8% 
Vaginal or Anal with Woman 31.5% 68.4% 
Oral Sex with Woman 38.5% 61.5% 
Unprotected Sex with Woman 40.3% 59.7% 
Vaginal or Anal with Man 75.2% 24.8% 
Oral Sex with Man 57.3% 42.7% 
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Unprotected Sex with Man 62.6% 37.4% 
Men Having Sex with Men 11.5% 88.5% 
Had a History of STD’s 48.9% 51.1% 
Has had an STD in the last 12 Months 22.9% 77.1% 
Incarcerated in the Last 12 Months 12.1% 87.9% 
Sexual Assault 8.8% 91.2% 
Note: * indicates there were not enough samples to meet Power. Note: Table created 
from data provided by FDOH STARS system and using IBM SPSS version 25. 
Northeast Region 
 The risk factors for the Northeast region can be found in Table 4. The risk factors 
in this region do not fit the current CDC recommendations for at-risk individuals. Of the 
reporting only 1.2% of the individuals acquired gonorrhea from a sex worker and only 
2.4% of those who contracted gonorrhea were sex workers. Of the respondents, 61.1% 
had a history of STD’s. 15.1% stated they contracted gonorrhea through men having sex 
with men which does not follow the CDC recommendations for at-risk. Having multiple 
sex partners was not a determining factor. At the time of infection 84.9% of the 
respondents stated they had only on partner; 9.5% had two partners; 2.9% had 3 partners; 
and 2.7% had 4 or more partners.  
Table 4  
Risk Factors Listed as Percentage Based on Respondents for the Northwest Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 9.2% 90.8% 
Intoxicated; Alcohol or Drug 9.5% 90.5% 
98 
 
Always Used Condoms 1.5% 98.5% 
Sometimes Used Condoms 67.0% 33.0% 
Never Used Condoms 10.9% 89.1% 
Condom Use with Main Partner 5.9% 94.1% 
Condom Use with Other Partner 35.0% 67.0% 
Anonymous Partner 13.8% 86.2% 
Meet Through the Internet 22.1% 77.9% 
New Partner <90 days 12.4% 87.6% 
Multiple Partners 25.1% 84.9% 
Met Partner in Bar 4.6% 95.4% 
Met Partner in Bath 1.7% 98.3% 
Knew self-HIV status 0% 100% 
Paid for Sex 1.2% 98.8% 
Was Paid for Sex 2.4% 97.6% 
Vaginal or Anal with Woman 21.9% 78.1% 
Oral Sex with Woman 22.2% 77.8% 
Unprotected Sex with Woman 22.8% 77.2% 
Vaginal or Anal with Man 80.7% 19.3% 
Oral Sex with Man 68.6% 31.4% 
Unprotected Sex with Man 67.6% 32.4% 
Men Having Sex with Men 15.1% 84.9% 
Had a History of STD’s 61.1% 48.9% 
Has had an STD in the last 12 Months 27.3% 72.7% 
Incarcerated in the Last 12 Months 3.6% 96.4% 
Sexual Assault 0.9% 99.1% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 




North Central Region 
 The risk factors for the North Central region can be found in Table 5. The risk 
factors in this region do not fit the current CDC recommendations for at-risk individuals. 
Of the reporting only 0.9% of the individuals acquired gonorrhea from a sex worker and 
only 3.3% of those who contracted gonorrhea were sex workers. Of the reporting 
respondents, 60.5% had a history of STD’s, 21.5% stated they contracted gonorrhea 
through men having sex with men although does not follow the CDC recommendations 
for at-risk, this is a greater percentage that in other regions. Having multiple sex partners 
was not a determining factor. At the time of infection 76.4% of the respondents stated 
they had only on partner; 15.3% had two partners; 4.1% had 3 partners; and 4.2% had 4 
or more partners.  
Table 5 
Risk Factors Listed as Percentage Based on Respondents for the North Central Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 48.9% 51.1% 
Intoxicated; Alcohol or Drug 30.0% 70.0% 
Always Used Condoms 4.6% 95.6% 
Sometimes Used Condoms 88% 12% 
Never Used Condoms 22.2% 77.8% 
Condom Use with Main Partner 13.2% 86.8% 
Condom Use with Other Partner 54.4% 45.6% 
Anonymous Partner 28.4% 71.6% 
Meet Through the Internet 17.6% 82.4% 
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New Partner <90 days 23.5% 76.5% 
Multiple Partners 23.6% 76.4% 
Met Partner in Bar 5.6% 94.4% 
Met Partner in Bath 0.5% 99.5% 
Knew self-HIV status 0% 100% 
Paid for Sex 0.9% 99.1% 
Was Paid for Sex 3.3% 96.7% 
Vaginal or Anal with Woman 29.5% 70.5% 
Oral Sex with Woman 29.3% 70.7% 
Unprotected Sex with Woman 34.0% 66.0% 
Vaginal or Anal with Man 89.4% 10.6% 
Oral Sex with Man 71.9% 28.1% 
Unprotected Sex with Man 77.2% 22.8% 
Men Having Sex with Men 15.1% 84.9% 
Had a History of STD’s 60.5% 39.5% 
Has had an STD in the last 12 Months 26.6% 73.4% 
Incarcerated in the Last 12 Months 10.7% 89.3% 
Sexual Assault 10.7% 89.3% 
Note: * indicates there were not enough samples to meet Power. Note: Table created 
from data provided by FDOH STARS system and using IBM SPSS version 25.  
West Central Region 
 The risk factors for the West Central region can be found in Table 6. The risk 
factors in this region do not fit the current CDC recommendations for at-risk individuals. 
Of the reporting only 2.1% of the individuals acquired gonorrhea from a sex worker and 
only 4.7% of those who contracted gonorrhea were sex workers. 61.8% of the 
respondents had a history of STD’s. 34.3% stated they contracted gonorrhea through men 
having sex with men which supports the CDC recommendations for at-risk. Having 
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multiple sex partners was not a determining factor. At the time of infection 71.4% of the 
respondents stated they had only on partner; 15.1% had two partners; 4.8% had 3 
partners; and 8.7% had 4 or more partners.  
Table 6 
Risk Factors Listed as Percentage Based on Respondents for the West Central Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 40.0% 60.0% 
Intoxicated; Alcohol or Drug 23.8% 76.2% 
Always Used Condoms 5.2% 94.8% 
Sometimes Used Condoms 77.4% 22.6% 
Never Used Condoms 24.3% 75.7% 
Condom Use with Main Partner 10.9% 89.1% 
Condom Use with Other Partner 37.8% 62.2% 
Anonymous Partner 31.9% 68.1% 
Meet Through the Internet 24.4% 75.6% 
New Partner <90 days 33.5% 66.5% 
Multiple Partners 28.6% 71.4% 
Met Partner in Bar 12.6% 87.4% 
Met Partner in Bath 3.6% 96.4% 
Knew self-HIV status 0% 100% 
Paid for Sex 2.1% 97.9% 
Was Paid for Sex 4.7% 95.3% 
Vaginal or Anal with Woman 33.7% 66.3% 
Oral Sex with Woman 29.5% 70.3% 
Unprotected Sex with Woman 31.0% 69.0% 
Vaginal or Anal with Man 91.5% 8.5% 
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Oral Sex with Man 70.1% 29.9% 
Unprotected Sex with Man 71.3% 28.7% 
Men Having Sex with Men 34.3% 65.7% 
Had a History of STD’s 61.8% 38.2% 
Has had an STD in the last 12 Months 28.3% 71.7% 
Incarcerated in the Last 12 Months 12.5% 87.5% 
Sexual Assault 5.1% 94.9% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
East Central Region 
 The risk factors for the East Central region can be found in Table 7. The risk 
factors in this region do not fit the current CDC recommendations for at-risk individuals. 
Of the reporting only 3.6% of the individuals acquired gonorrhea from a sex worker and 
only 3.6% of those who contracted gonorrhea were sex workers. Those who had a history 
of an STD made up 57.9% of the respondents. In addition, 29.3% stated they contracted 
gonorrhea through men having sex with men which supports the CDC recommendations 
for at-risk. Having multiple sex partners was not a determining factor. At the time of 
infection 76.6% of the respondents stated they had only on partner; 12% had two 
partners; 3.9% had 3 partners; and 7.5% had 4 or more partners.  
Table 7 
Risk Factors Listed as Percentage Based on Respondents for the East Central Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 58.9% 41.1% 
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Intoxicated; Alcohol or Drug 22.0% 78.0% 
Always Used Condoms 3.5% 96.5% 
Sometimes Used Condoms 71.6% 28.4% 
Never Used Condoms 20.8% 79.2% 
Condom Use with Main Partner 8.7% 91.3% 
Condom Use with Other Partner 40.9% 59.1% 
Anonymous Partner 28.9% 71.1% 
Meet Through the Internet 21.1% 78.9% 
New Partner <90 days 21.4% 78.6% 
Multiple Partners 23.4% 76.6% 
Met Partner in Bar 7.1% 92.9% 
Met Partner in Bath 1.2% 98.8% 
Knew self-HIV status 0% 100% 
Paid for Sex 3.6% 96.4% 
Was Paid for Sex 3.6% 96.4% 
Vaginal or Anal with Woman 28.1% 71.9% 
Oral Sex with Woman 30.9% 69.1% 
Unprotected Sex with Woman 31.6% 68.4% 
Vaginal or Anal with Man 87.7% 12.3% 
Oral Sex with Man 73.7% 26.3% 
Unprotected Sex with Man 74.8% 25.2% 
Men Having Sex with Men 29.3% 70.7% 
Had a History of STD’s 57.9% 42.1% 
Has had an STD in the last 12 Months 30.3% 69.7% 
Incarcerated in the Last 12 Months 7.7% 92.3% 
Sexual Assault 3.4% 96.6% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 





 The risk factors for the Southeast region can be found in Table 8. The risk factors 
in this region do not fit the current CDC recommendations for at-risk individuals. Of the 
reporting 8.47% of the individuals acquired gonorrhea from a sex worker which is much 
higher than in other regions. Only 3.4% of those who contracted gonorrhea were sex 
workers. Of those reporting, 49.2% of the respondents had a history of STD’s which 
lower in other regions as well as comparing to Statewide. Only 17.6% stated they 
contracted gonorrhea through men having sex with men which does not support the CDC 
recommendations for at-risk. Having multiple sex partners was not a determining factor. 
At the time of infection 79.9% of the respondents stated they had only on partner; 12.6% 
had two partners; 2.6% had 3 partners; and 4.9% had 4 or more partners.  
Table 8 
Risk Factors Listed as Percentage Based on Respondents for the Southeast Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 52.2% 47.8% 
Intoxicated; Alcohol or Drug 17.6% 82.4% 
Always Used Condoms 6.9% 93.1% 
Sometimes Used Condoms 77.5% 22.5% 
Never Used Condoms 52.0% 48.0% 
Condom Use with Main Partner 9.6% 90.4% 
Condom Use with Other Partner 19.7% 80.3% 
Anonymous Partner 31.8% 68.2% 
Meet Through the Internet 19.8% 80.2% 
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New Partner <90 days 27.9% 72.1% 
Multiple Partners 20.1% 79.9% 
Met Partner in Bar 7.4% 92.6% 
Met Partner in Bath 0.6% 99.4% 
Knew self-HIV status 0% 100% 
Paid for Sex 8.5% 91.5% 
Was Paid for Sex 3.4% 96.4% 
Vaginal or Anal with Woman 37.3% 62.7% 
Oral Sex with Woman 32.2% 67.8% 
Unprotected Sex with Woman 35.8% 64.2% 
Vaginal or Anal with Man 81.2% 18.8% 
Oral Sex with Man 63.9% 36.1% 
Unprotected Sex with Man 64.9% 35.1% 
Men Having Sex with Men 17.6% 82.4% 
Had a History of STD’s 49.2% 50.8% 
Has had an STD in the last 12 Months 18.7% 81.3% 
Incarcerated in the Last 12 Months 8.5% 91.5% 
Sexual Assault 4.6% 95.4% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Southwest Region 
 The risk factors for the Southwest region can be found in Table 9. The risk factors 
in this region do not fit the current CDC recommendations for at-risk individuals. Of the 
reporting 2.5% of the individuals acquired gonorrhea from a sex worker which is much 
higher than in other regions. Only 2.8% of those who contracted gonorrhea were sex 
workers. Lower than other regions as well as comparing to Statewide, 52.5% of the 
respondents had a history of STD’s. Interesting, 22.6% stated they contracted gonorrhea 
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through men having sex with men which slightly supports the CDC recommendations for 
at-risk. Having multiple sex partners was not a determining factor. At the time of 
infection 80.8% of the respondents stated they had only on partner; 11.8% had two 
partners; 3.7% had 3 partners; and 3.7% had 4 or more partners.  
Table 9 
Risk Factors Listed as Percentage Based on Respondents for the Southwest Region of 
Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 49.5% 50.5% 
Intoxicated; Alcohol or Drug 27.8% 72.2% 
Always Used Condoms 7.8% 92.2% 
Sometimes Used Condoms 87.1% 12.9% 
Never Used Condoms 38.1% 61.9% 
Condom Use with Main Partner 14.7% 85.3% 
Condom Use with Other Partner 51.3% 48.7% 
Anonymous Partner 9.6% 90.4% 
Meet Through the Internet 19.8% 80.2% 
New Partner <90 days 25.1% 74.9% 
Multiple Partners 23.2% 76.8% 
Met Partner in Bar 6.7% 93.3% 
Met Partner in Bath 0.6% 99.4% 
Knew self-HIV status 0% 100% 
Paid for Sex 2.5% 97.5 
Was Paid for Sex 2.8% 97.2% 
Vaginal or Anal with Woman 32.8% 67.2% 
Oral Sex with Woman 32.5% 67.5% 
Unprotected Sex with Woman 35.2% 64.8% 
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Vaginal or Anal with Man 83.4% 16.6% 
Oral Sex with Man 61.8% 38.2% 
Unprotected Sex with Man 75.1% 24.9% 
Men Having Sex with Men 12.0% 88.0% 
Had a History of STD’s 52.5% 47.5% 
Has had an STD in the last 12 Months 24.2% 75.8% 
Incarcerated in the Last 12 Months 11.0% 89.0% 
Sexual Assault 8.0% 92.0% 
Note: * indicates there were not enough samples to meet Power. Note: Table created from 
data provided by FDOH STARS system and using IBM SPSS version 25.  
South Region 
 The risk factors for the South region can be found in Table 10. The risk factors in 
this region do not fit the current CDC recommendations for at-risk individuals. Of the 
reporting 2.0% of the individuals acquired gonorrhea from a sex worker which is much 
higher than in other regions. Only 4.0% of those who contracted gonorrhea were sex 
workers. Higher than other regions and the State, 66.7% of the respondents had a history 
of STD’s. Supporting the CDC recommendations for at-risk groups, 55.3% stated they 
contracted gonorrhea through men having sex with men. At the time of infection 55.9% 
of the respondents stated they had only on partner; 15.5% had two partners; 7.9% had 3 
partners; and 20.7% had 4 or more partners.  
Table 10 
Risk Factors Listed as Percentage Based on Respondents for the South Region of Florida 
Risk Factor Percentage Yes Percentage No 
Drug Use 49.8% 50.2% 
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Intoxicated; Alcohol or Drug 15.0% 85% 
Always Used Condoms 7.5% 92.5% 
Sometimes Used Condoms 69.0% 11.0% 
Never Used Condoms 16.8% 83.2% 
Condom Use with Main Partner 17.3% 82.7% 
Condom Use with Other Partner 38.2% 61.8% 
Anonymous Partner 44.6% 55.4% 
Meet Through the Internet 32.9% 67.1% 
New Partner <90 days 42.6% 57.4% 
Multiple Partners 28.5% 71.5% 
Met Partner in Bar 19.3% 80.7% 
Met Partner in Bath 8.3% 91.7% 
Knew self-HIV status 0% 100% 
Paid for Sex 2.0% 98.0% 
Was Paid for Sex 4.0% 96.0% 
Vaginal or Anal with Woman 19.4% 80.6% 
Oral Sex with Woman 21.2% 78.8% 
Unprotected Sex with Woman 17.2% 82.8% 
Vaginal or Anal with Man 86.4% 13.6% 
Oral Sex with Man 77.3% 22.7% 
Unprotected Sex with Man 65.3% 34.7% 
Men Having Sex with Men 55.3% 44.7% 
Had a History of STD’s 66.7% 33.3% 
Has had an STD in the last 12 Months 33.1% 66.9% 
Incarcerated in the Last 12 Months 4.6% 95.4% 
Sexual Assault 2.0% 98.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
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Study Results for Research Question 1 
Research Question 1:  Are there differences in using last-line-of-antibiotic-defense 
between Florida as a whole and each of the eight regions?   
Hypothesis 1 
H0: There is no statistical significance between each of the eight different regions 
and Florida as a whole for the last-line-of-antibiotic-defense associated with 
gonococcal infections. 
Ha: There is a statistical significance between each of the eight different regions 
and Florida as a whole for the last-line-of-antibiotic-defense associated with 
gonococcal infections. 
Findings 
Based on the findings the null hypothesis can be rejected when applied to the 
Northwest, Northeast, North Central, East Central, West Central, Southeast, and South 
regions but must be accepted for the Southwest region. The results supporting these 
findings are as follows. 
Chi-square and cross tabulations were conducted to compare the last-line-of-
antibiotic-defense between Florida as a whole and the eight different regions. There is a 
statistically significant association between Florida and the Northwest Region in regard 
to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 14.652, p < 0.05. The results of 
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a 
lower rate for the Northwest region (68.2%) versus Florida (84.8%) (Table A1 Appendix 
A). There is a statistically significant association between Florida and the North Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 29245) = 28.914, p < 
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0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a higher rate for the North Central Region (69.3%) versus Florida 
(81.7%) (Table A2 Appendix A). There is a statistically significant association between 
Florida and the Northeast Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N 
= 33564) = 28.796, p < 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a lower rate for the Northeast Region (70.0%) 
versus Florida (80.4%) (Table A3 Appendix A). There is a statistically significant 
association between Florida and the West Central Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 64192) = 56.274, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the West Central Region (69.5%) versus Florida (84.4%) (Table A4 Appendix A). 
There is a statistically significant association between Florida and the East Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 48836) = 61.793, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a lower rate for the East Central Region (69.8%) versus Florida 
(73.6%) (Table A5 Appendix A). There is not a statistically significant association 
between Florida and the Southwest Region in regard to the last-line-of-antibiotic-defense: 
χ2 (4, N = 48836) = 61.793, p > 0.05. The results of the cross tabulation indicate that the 
last-line-of-antibiotic-defense was prescribed at a lower rate for the Southwest region 
(70%) versus Florida (90.2%) (Table A6 Appendix A). There is a statistically significant 
association between Florida and the Southeast Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 18037) = 54.963, p < 0.05. The results of the cross 
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tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the Southwest Region (68.2%) versus Florida (84.6%) (Table A7 Appendix A). There 
is a statistically significant association between Florida and the South Region in regard to 
the last-line-of-antibiotic-defense: χ2 (4, N = 64110) = 103.973, p < 0.05. The results of 
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a 
lower rate for the South Region (69.6%) versus Florida (73.7%) (Table A8 Appendix A).  
Study Results for Research Question 2 
Research Question 2:  Are there differences in using last-line-of-antibiotic-defense 
among the eight Florida regions?  
Hypothesis 2: 
 
H0: There is no statistical significance between the eight Florida regions in regard 
to the last-line-of-antibiotic-defense for gonococcal infections.  
Ha: There is a statistical significance between the eight Florida regions in regard 
to the last-line-of-antibiotic-defense for gonococcal infections. 
Findings 
Based on the findings the null hypothesis can be rejected. The results supporting 
the findings are the following. Chi-square and a cross tabulations were conducted to 
compare the last-line-of-antibiotic-defense between the eight different regions.  
Northwest Region 
There is a statistically significant association between the Northwest Region and 
the North Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
16945) = 36.322, p < 0.05. The results of the cross tabulation indicate that the last-line-
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of-antibiotic-defense was prescribed at a lower rate for the Northwest Region (84.4%) 
versus the North Central Region (85.4%). There is not a statistically significant 
association between the Northwest Region and the Northeast Region in regard to the last-
line-of-antibiotic-defense: χ2 (4, N = 16946) = 6.601, p > 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the Northwest Region (78.8%) versus the Northeast Region (84.9%). There is a 
statistically significant association between the Northwest Region and the West Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 12.021, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a lower rate for the Northwest Region (80.6%) versus the West Central 
Region (85%). There is a statistically significant association between the Northwest 
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, 
N = 16944) = 10.894, p < 0.05. The results of the cross tabulation indicate that the last-
line-of-antibiotic-defense was prescribed at a higher rate for the Northwest Region 
(84.4%) versus the East Central Region (69.5%). There is a statistically significant 
association between the Northwest Region and the Southwest Region in regard to the 
last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 10.768, p < 0.05. The results of the 
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher 
rate for the Northwest Region (73.6%) versus the Southwest Region (69.8%). There is a 
statistically significant association between the Northwest Region and the Southeast 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 13.113, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
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was prescribed at a higher rate for the Northwest Region (85%) versus the Southeast 
Region (84.7%). There is not a statistically significant association between the Northwest 
Region and the South Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
16946) = 3.950, p > 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the Northwest Region (80.2%) 
versus the South Region (84.9%). 
Northeast Region 
There is a statistically significant association between the Northeast Region and 
the North Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
29244) = 30.497, p < 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a higher rate for the Northeast Region (81.6%) 
versus the North Central Region (80.1%). There is not a statistically significant 
association between the Northeast Region and the Northwest Region in regard to the last-
line-of-antibiotic-defense: χ2 (4, N = 16946) = 6.601, p > 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the Northeast Region (78.8%) versus the Northwest Region (84.9%). There is a 
statistically significant association between the Northeast Region and the West Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 33567) = 104.433, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a higher rate for the Northeast Region (81.6%) versus the West Central 
Region (80.9%). There is a statistically significant association between the Northeast 
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, 
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N = 33564) = 18.613, p < 0.05. The results of the cross tabulation indicate that the last-
line-of-antibiotic-defense was prescribed at a lower rate for the Northeast Region (71.3%) 
versus the East Central Region (80.2%). There is not a statistically significant association 
between the Northeast Region and the Southwest Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 8409) = 8.017, p > 0.05. The results of the cross tabulation 
indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the 
Northeast Region (90%) versus the Southwest Region (73.4%). There is a statistically 
significant association between the Northeast Region and the Southeast Region in regard 
to the last-line-of-antibiotic-defense: χ2 (4, N = 18037) = 30.101, p < 0.05. The results of 
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a 
higher rate for the Northeast Region (85.9%) versus the Southeast Region (78.4%). There 
is a statistically significant association between the Northeast Region and the South 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 33565) = 17.710, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a lower rate for the Northeast Region (79.3%) versus the South Region 
(80.3%). 
North Central Region 
There is a statistically significant association between the North Central Region 
and the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
16945) = 36.322, p < 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a higher rate for the North Central Region 
(85.4%) versus the Northwest Region (84.4%). There is a statistically significant 
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association between the North Central Region and the Northeast Region in regard to the 
last-line-of-antibiotic-defense: χ2 (4, N = 29244) = 30.497, p < 0.05. The results of the 
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower 
rate for the North Central Region (80.1%) versus the Northeast Region (81.6%). There is 
a statistically significant association between the North Central Region and the West 
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 29245) = 
10.644, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a higher rate for the North Central Region (81.6%) 
versus the West Central Region (81.1%). There is a statistically significant association 
between the North Central Region and the East Central Region in regard to the last-line-
of-antibiotic-defense: χ2 (4, N =29242) = 23.896, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the North Central Region (74.5%) versus the East Central Region (81.2%). There is 
not a statistically significant association between the North Central Region and the 
Southwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8408) = 
1.672, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-
defense was prescribed at a higher rate for the North Central Region (90.5%) versus the 
Southwest Region (80.5%). There is a statistically significant association between the 
North Central Region and the Southeast Region in regard to the last-line-of-antibiotic-
defense: χ2 (4, N = 18036) = 12.749, p < 0.05. The results of the cross tabulation indicate 
that the last-line-of-antibiotic-defense was prescribed at a higher rate for the North 
Central Region (90.5%) versus the Southeast Region (80.5%). There is a statistically 
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significant association between the North Central Region and the South Region in regard 
to the last-line-of-antibiotic-defense: χ2 (4, N = 29243) = 13.432, p < 0.05. The results of 
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a 
lower rate for the North Central Region (80.1%) versus the South Region (81.1%). 
West Central Region 
There is a statistically significant association between the West Central Region 
and the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
16946) = 12.021, p < 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a higher rate for the West Central Region (85%) 
versus Northwest Region (80.6%) the. There is a statistically significant association 
between the West Central Region and the Northeast Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 33567) = 104.433, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the West Central Region (80.9%) versus the Northeast Region (81.6%). There is a 
statistically significant association between the West Central Region and the North 
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 29245) = 
10.644, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the West Central Region (81.1%) 
versus the North Central Region (81.6%). There is a statistically significant association 
between the West Central Region and the East Central Region in regard to the last-line-
of-antibiotic-defense: χ2 (4, N = 48839) = 20.258, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
117 
 
for the West Central Region (72.6%) versus the East Central Region (83.1%). There is 
not a statistically significant association between the West Central Region and the 
Southwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 
8.838, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-
defense was prescribed at a higher rate for the West Central Region (90.3%) versus the 
Southwest Region (78.7%). There is a statistically significant association between the 
West Central Region and the Southeast Region in regard to the last-line-of-antibiotic-
defense: χ2 (4, N = 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate 
that the last-line-of-antibiotic-defense was prescribed at a higher rate for the West Central 
Region (85.5%) versus the Southeast Region (79%). There is a statistically significant 
association between the West Central Region and the South Region in regard to the last-
line-of-antibiotic-defense: χ2 (4, N = 64113) = 33.992, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate 
for the West Central Region (73.9%) versus the South Region (84.7%). 
East Central Region 
There is a statistically significant association between the East Central Region and 
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16944) = 
10.894, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the East Central Region (69.5%) 
versus the Northwest Region (84.4%). There is a statistically significant association 
between the East Central Region and the Northeast Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 33564) = 18.613, p < 0.05. The results of the cross 
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tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate 
for the East Central Region (80.2%) versus the Northeast Region (71.3%). There is a 
statistically significant association between the East Central Region and the North 
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N =29242) = 
23.896, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a higher rate for the East Central Region (81.2%) 
versus the North Central Region (74.5%). There is a statistically significant association 
between the East Central Region and the West Central Region in regard to the last-line-
of-antibiotic-defense: χ2 (4, N = 48839) = 20.258, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate 
for the East Central Region (83.1%) versus the West Central Region (72.6%). There is a 
statistically significant association between the East Central Region and the Southwest 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8407) = 9.747, p < 0.05. 
The results of the cross tabulation indicate that the last-line-of-antibiotic-defense was 
prescribed at a higher rate for the East Central Region (90.5%) versus the Southwest 
Region (80.5%). There is a statistically significant association between the East Central 
Region and the Southeast Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N 
= 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a higher rate for the East Central Region (85.4%) 
versus the Southeast Region (76.2%). There is not a statistically significant association 
between the East Central Region and the South Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 48838) = 5.146, p > 0.05. The results of the cross tabulation 
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indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the East 
Central Region (90.5%) versus the South Region (80.5%). 
Southwest Region 
There is a statistically significant association between the Southwest Region and 
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 
10.768, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the Southwest Region (69.8%) 
versus the Northwest Region (73.6%). There is not a statistically significant association 
between the Southwest Region and the Northeast Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 8409) = 8.017, p > 0.05. The results of the cross tabulation 
indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate for the 
Southwest Region (73.4%) versus Northeast Region (90%) the. There is not a statistically 
significant association between the Southwest Region and the North Central Region in 
regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8408) = 1.672, p > 0.05. The 
results of the cross tabulation indicate that the last-line-of-antibiotic-defense was 
prescribed at a lower rate for the Southwest Region (80.5%) versus the North Central 
Region (90.5%). There is not a statistically significant association between the Southwest 
Region and the West Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, 
N = 8409) = 8.838, p > 0.05. The results of the cross tabulation indicate that the last-line-
of-antibiotic-defense was prescribed at a higher rate for the Southwest Region (78.7%) 
versus the West Central Region (90.3%). There is a statistically significant association 
between the Southwest Region and the East Central Region in regard to the last-line-of-
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antibiotic-defense: χ2 (4, N = 8407) = 9.747, p < 0.05. The results of the cross tabulation 
indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate for the 
Southwest Region (80.5%) versus the East Central Region (90.5%). There is a 
statistically significant association between the Southwest Region and the Southeast 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 13.287, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a lower rate for the Southwest Region (85.3%) versus the Southeast 
Region (90.5%). There is not a statistically significant association between the Southwest 
Region and the South Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 
8409) = 4.268 p > 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the Southwest Region (76.5%) 
versus the South Region (90.3%). 
Southeast Region 
There is a statistically significant association between the Southeast Region and 
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 
13.113, p < 0.05. The results of the cross tabulation indicate that the last-line-of-
antibiotic-defense was prescribed at a lower rate for the Southeast Region (84.7%) versus 
the Northwest Region (85%). There is a statistically significant association between the 
Southeast Region and the Northeast Region in regard to the last-line-of-antibiotic-
defense: χ2 (4, N = 18037) = 30.101, p < 0.05. The results of the cross tabulation indicate 
that the last-line-of-antibiotic-defense was prescribed at a lower rate for the Southeast 
Region (78.4%) versus the Northeast Region (85.9%). There is a statistically significant 
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association between the Southeast Region and the North Central Region in regard to the 
last-line-of-antibiotic-defense: χ2 (4, N = 18036) = 12.749, p < 0.05. The results of the 
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower 
rate for the Southeast Region (80.5%) versus the North Central Region (90.5%). There is 
a statistically significant association between the Southeast Region and the West Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 18037) = 25.723, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a lower rate for the Southeast Region (79%) versus the West Central 
Region (85.5%). There is a statistically significant association between the Southeast 
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, 
N = 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate that the last-
line-of-antibiotic-defense was prescribed at a lower rate for the Southeast Region (76.2%) 
versus the East Central Region (85.4%). There is a statistically significant association 
between the Southeast Region and the Southwest Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 8409) = 13.287, p < 0.05. The results of the cross tabulation 
indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the 
Southeast Region (90.5%) versus the Southwest Region (85.3%). There is a statistically 
significant association between the Southeast Region and the South Region in regard to 
the last-line-of-antibiotic-defense: χ2 (4, N = 16037) = 17.020, p < 0.05. The results of 
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a 




There is not a statistically significant association between the South Region and 
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 
3.950, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-
defense was prescribed at a higher rate for the South Region (84.9%) versus the 
Northwest Region (80.2%). There is a statistically significant association between the 
South Region and the Northeast Region in regard to the last-line-of-antibiotic-defense: χ2 
(4, N = 33565) = 17.710, p < 0.05. The results of the cross tabulation indicate that the 
last-line-of-antibiotic-defense was prescribed at a higher rate for the South Region 
(80.3%) versus the Northeast Region (79.3%). There is a statistically significant 
association between the South Region and the North Central Region in regard to the last-
line-of-antibiotic-defense: χ2 (4, N = 29243) = 13.432, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate 
for the South Region (81.1%) versus the North Central Region (80.1%). There is a 
statistically significant association between the South Region and the West Central 
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 64113) = 33.992, p < 
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense 
was prescribed at a higher rate for the South Region (84.7%) versus the West Central 
Region (73.9%). 
There is not a statistically significant association between the South Region and 
the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 48838) 
= 5.146, p > 0.05. The results of the cross tabulation indicate that the last-line-of-
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antibiotic-defense was prescribed at a lower rate for the South Region (80.5%) versus the 
East Central Region (90.5%). There is not a statistically significant association between 
the South Region and the Southwest Region in regard to the last-line-of-antibiotic-
defense: χ2 (4, N = 8409) = 4.268 p > 0.05. There is a statistically significant association 
between the South Region and the Southeast Region in regard to the last-line-of-
antibiotic-defense: χ2 (4, N = 16037) = 17.020, p < 0.05. The results of the cross 
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate 
for the South Region (85.2%) versus the Southeast Region (79.7%).  
Study Results for Research Question 3 
Research Question 3: What are the statistically significant factors associated with being 
treated with last-line-of-antibiotic-defense in each of the eight regions and the 
state of Florida? 
Hypothesis 3: 
 
H0: There are no statistically significant factors associated with being treated with 
last-line-of-antibiotic-defense in the eight regions.  
Ha: There are statistically significant factors associated with being treated with 
last-line-of-antibiotic-defense in the eight regions.  
Findings 
There is statistical significance between the initial treatment and statistically 
significant risk factors and demographics per region. Based on these findings the null 
hypothesis can be rejected. The results supporting these findings area as follows. Multiple 
logistic regression models were conducted for each of the eight regions and Florida as a 
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whole. Race/ethnic populations, age range, gender, men who have sex with men, sexual 
orientation, and pregnancy in relationship to the prescribed last-line-of-antibiotic-defense 
were compared. There are 27 identified significant risk factors that were also compared to 
the last-line-of-antibiotic-defense.  
State of Florida 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are race/ethnicity, age 
range, gender, pregnancy, always use condoms, HIV self-aware, oral sex with female, 
unprotected anal or vaginal sex with a male, history of a prior STD, and had an STD in 
the last 12 months from the time of the infection (Table B1 Appendix B). The multiple 
logistic regression for Florida there are ten statistically significant variables. Of those ten 
statistically significant variables three have an increased likelihood of being prescribed 
the last-line-of-antibiotic-defense. This then indicates that these particular variables could 
be indicative of the probability of developing drug resistance for gonococcal infections. 
These variables are age range which has a 3.4% increase likelihood of being prescribed 
the last-line-of-antibiotic-defense, oral sex with a female has a 22.1% greater likelihood 
of receiving the last-line-of-antibiotic-defense, and sex with a male has a 16.6% greater 
likelihood of being prescribed the last-line-of-antibiotic-defense. Race/ethnicity, gender, 
pregnancy, always using condoms, knowing your HIV status, history of a prior STD, 
history of a prior STD within 90 days, and gender may all be protective factors Since 
these are less likely to be prescribed the last-line-of-antibiotic-defense. It appears that 
gender would be the greatest protective factor. Within gender alone as an internal 
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comparison an odds ratio was conducted for males versus females (female versus male, 
OR = 0.756 (95% CI: 0.742, 0.770). Females have a less likelihood of being prescribed 
the last-line-of-antibiotic-defense versus males (OR = 0.944 (95% CI: 0.941, 0.948)) and 
males have a 5.96% greater likelihood of being prescribed the last-line-of-antibiotic-
defense. 
Northwest Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are age range, men who 
have sex with men, sexual orientation, pregnancy, sometimes use condoms, never use 
condoms, HIV self-aware, oral sex with female, unprotected anal or vaginal sex with a 
male, and had history of a prior STD (Table B2 Appendix B). In the Northwest Region 
there are eight statistically significant risk factors based on the multiple logistic 
regression. Of the eight variables four variables have an increased likelihood of being 
prescribed the last-line-of-antibiotic-defense. Age groups have only a 2.3% increase 
likelihood of being prescribed the last-line-of-antibiotic-defense. If a person had a history 
of a prior STD have a 25.1% chance increased likelihood of being prescribed the last-
line-of-antibiotic-defense. Those who only use condoms sometimes have a 135.6% 
increased chance of being prescribed the last-line-of-antibiotic-defense. Those who never 
use condoms have a 137.2% increase chance of being prescribed the last-line-of-
antibiotic-defense. This then indicates that these particular variables could be indicative 
of the probability of developing drug resistance for gonococcal infections. The remaining 
variables such as knowing HIV status, pregnancy, sexual orientation, and men who have 
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sex with men are more likely to be protective factors, with men who have sex with men 
being the greatest protective factor.  
Northeast Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are age range, gender, 
sexual orientation, pregnancy, sometimes use condoms, new partner within 90 days at the 
time of the infection, number of sex partners, HIV self-aware, oral sex with female, and 
incarcerated within the last 12 months from the time of infection (Table B3 Appendix B). 
The multiple logistic regression for the Northeast Region indicates that there are ten 
statistically significant risk factors. There are three risk factors that are at an increased 
risk of being prescribed the last-line-of-antibiotic-defense. Age range has a 6.2% 
increased risk of being prescribed the last-line-of-antibiotic-defense. The number of sex 
partners have a 14% increase of being prescribed the last-line-of-antibiotic-defense. 
Having oral sex with a female is a 149.4% increase chance of being prescribed the last-
line-of-antibiotic-defense. There are seven factors that may have a protective effect these 
are gender, sexual orientation, pregnancy, sometimes using condoms, new partner within 
90 days, knowing HIV status, and incarcerated within the last 12 months. Of these factors 
gender has the greatest protective effect. Within gender alone as an internal comparison, 
an odds ratio was conducted for males versus females (female versus male, OR = 0.616 
(95% CI: 0.584, 0.651). Females have a less likelihood of being prescribed the last-line-
of-antibiotic-defense versus males (OR = 0.911 (95% CI: 0.901, 0.920)) and males have a 
9.79% greater likelihood of being prescribed the last-line-of-antibiotic-defense. 
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North Central Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are race/ethnicity, 
gender, men who have sex with men, sexual orientation, pregnancy, condom use with 
other partners, HIV self-aware, and oral sex with male (Table B4 Appendix B). The 
multiple logistic regression for the North Central Region indicates that there are nine 
statistically significant risk factors. There is only one risk factor that are at an increased 
risk of being prescribed the last-line-of-antibiotic-defense. Those who used condoms with 
their other partner had a 99.3% increased risk of being prescribed the last-line-of-
antibiotic-defense. There are eight factors that may have a protective effect these are 
race/ethnics, gender, men who have sex with men, sexual orientation, pregnancy, 
knowing HIV status, and oral sex with a male. Of these factors, pregnancy has the 
greatest protective effect.  
West Central Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are race/ethnicity, age 
range, gender, men who have sex with men, sexual orientation, pregnancy, condom use 
with other partners, HIV self-aware, and vaginal or anal sex with a female (Table B5 
Appendix B). The multiple logistic regression for the West Central Region indicates that 
there are eight statistically significant risk factors. There is only one risk factor that are at 
an increased risk of being prescribed the last-line-of-antibiotic-defense. Age range had a 
4.0% increased risk of being prescribed the last-line-of-antibiotic-defense. There are 
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seven factors that may have a protective effect, and these are race/ethnics, gender, men 
who have sex with men, sexual orientation, pregnancy, knowing HIV status, and vaginal 
or anal sex with a female. Of these factors, pregnancy has the greatest protective effect.  
East Central Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are race/ethnicity, age 
range, gender, pregnancy, drug use, always use condoms, HIV self-aware, and victim of 
sexual assault (Table B6 Appendix B). The multiple logistic regression for the East 
Central Region indicates that there are eight statistically significant risk factors. There are 
two risk factors that are at an increased risk of being prescribed the last-line-of-antibiotic-
defense. Age range had a 4.7% increased risk of being prescribed the last-line-of-
antibiotic-defense. Condom use always had a 77.6% increased risk of being prescribed 
the last-line-of-antibiotic-defense. There are six factors that may have a protective effect, 
and these are race/ethnics, gender, pregnancy, drug use, knowing HIV status, and victim 
of sexual assault. Of these factors, pregnancy has the greatest protective effect.  
Southeast Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are age range, men who 
have sex with men, sexual orientation, pregnancy, HIV self-aware, was paid for sex, 
vaginal or anal sex with a man, incarcerated within the last 12 months from the time of 
infection, and victim of sexual assault (Table B7 Appendix B). The multiple logistic 
regression for the Southeast Region indicates that there are nine statistically significant 
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risk factors. There two risk factors that are at an increased risk of being prescribed the 
last-line-of-antibiotic-defense. Age range had an 8.1% increased risk of being prescribed 
the last-line-of-antibiotic-defense. Those who were incarcerated within the last 12 months 
of the time of the infection had a 29.3% increased risk of being prescribed the last-line-
of-antibiotic-defense. There are seven factors that may have a protective effect, and these 
are men who have sex with men, sexual orientation, pregnancy, knowing HIV status, was 
paid for sex, vaginal or anal sex with a male, and victim of sexual assault. Of these 
factors, victim of sexual assault has the greatest protective effect.  
Southwest Region 
 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are age range, sexual 
orientation, pregnancy, oral sex with a female, and a history of a prior STD (Table B8 
Appendix B). The multiple logistic regression for the Southwest Region indicates that 
there are five statistically significant risk factors. There are two risk factors that are at an 
increased risk of being prescribed the last-line-of-antibiotic-defense. Age range had an 
4.9% increased risk of being prescribed the last-line-of-antibiotic-defense. Those who 
had oral sex with a female had a 141.2% increased risk of being prescribed the last-line-
of-antibiotic-defense. There are three factors that may have a protective effect, and these 
are sexual orientation, pregnancy, and those who had a history of a prior STD within the 
last 12 months from the time of the infection. Of these factors, pregnancy has the greatest 




 The results of the multiple logistic regression indicate that some of the 
demographics and risk factors are statistically significant. These are race/ethnicity, age 
range, gender, men who have sex with men, sexual orientation, pregnancy, HIV self-
aware, and was paid for sex (Table B9 Appendix B). The multiple logistic regression for 
the South Region indicates that there are eight statistically significant risk factors. There 
are three risk factors that are at an increased risk of being prescribed the last-line-of-
antibiotic-defense. Age range had an 5% increased risk of being prescribed the last-line-
of-antibiotic-defense. Men who have sex with men had an 48.7% increased risk of being 
prescribed the last-line-of-antibiotic-defense. Sexual orientation had a 16% increased risk 
of being prescribed the last-line-of-antibiotic-defense. There are five factors that may 
have a protective effect, and these are race/ethnicity, gender, pregnancy, knowing HIV 
status, and was paid for sex. Of these factors, gender has the greatest protective effect. 
Within gender alone as an internal comparison, an odds ratio was conducted for males 
versus females (female versus male, OR = 0.829 (95% CI: 0.799, 0.860). Females have a 
less likelihood of being prescribed the last-line-of-antibiotic-defense versus males (OR = 
0.952 (95% CI: 0.942, 0.961)) and males have a 5.2% greater likelihood of being 
prescribed the last-line-of-antibiotic-defense. 
Risk-factor comparisons for the Regions 
 Every region with the accept of the North Central Region shares one common 
increased risk factor of statistical significance that has an increased likelihood for being 
prescribed the last-line-of-antibiotic-defense. That risk factor is age ranges. The North 
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Central Region also has age range as an increased likelihood for being prescribed the last-
line-of-antibiotic-defense but based on a p-value of 0.05 it was not considered 
statistically significant. Had the p-value been 0.10 then it would have been considered 
statistically significant. The Northwest Region, the North Central Region, and the East 
Central Region, shared some level of condom use as having an increased likelihood for 
being prescribed the last-line-of-antibiotic-defense. The North East Region and the 
Southwest Region shared oral sex with a female as having an increased likelihood for 
being prescribed the last-line-of-antibiotic-defense.  
Protective Factor Comparisons for the Regions 
 All regions shared a statistically significant protective factor and that was 
pregnancy. There were other statistically significant protective factors that had 
commonality in the Regions. All regions except for the Southwest Region shared the 
protective factor and a reduced risk for being prescribe the last-line-of-antibiotic-defense 
for those who knew their HIV status. There were other shared common protective factors 
for some of the Regions. Race/ethnics was shared for the North Central Region, the West 
Central Region, the East Central Region, and the South Region. Gender was shared for 
the Northeast Region, the North Central Region, the West Central Region, the East 
Central Region, and the South Region. Sexual orientation was shared with the Northwest 
Region, the North Central Region, the West Central Region, Southeast Region, and the 
Southwest Region. The South East Region and the South Region shared those who were 
paid for sex as a protective factor. The remaining statistically significant protective 
factors within each region are unique to those areas.  
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Protective and Risk-factor comparisons for the Regions 
In some instances, a protective factor in one region became a risk factor in 
another region. Men who have sex with men is considered a protective factor in the 
Northwest Region, the North Central Region, the West Central Region, and the Southeast 
Region but is a risk factor in the South Region. Sexual orientation is considered a 
protective factor in the Northwest Region, the North East Region, the North Central 
Region, the West Central Region, Southeast Region, and the Southwest Region but is a 
risk factor in the South Region. Incarcerated within the last 12 months from the time of 
the infection was a protective factor in the Northeast Region but was a risk factor in the 
Southeast Region.  
Risk-factor comparisons for the Regions and State 
Florida and every region with the accept of the North Central Region shares one 
common increased risk factor of statistical significance that has an increased likelihood 
for being prescribed the last-line-of-antibiotic-defense. That risk factor is age ranges. The 
state of Florida, the North East Region, and the Southwest Region shared oral sex with a 
female as having an increased likelihood for being prescribed the last-line-of-antibiotic-
defense. No other increased likelihood for being prescribed the last-line-of-antibiotic-
defense risk factors were shared among Florida and the regions (Table 11). Florida and 
regions had unshared risk factors for the increased likelihood for being prescribed the 
last-line-of-antibiotic-defense. For instance, Florida had vaginal or anal sex unprotected 
with a male; the Northwest Region had for those who had history of STD any time in 
their past; the Northeast Region had an increased risk for a number of sex partners; the 
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Southeast Region had an increased risk for those who incarcerated within the last 12 
months since the time of the infection; and the South region had an increased risk for 
those men who had sex with men and sexual orientation (Table 11).  
Protective Factor Comparisons for the Regions and State 
Florida and all regions shared a statistically significant protective factor and that 
was pregnancy. There were other statistically significant protective factors that had 
commonality in the Regions and the State. Florida and all regions except for the 
Southwest Region shared the protective factor and a reduced risk for being prescribe the 
last-line-of-antibiotic-defense for those who knew their HIV status. There were other 
shared common protective factors for some of the Regions and State. Race/ethnics was 
shared for the state of Florida, the North Central Region, the West Central Region, the 
East Central Region, and the South Region. Gender was shared for the state of Florida, 
the Northeast Region, the North Central Region, The West Central Region, the East 
Central Region, and the South Region. Sexual orientation was shared with the Northwest 
Region, the North Central Region, the West Central Region, Southeast Region, and the 
Southwest Region. Florida and the Southwest Region shared history of an STD in the last 
12 months from the time of infection as a protective factor. The South East Region and 
the South Region shared those who were paid for sex as a protective factor. The 
remaining statistically significant protective factors within Florida and each region are 
unique to those areas (Table 11).  
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Protective and Risk-factor Comparisons for the Regions and State 
In some instances, a protective factor in one region or the state became a risk 
factor in another region or for the State. Condom use always is a protective factor in 
Florida but a risk factor in the East Central Region. In Florida having a history of an STD 
at any time is a protective factor but is a risk factor in the Northwest Region. Also, in 
Florida always using condoms is a protective factor but in the East Central Region it is 
considered a risk factor. A similar comparison but not exact is that vaginal or anal 
unprotected sex with a male is a risk factor in the state of Florida, but vaginal or anal sex 
with a male is considered a protective factor in the Southeast Region (Table 11).  
Table 11  
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Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Summary 
 The data provided by Florida presented significant findings. These findings 
indicate that there are statistically significant predictive risk factors related to 
antimicrobial resistant gonorrhea. The findings also indicate that there are variations 
between Florida as a whole and the individual regions. No region, nor Florida shared the 
exact same results. Each had its own unique and specific risk factors. Thus, further 
supporting the intended purpose of this study. The research questions were able to be 
successfully answered and provided statistically significant insight. The results of this 




Chapter 5: Discussion 
Introduction 
The purpose of this study was to identify at-risk groups for contracting drug-
resistant gonorrhea. Drug resistance is driven by overuse of antibiotics. The CDC as well 
as work conducted by Alirol et al. (2017), Barbee (2014), Chesson et al. (2014), Hooke 
et. al. (2013), Kirkcaldy (2016), Marti et al. (2016), Tapsall et al. (2009), Tuite et al. 
(2017), Unemo and Shafer (2014), Ventola (2015), Whiley et al. (2012), and Wi et al. 
(2017), indicated that there is only one effective last-line-of-antibiotic-defense left and 
continued use of this last-line-of-antibiotic-defense will lead to complete drug resistance. 
Unless new antibiotics are derived, it is only a matter of time before there is no cure. In 
March of 2018, the first fully drug-resistant strain of gonorrhea emerged (Ducharme, 
2018). Since there is currently only one CDC recommended treatment for drug-resistant 
gonorrhea, aggressive targeted interventions will be the next step. It is important to 
identify who these at-risk individuals are. The identification process was based on the 
prescribed last-line-of-antibiotic-defense. Comparisons were conducted between the last-
line-of-antibiotic-defense and demographic and risk factors to provide statistically 
significant models. This information can now be used to develop targeted interventions.  
As mentioned in earlier chapters, demographics change throughout the state of 
Florida. The state was split into eight different regions as assigned by the FDOH (Figure 
1). The results indicated that each region has differences from one another and the state 
of Florida. The statistically significant factors are not fully uniform from region to region, 
nor in comparison to the state. Although there are some similar characteristics, findings 
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indicate that those who are at-risk for contracting drug-resistant gonococcal infections 
vary differently among the different regions and Florida.  
The secondary data on risk factors for gonococcal infection were provided by the 
FDOH for this study. The data were statistically evaluated to identify the statistically 
significant at-risk groups for contracting drug-resistant strains of gonorrhea for Florida as 
well as eight different regions of the state. The concept of contracting drug-resistant 
strains can be looked at in two different ways: (a) One can directly contract a drug-
resistant strain from someone who is carrying the drug-resistant strain.  (b) The 
gonococcal strain can become drug resistant within the individual (Reygaert, 2018). This 
can occur through transduction between reservoir bacteria in the Neisseria genus (Igawa, 
2018; Wadsworth, Arnold, Sater, & Grad, 2018). Currently, gonorrhea has begun to 
become resistant to the last line of antibiotic treatment and it is also believed to be driven 
through reservoir bacteria in the Neisseria genus (Igawa, 2018; Martin et al., 2019). A 
study by Sánchez-Busó and Harris (2019) looked at genomics to understand the pathway 
mechanisms. They indicated that not only is drug-resistant gonorrhea being passed in 
high-risk groups, but it may also be silently spreading in the low-risk groups, thus leading 
to a public health crisis.  
 Since Florida stopped monitoring for drug resistance in 2013, and tested for drug 
resistance only in select populations, this study was challenging to conduct. First, the 
drug-resistant gonococcal data were biased and could not be used because not all infected 
individuals were tested. The state only tested those groups that were identified as high 
risk by the CDC and those demographic groups do not necessary coincide with the 
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diverse demographics within the state of Florida. Additionally, there was only one testing 
site in the entire state of Florida from the 1990’s to 2013. This testing site was located in 
the South Region making it difficult for individuals residing in other areas of the state to 
access. Because there was no significant data directly related to drug resistance, this 
study took a different approach that was supported by the literature and evaluated risk 
factors and demographics that were at-risk for being prescribed the last-line-of-antibiotic-
defense. This in turn elucidates the most likely groups to develop, contract, and evolve 
drug-resistant gonorrhea. The findings were then used to develop a predictive model for 
drug resistance for Florida and the eight Florida regions. Ultimately the goal is to utilize 
these findings to create targeted interventions to prevent, slow, or even stop the spread of 
drug-resistant variants in the state of Florida.  
Interpretation of the Findings 
There were descriptive statistics that were incorporated into the interpretation of 
the findings. The biggest populations for contracting gonorrhea were heterosexuals 
(74.2%), African American (52.9%), males (54.3%) and under the age of 30 years (73%). 
The highest concentration of infections were those ages 20 to 24 years. Other key factors 
that stood out was that unprotected sex (94.7%) and having a history of an STD (60.2%). 
Preventative measures would focus on these key demographics and risk factors. There 
also needs to be intervention focus on those who have had and STD. This information can 
be presented at the time of diagnosis with emphasis on drug resistance. Safe sex practices 
will always need emphasis  
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The descriptive statistics elucidated some interesting findings per each region. 
The Northwest Region’s largest populations for contracting gonorrhea were 
heterosexuals (89.2%), African Americans (43.7%), females (52.1%), and those under the 
age of 30 years (76.8%). The highest concentration of infections were those ages 20 to 24 
years (33.4%). Other key factors that stood out was that unprotected sex either vaginal or 
anal with a man and having a history of an STD. The Northeast Region’s largest 
populations for contracting gonorrhea were heterosexuals (79.1%), African Americans 
(67.5%), males (51.5%), and those under the age of 30 years (73.7%). The highest 
concentration of infections was individual between ages 20 to 24 years (33.2%). Other 
key factors that stood out were that unprotected sex either vaginal or anal with a man, 
oral sex with a man, and having a history of an STD. The North Central Region’s largest 
populations for contracting gonorrhea were heterosexuals (88.7%), African Americans 
(59%), females (52.6%), and those under the age of 30 years (90.5%). Other key factors 
was sex while intoxicated and drug use among the infected. As for age, the highest 
concentration of infections were those ages 20 to 24 years (37.2%). Other key factors that 
stood out was that unprotected sex either vaginal or anal with a man, oral sex with a man, 
and having a history of an STD.  
The West Central Region’s largest populations for contracting gonorrhea were 
heterosexuals (79.4%), African Americans (53.3%), males (52.2%), and those under the 
age of 30 years (74.1%). As for age, the highest concentration of infections were those 
ages 20 to 24 years (32.2%). Other key factors that stood out was that unprotected sex 
either vaginal or anal with a man, oral sex with a man, and having a history of an STD. 
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Drug use was also a factor in this region. The East Central Region’s largest populations 
for contracting gonorrhea were heterosexuals (79.4%), African Americans (53.3%), 
males (52.1%) and those under the age of 30 years (74.1%). As for age, the highest 
concentration of infections were those ages 20 to 24 years (32.3.%). Other key factors 
that stood out was that unprotected sex either vaginal or anal with a man, oral sex with a 
man, and having a history of an STD. Drug use was also a factor in this region.  
The Southeast Region’s largest populations for contracting gonorrhea were 
heterosexuals (86.6%), African Americans (58%), males (52.3%), and those under the 
age of 30 years (72.4%). As for age, the highest concentration of infections were those 
ages 20 to 24 years (31.9%). Other key factors that stood out was that unprotected sex 
either vaginal or anal with a man, oral sex with a man, and having a history of an STD. 
Drug use was also a factor in this region. The Southwest Region’s largest populations for 
contracting gonorrhea were heterosexual (85.7%), African Americans (45.2%), males 
(50.8%) and those under the age of 30 years (75.8%). As for age, the highest 
concentration of infections were those ages 20 to 24 years (32.4%). Other key factors that 
stood out were unprotected sex either vaginal or anal with a man, oral sex with a man, 
and having a history of an STD. Drug use was also a factor in this region. The South 
Region’s largest populations for contracting gonorrhea were homosexuals (48.2%), 
African American (47.4%), males (63.9%) and those under the age of 30 years (67.2%). 
It is also important to note that 20.3% of the infected population was Hispanic. As for 
age, the highest concentration of infections were those ages 20 to 24 years (28.8%). 
There is a larger increase in the Hispanic population in this area in comparison to other 
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regions. Other key factors that stood out was that unprotected sex either vaginal or anal 
with a man, oral sex with a man, and having a history of an STD. Drug use was also a 
factor in this region.  
Overview 
 All of the regions and Florida share some commonalities, but none are exactly the 
same to each other.  This indicates that each region and Florida, each have their own 
unique risk factors.  The core common demographics for gonococcal infections are those 
African American and those under the age of 30 years with the highest concentration in 
the age range of 20 to 24 years. Gender changes depending on region but begins to 
concentrate in males as one moves south in the State. Along this southern movement drug 
use, men who have sex with men, and the infections in the Hispanic population became 
more prominent. This is reflective of the demographic changes that occur when one 
moves from the northern end to the southern end of the State. The northern end of the 
state to the central and west central area is primarily farming, rural, and is considered 
conservative. As one moves south the state becomes more populated and drifts to a less 
conservative, high paced, wealthy, and celebratory atmosphere. Risk factors that were 
consistent across the regions and the state were lack of condom use (safe sex practices) 
and had a history of a prior STD. This is an important finding. Repeated gonococcal 
infections in the same population coupled with the use of last-line-of-antibiotic-defense, 
which the dominantly prescribe medication in all regions and the State, increases the 
chances of developing drug-resistant strains.  
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Research Question 1:  Are there differences in using last line antibiotic defense between 
Florida as a whole and each of the eight regions?   
 The differences were compared using Chi-square and cross-tabulation analysis. 
The findings support that there are variations among the regions in relationship to the 
state indicating that last-line-of-antibiotic-defense may drive drug resistance differently 
by region verses the State. Comparing the state to all the regions, across the board the 
state as a whole the last-line-of-antibiotic-defense was prescribed higher in compared to 
some regions and lower compared to other regions. For instance, with ethnics, the last-
line-of-antibiotic-defense was prescribed higher in the Northwest, Northeast, North 
Central, West Central, Southeast, and Southwest Regions than the state of Florida, 
whereas the last-line-of-antibiotic-defense was prescribed at a lower rate for the East 
Central and South Regions than the state of Florida. These findings were statistically 
significant for every region except for the Southwest region.  
Research Question 2:  Are there differences in using last-line-of-antibiotic-defense 
among the eight Florida regions?  
 The regions were compared to one another using Chi-square and cross tabulation 
analysis. The regions were compared to each other. The East Central region was 
prescribed the last-line-of-antibiotic-defense at a higher rate than five of the seven other 
regions. The South region was prescribed the last-line-of-antibiotic-defense at a higher 
rate than four of the seven other regions. The Northwest, Northeast, and North Central 
regions were prescribed the last-line-of-antibiotic-defense at a rate higher than three of 
the seven other regions. The West Central region was prescribed the last-line-of-
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antibiotic-defense at a rate higher than two of the seven other regions. The Southeast 
region was prescribed the last-line-of-antibiotic-defense at a rate higher than one of the 
seven other regions. The Southwest region was prescribed the last-line-of-antibiotic-
defense at a rate lower than the seven other regions. Based on these findings it can be 
elucidated that the East Central and South regions have a high probability of developing 
drug resistance strains of gonorrhea. This indicates that residents in these regions are at a 
higher risk of contracting drug-resistant gonorrhea.  
Research Question 3: What are the statistically significant factors associated with being 
treated with last-line-of-antibiotic-defense in each of the eight regions and the 
state of Florida? 
 A multiple logistic regression calculation was conducted to identify predictive 
risk and demographic factors. Inclusive a calculation for Florida was conducted to use as 
a comparison. 
Northwest Region 
 The final results indicate for the Northwest Region, there were four risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
They were age, sometimes using condoms, never using condoms, and history of an STD. 
Overall, the age groups that had the highest rates among the total infected population 
were those between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to 
29 years. These age groups not only were the majority of the infection, but they were 
most often prescribed the last-line-of-antibiotic-defense at rates of 80% or greater. The 
lack of condom use leading to unprotected sex, is a risk factor. Having a prior history of 
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an STD is also a risk factor. Contrary to the CDC statement that men who have sex with 
men are at-risk it seems that in this region men who have sex with men are a protective 
factor. Inclusive of protection is sexual orientation, awareness of HIV status, and 
pregnancy. Targeted intervention for the Northwest Region should focus on individuals 
ages 16 to 29 years and who have had a history of a prior STD. In addition, emphasis 
needs to focus on condom use. This would also reduce the chance of drug resistance.  
Northeast Region 
 The final results indicate for the Northeast Region, there were three risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
These were age, number of sex partners, and oral sex with a female. Overall, the age 
groups that had the highest rates of gonococcal infections were those between the ages of 
20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age groups not 
only were the majority of the infection, but they were most often prescribed the last-line-
of-antibiotic-defense at rates of 79% or greater. The number of sex partners and oral sex 
with a female are also considered a risk factor compared to other factors. Protective 
factors are gender, sexual orientation, pregnancy, sometimes using condoms, new partner 
within the first 90 days, aware of HIV status, and incarcerated within 12 months of the 
time of the infection. Other protective factors such as sexual orientation and awareness of 
the HIV status may contribute to a greater awareness of sexually transmitted diseases 
thus greater care maybe utilized during sexual contact. If a targeted intervention would be 
created for the Northeast Region, it is recommended that it be focused an age, especially 
those between the ages of 16 and 29 years.  
145 
 
North Central Region 
 Interestingly, in this region the only risk factor is the lack of condom use with the 
other partner in relationship to their main partner where condom use was regularly 
practiced. Age would have been a risk factor if p<0.10 instead of p<.05. There were no 
other significant risk factors. The rest were protective factors such as race/ethnics, 
gender, men who have sex with men, sexual orientation, pregnancy, oral sex with men, 
and aware of HIV status. This may be due to the remoteness of the North Central Region 
in comparison to the rest of the state of Florida. There are two semi-major cities: 
Tallahassee and Gainesville. Tallahassee is the capital of Florida and the population is 
only considered large when government is in session and Florida state University is 
hosting courses. Gainesville population is only considered large when the University of 
Florida is hosting courses. During the offseason, the population decreases in those areas. 
In addition, during the reporting of an infection, a patient’s home location is normally 
reported. Considering these two cities are transient due to the two universities and 
government headquarters, the reporting of the infection may be assigned to a different 
geographical location in the State. As for targeted intervention, this region hosts the two 
of the three largest universities in Florida targeted intervention should still focus on 
young adults, the age groups between the age of 16 and 29 years. Although age was 
considered statistically not significant based on a p< 0.05 if one were to base statistical 
significance on a p<0.10 being statistically significant then age would be considered 
statistically significant. Greater than 80% of the individuals in these age categories 
received the last-line-of-antibiotic-defense.  
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West Central Region 
 The final results indicate for the West Central Region, there were two risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
These are age. Overall, the age groups that had the highest rates of gonococcal infections 
were those between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to 
29 years. These age groups not only were the majority of the infection, but they were 
often prescribed the last-line-of-antibiotic-defense at rates of 84% or greater. Protective 
factors include race/ethnics, gender, men who have sex with men, sexual orientation, 
pregnancy, aware of HIV status, and vaginal or anal sex with a female. If a targeted 
intervention were created for the West Central Region, it is recommended that it be 
focused a specific age group, especially those between the ages of 16 and 29 years. 
Southeast Region 
The final results indicate for the Southeast Region, there are two risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
These were age and incarcerated within the last 12 months from the time of the infection. 
Overall, the age groups that had the highest rates of gonococcal infections were those 
between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to 29 years. 
These age groups not only were the majority of the infection, but they were often 
prescribed the last-line-of-antibiotic-defense at rates of 72% or greater. This was much 
lower than in other regions, none the less still a high level overall. Protective factors 
include gender, men who have sex with men, sexual orientation, pregnancy, aware of 
HIV status, was paid for sex, and vaginal or anal sex with a male. Although it may be 
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considered a risk factor, an individual who is paid for sex may be more aware of the 
possibilities of STD infections and will take additional precautions. If a targeted 
intervention would be created for the Southeast Region, it is recommended that it be 
focused some specific age groups, especially those between the ages of 16 and 29 years. 
Southwest Region 
The final results indicate for the Southwest Region, there are two risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
These were age and oral sex with a female. Overall, the age groups that had the highest 
rates of gonococcal infections were those between the ages of 20 to 24 years then 
followed by 16 to 19 years and 25 to 29 years. These age groups not only were the 
majority of the infection, but they were often prescribed the last-line-of-antibiotic-
defense at rates of 85% or greater. Protective factors sexual orientation, pregnancy, aware 
of HIV status, and had a history of an STD in the last 12 months from the time of the 
infection. If a targeted intervention would be created for the southwest region, it is 
recommended that it be focused some specific age groups, especially those between the 
ages of 16 and 29 years. 
South Region 
The final results indicate for the South Region, there are three risk factors 
contributing to drug resistance by being prescribed the last line of antibiotic treatment. 
These were age, men who have sex with men (MSM), and sexual orientation. Overall, the 
age groups that had the highest rates of gonococcal infections were those between the 
ages of 20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age 
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groups not only were the majority of the infection, but they were often prescribed the 
last-line-of-antibiotic-defense at rates of 85% or greater. Additionally, the South Region 
which encompasses a large LGBT population which host large city-wide events 
regularly. It is also an international tourist hotspot. Fort Lauderdale, Miami, Miami 
Beach, and Key West are located in this region. These cities are known for extravagant 
lifestyles and nightlife. Miami hosts a large Latin American population and the culture 
celebrates regularly and extravagantly in Miami. Brazilian Carnival and Carnival de 
Barranquilla are some of the largest Latin costume-based festivals that attract a variety of 
individual. The free-living lifestyle is well known in the south region and among the 
LGBT community. Thus, LGBT population can be considered at-risk in this region. 
Protective factors race/ethnics, gender, pregnancy, aware of HIV status, and was paid for 
sex. If a targeted intervention would be created for the southwest region, it is 
recommended that it be focused an age, especially those between the ages of 16 and 29 
years. 
State of Florida 
The final results indicate for the state of Florida, the risk factors contributing to 
drug resistance by being prescribed the last line of antibiotic treatment were 1) age range, 
2) oral sex with a female, and 3) unprotected vaginal or anal sex with a male. These 
groups are most at-risk for contracting or developing drug resistance. Overall, the age 
groups that had the highest rates of gonococcal infections were those between the ages of 
20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age groups not 
only were the majority of the infection, but they were often prescribed the last-line-of-
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antibiotic-defense at rates of 80% or greater. This then can be interpreted that those in 
these age categories are most likely to contract or develop drug-resistant strains of 
gonorrhea. Oral sex is often performed without a condom and can lead to infections. 
Having unprotected vaginal or anal sex with a male is also a mechanism for transmission 
of the infections. This can include females or males having unprotected sex with a male. 
Again, having unprotected sex can drive infections. From a Statewide perspective, 
targeting the ages 16 to 29 years would have the greatest impact. These are the highest 
groups for infection as well as being prescribed the last-line-of-antibiotic-defense. 
Adding condom use will reduce the chances of contracting drug-resistant gonorrhea as 
well as evolving drug-resistant gonorrhea. This is evident since in Florida results, always 
using condoms is considered a protective factor. Interesting enough knowing one’s HIV 
status was a protective factor not only in the state but in all regions. This may indicate 
that those who are aware of their HIV status may be more aware of other infections and 
are more cautious in their sexual behaviors. The same holds true for those who had a 
history of an STD at any time in their life. This also seems to be a protective factor 
indicating that they may be more aware of infections. Race/ethnics and gender were also 
considered protective factors. In Florida and all Regions pregnancy is also a protective 
factor. Upon further investigation the last-line-of-antibiotic-defense at times is avoided if 
possible, for pregnant women since those particular antibiotics are not approved to be 
prescribed to a woman when pregnant unless there is no other option (Davis et al., 1996). 
In 2019, after the time of the data for this study, the next generation (third variation of the 
medication) of last-line-of-antibiotic-defenses have been approved to be used with 
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pregnant women (Arumugham & Cascella, 2019). In the future pregnancy may become a 
risk factor, but at the time of this study it is considered a protective factor.  
The over-arching result of these comparisons were compiled into Table 11. There 
is a commonality among all the regions and Florida as well as differences. The most 
common contributing risk factor for driving drug resistance would be age range. From 
there, secondarily would-be condom use. Each region and Florida had unique risk factors 
that differed among each other. This indicates that each region and the State are not the 
same and targeted interventions need to be developed to target each specifically. These 
results are discussed further in the Developing Targeted Intervention section.  
Limitation of the Study 
 The intent of this study was to identify what demographic and risk factor groups 
would be most likely to contract drug-resistant variants of gonorrhea. The difficulty with 
this type of study is that there is little to no data tracking drug resistance in the state of 
Florida. The state had two tracking locations for drug resistance. They were West Palm 
Beach from 1987 to 1998 and then Miami from 1998 to 2013. Since 2013 there has been 
no tracking of drug resistance for the State. These locations are in the southern end of 
Florida making it difficult for people in the rest of the state to access limiting it to those 
in the southern parts of the State. Testing at these locations were not broad reaching. If 
the patient did not fit the CDC recommendations such as men who have sex with men, 
pregnant, or sex workers then they were not tested. The testing itself was biased. This 
may have been due to limited funding. This biased data was not sufficient to conduct 
analysis and was not used for this study. This study was looking at factors outside of the 
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recommendations by the CDC to identify unknowns and populations that were most 
likely missed due to bias and biased testing.  
 The next option was to look at prescribing of the last-line-of-antibiotic-defense 
treatment as a driving force of drug resistance. From a biological standpoint this is the 
most logical route. The CDC as well as other researchers have indicated that unless new 
antibiotics are developed to specifically fight gonorrhea, the last line of antibiotic 
treatment will soon fail. Currently the last line is cefixime and ceftriaxone either in 
combination with each other or in combination with other antibiotics such as doxycycline 
or azithromycin. Eventually continued use of antimicrobials will lead to the evolution of 
resistance to that antimicrobial. This study evaluated the prescribed last line of antibiotic 
treatment as the dependent variable against the different demographic and risk factors as 
a predictor for drug resistance. Not everyone in the data set received the last line of 
antibiotic treatment. This then provided a yes versus no evaluation that could then be tied 
to driving forces of antibiotic resistance. There were also other limitations to the 
prescribed last line of antibiotic treatment data. This information was limited to only 
initial prescribed treatment. There was no method to identify if the prescribed treatment 
worked or if further treatments were needed.  
 There were other limitations with the data. The data collected was only for those 
who were infected and tested positive for gonorrhea. There was no data regarding those 
who were not infected or may have tested negative. This limited comparisons and 
negated some of the research questions. As for the data itself, all sections were 
completed. There was no missing data. But what was often recorded was either “did not 
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report” or “refused to answer.” These were treated as a no or negative answer since there 
was no method to prove that the answers were a positive answer. Due to security and 
privacy issues, no personal data were released. There was no method to contact the 
infected individual to gain additional information. This limited the research to only the 
data that was provided. The data failed to identify if the person infected was a repeat 
gonococcal infection specifically. The data did indicate if they have had an STD in the 
past or within the last 12 months since the time of their infection, but never identified the 
type of STD infection. This would have been helpful to look at repeat gonococcal 
infections coupled with last line of antibiotic treatment as a driving force for 
antimicrobial resistance.  
 The data itself may have other biases. Gonococcal infections are mandatory to 
report in the state of Florida. The information is required by Florida but is reported 
remotely by many different health care workers across the State. Some data entry sections 
were stated in ambiguity which could cause confusion among the reporters. There were at 
times double negative statements. For instance, when it came to drug use, the section was 
stated as “did not use drugs.” A person who did use drugs would have a no answer and 
someone who does not use drug would have a yes answer. This could cause some 
confusion when filling out the data quickly, leading to recording bias. Without the 
reporters carefully reading and understanding what was being asked, it could have been 
reported incorrectly. Again, due to security and privacy issues, there was no method in 
which to confirm if the reporting was done correctly. The data set held over 37 million 
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data points combined with no connective data being included, making it impossible to 
confirm that every data point was entered correctly.  
 Florida Department of Health specifically stated that some additional data were 
not going to be supplied. They specifically stated that no data with anyone under the age 
of 16 years was going to be provided. They did not state directly why this was so, but it 
was elucidated that it could be a number of the following reasons such as indicating 
sexual molestation of a minor, they did not want information regarding gonococcal 
infections with minors reported to the public, or worries over community concerns. This 
limited the data to those 16 years and older and primarily adults. This limits an 
understanding to what extent if any are gonococcal infections affecting high school aged 
individuals. It is not known if interventions are necessary for freshman and sophomore 
aged high school students since this data were not made available by the State. 
Regardless of some of the limiting factors, there was enough data to successfully develop 
a predictive model for at-risk groups for driving and contracting drug-resistant gonorrhea 
infections.  
Recommendations 
Developing Targeted Interventions 
No model is ever perfect. When determining who is most likely at risk for drug-
resistant gonorrhea, there are many factors that need to be considered. The data that was 
provided by Florida was evaluated until the statistics in conjunction with statistical 
significance elucidated targeted risk factors and demographic groups that should be the 
focus for intervention in the immediate future. The statistics indicated that given a 
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statewide initiative it would be best to focus funding and person power at age range with 
emphasis on condom use. It seems that those under the age of 30 years had the highest 
number of gonorrhea infections. The most significant were those between the ages of 20 
to 24 years followed secondarily by those between the ages of 16 to 19 years, and thirdly 
those between the ages of 25 to 29 years. Additionally, these were not only the majority 
of those who contracted gonorrhea, but they were also the highest groups that were 
prescribed the last line of antibiotic treatment. What this means is that this particular age 
group will be driving drug resistance and thus spreading drug-resistant gonorrhea to 
others within that age category. For the state of Florida, the mean age for a man to be 
married for the first time is 29.4 years and for a woman it is 28.2 years (United States 
Census Bureau, 2019). Marriage in general is a commitment to monogamy, which 
virtually eliminates STD infections provided each person is committed to the relationship 
in that manner. It can be concluded that those under the age of 30 years especially those 
between the ages of 20 to 24 years and 16 to 19 years will be the most likely to contract 
drug-resistant strains of gonorrhea. There are three mechanisms in which to avoid the 
spread of drug-resistant strains of gonorrhea. The mechanisms are abstinence, proper use 
of barriers such as dental dams and condoms, and a committed monogamist relationship 
that has had STD testing prior to sexual contact.  
 Within each region there are a few additional areas of focus to be included in an 
intervention strategy. The Northwest region would need to be age range and condom use. 
Additionally, there seems to be a lack of follow-up education after an infection. Having a 
prior STD does not dissuade individuals from becoming infected again, creating an 
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additional risk factor for drug resistance. For the Northwest Region, there would need to 
be an educational program that focuses on the dangers of contracting STD’s repetitively. 
Northeast Region has a slightly different necessary focus. The additional focus beyond 
age range and condom use which must be inclusive in the intervention, would be the 
number of sex partners someone has. Intervention in this area would have to educate the 
public that the more sex partners you have not only are you more likely of contracting 
gonorrhea, but you may end up contracting a drug-resistant strain that is incurable. North 
Central Region just slightly fell short for age range as being statistically significant 
(p=0.079). It is the opinion of this author that it should still be included as a risk factor 
for intervention purposes. The other aspect was condom usage with another partner. This 
indicates that the individual has a second relationship outside of the primary and may be 
careless with the second individual. Same as with Florida the North Central Region needs 
to focus on the under 30 years of age and condom usage. The only area of focus for the 
West Central Region is age range. This means that those under the age of 30 are at most 
risk for drug-resistant gonorrhea. East Central Region is similar to Florida and that is 
those who are at risk are at 30 years of age and under and proper use of condoms should 
be added to the intervention programs. The Southeast region also identifies the at-risk 
category for those who are under the age of 30 years but differs in the fact that it includes 
those who were incarcerated within 12 months of the infection. This may mean that there 
is a lack of STD education for those who have been incarcerated. It would be beneficial 
as part of release programs to teach those individuals that not only are they at risk for 
contracting gonorrhea they may also be at-risk for contracting drug-resistant strains. 
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Southwest Region will also need to focus on intervention strategies for those under the 
age of 30 years. As for the South Region this is where the most drastic shift in at-risk 
groups exists. The South Region shares the same at-risk category for age range with all 
the other regions and the state as a whole. Where it differs is that men who have sex with 
men (MSM) and sexual orientation become a risk factor. The South Region of Florida is 
well known for its high LGBT populations of which the CDC has identified as a-risk. As 
mentioned earlier this is also the location of the only testing site for drug-resistant strains 
thus why the collected drug-resistant data would be biased. For the South Region focus 
should be on those under the age of 30 years, men who have sex with men, and men who 
identify as homosexual or bisexual.  
Positive Social Change Implications 
 Any infectious disease can be stopped if there is no receptive host. There are 
many issues with gonorrhea such as its asymptomatic behavior. From an infectious 
standpoint, this pathogen is passed through sexual contact. Unfortunately, even in this 
most modern of times the act of sex, discussion of sex, or thought of sex is considered a 
taboo topic in many social settings. The discussion of sex often becomes non-existent 
when the topic of sexually transmitted infections (STI) is introduced. In Florida there is 
little to no discussion with the public regarding these easily avoidable infections. If 
individuals would just practice safe sex, have regular medical testing for STI’s, and have 
monogamous relationships, most if not all of the STI’s would become eradicated. This is 
not an unreasonable objective. In order to achieve this possibility, the population needs to 
understand the importance of infection avoidance. The statistically significant risk 
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populations in each region need to be educated on the risks of contracting drug-resistant 
variants and it needs to be done in a direct non-pacifistic manner. It is extremely 
important that the information is presented to them with methods that would require 
behavioral modification. As presented in this study the over-arching risk group is age 
range. The highest incidences and the most prescribed group for last-line-of-antibiotic-
defense are those under the age of 30 years with highest concentration in those between 
the age of 20 to 24 years followed by 16 to 19 years and then 25 to 29 years. In the 
current age of social media where interactive connections are just a cell phone tap away, 
there has been a growing trend of “no strings attached” hook-up apps. These apps such as 
Tinder, Plenty O’ Fish, FET Life, Wild, Adult Friend Finder, and the like, all lead to 
quick sexual encounters without regrets or worries. The greatest demographic group 
which is highly versed in these phone-based connection apps and use them regularly are 
those who are between the ages of 16 to 29 years. The highest category of infection and 
being prescribed the last-line-of-antibiotic-defense is the age group of 20 to 24 years 
followed by 16 to 19 years and then 25 to 29 years. Since gonorrhea can be asymptomatic 
an individual who is sexually active may be a “super spreader” of this infection. 
Additionally, the spread is greatly attributed to the manner in which people interact with 
each other sexually, interventions of this magnitude will only be successful if the societal 
understandings, approaches, discussions, and attitudes towards sex, change. There needs 
to be a well-driven-home message that casual sex in this day and age can lead to 
gonorrhea infections that are uncurable and the message needs to reach those especially 




 This study answered the question of who would be most at-risk for contracting or 
developing drug-resistant strains of gonorrhea in each region and Florida. Each region 
and Florida have unique risk factors that differ from each.  Although each has its own 
unique risk factors, there was a common risk factor shared. In all statistical models 
conducted in this research, age was the most common and repetitive risk factor. Often 
individuals have sexual relationships within their age groups. Connecting high rates of 
prescribing last-line-of-antibiotic-defense with high rates of infection within the same 
group, there is a significant chance that the group will develop drug-resistance and then 
pass the drug-resistant variant to others within the group. Florida needs to focus on safe 
sex practices and emphasize that contracting drug-resistant gonorrhea is possible and 
most likely for those under the age of 30 years. Considering the average age of first 
marriages in the state are is 29.4 years for a male and 28.2 years for a woman. There is a 
significant chance that those below these ages are sexually active. With the many 
different “hook up” sites promoting random inconsequential sexual encounters, just 
supports that under the age of 30 years are most like to be the driving force. Coupled with 
age, each region needs to focus on the additional risk factors unique to each.  The 
combined effort will maximize the success of prevention.  
 Future studies would focus on of those who have contracted gonorrhea, identify 
who has contracted drug-resistant strains and who has contracted regular strains in all 
infected individuals and not just select groups. This would provide a more precise 
understanding of who is at-risk of contracting and spreading drug-resistant gonococcal 
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infections. But before this type of study can be conducted Florida needs to test for drug-
resistant strains in all infected individuals. This would provide a stronger identification of 
who would be at-risk for contracting drug-resistant strains. With this knowledge more 
realistic interventions can be conducted.  Although the United States is a diverse nation, 
nationwide focus is not always effective. Regional and community-based focus should be 
the goal.  
 A second area of future research in gonococcal infections would focus on the 
local communities and identify clusters of gonococcal infections. The state had expressed 
concerns that this could be culturally problematic. Areas with heavy religious influence 
may not appreciate studies such as this in their community. Although identifying clusters 
is helpful, there may be community resistance. Being able to identify clusters would 
significantly narrow the focus of intervention and culturally sensitive interventions could 
be created.  
 A third area of future research would evaluate the influences of “hook up” sites 
and apps on the contraction and spread of gonococcal infections. Many of these sites are 
how individuals, especially those 30 years and under, meet others for sexual connections 
or long-term relationships. Within the research it would also be interesting to see if these 
sites drive drug resistance or pass drug-resistant strains. Through these sites it could be 
possible to perform contact tracing, infection tracking, and cluster mapping.   
A final area of future research is to evaluate comorbidity. The study would 
identify if there were other STD infections at the time of the gonococcal infection 
occurred. Gonorrhea is known to be asymptomatic in many cases. It would be interesting 
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to study if gonococcal infections had influence on other infections such as HIV/AIDS. 
Questions such as does a gonococcal infection make it easier to contract other STD’s 
such as HIV/AIDS?  Do some individuals contract other STD’s at the same time they 
contracted gonorrhea? These areas of research would help develop a better understanding 
of how gonorrhea spreads, becomes drug resistant, and is influenced by anthropogenic 
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Appendix A: Results of the Cross-Tabulations Associated with the Comparing Florida as 

























Results of Cross Tabulation Comparing Florida as a Whole with the Northwest Region 
for the Last-line-of-antibiotic-defense  





















24.5% 65.3% 10.2% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
9.4% 8.1% 9.0% 8.5% 








22.2% 68.2% 9.6% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
85.0% 84.8% 84.8% 84.9% 
Total 18.9% 57.9% 8.1% 84.9% 
Not Effective 
Antibiotic 




18.8% 72.2% 9.0% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
5.7% 7.1% 6.3% 6.7% 
Total 1.3% 4.8% 0.6% 6.7% 




22.2% 68.2% 9.6% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 22.2% 68.2% 9.6% 100.0% 
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Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A2 
 
Results of Cross Tabulation Comparing Florida as a Whole with the North Central 
Region for the Last-line-of-antibiotic-defense  


















Did Not Report Count 712 2368 339 3419 
Within North Central 
Region Last-line-of-
antibiotic-defense 
20.8% 69.3% 9.9% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
11.5% 11.7% 11.8% 11.7% 




Count 4967 16475 2342 23784 
Within North Central 
Region Last-line-of-
antibiotic-defense 
20.9% 69.3% 9.8% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
80.0% 81.7% 81.8% 81.3% 
Total 17.0% 56.3% 8.0% 81.3% 
Not Effective 
Antibiotic 
Count 529 1330 183 2042 
Within North Central 
Region Last-line-of-
antibiotic-defense 
25.9% 65.1% 9.0% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
8.5% 6.6% 6.4% 7.0% 
Total 1.8% 4.5% 0.6% 7.0% 
Total Count 6208 20173 2864 29245 
Within North Central 
Region Last-line-of-
antibiotic-defense 
21.2% 69.0% 9.8% 100.0% 
177 
 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 21.2% 69.0% 9.8% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A3 
 
Results of Cross Tabulation Comparing Florida as a Whole with the Northeast Region 
for the Last-line-of-antibiotic-defense  





















21.9% 68.8% 9.3% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
11.6% 10.6% 10.4% 10.8% 








20.4% 70.0% 9.6% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
81.2% 80.4% 80.3% 80.6% 
Total 16.4% 56.4% 7.7% 80.6% 
Not Effective 
Antibiotic 




16.8% 73.0% 10.3% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
7.2% 9.0% 9.2% 8.7% 
Total 1.5% 6.3% 0.9% 8.7% 
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20.3% 70.1% 9.6% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 20.3% 70.1% 9.6% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A4 
 
Results of Cross Tabulation Comparing Florida as a Whole with the West Central Region 



















Did Not Report Count 823 3547 446 4816 
Within West Central 
Region Last-line-of-
antibiotic-defense 
17.1% 73.7% 9.3% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
6.1% 7.9% 7.8% 7.5% 




Count 11767 37867 4841 54475 
Within West Central 
Region Last-line-of-
antibiotic-defense 
21.6% 69.5% 8.9% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
86.5% 84.4% 84.8% 84.9% 
Total 18.3% 59.0% 7.5% 84.9% 
Not Effective 
Antibiotic 
Count 1006 3473 422 4901 
Within West Central 
Region Last-line-of-
antibiotic-defense 
20.5% 70.9% 8.6% 100.0% 
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Within state of Florida 
Last Line of Antibiotic 
Treatment 
7.4% 7.7% 7.4% 7.6% 
Total 1.6% 5.4% 0.7% 7.6% 
Total Count 13596 44887 5709 64192 
Within West Central 
Region Last-line-of-
antibiotic-defense 
21.2% 69.9% 8.9% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 21.2% 69.9% 8.9% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A5 
 
Results of Cross Tabulation Comparing Florida as a Whole with the East Central Region 




















Did Not Report Count 2467 6542 737 9746 
Within East Central 
Region Last-line-of-
antibiotic-defense 
25.3% 67.1% 7.6% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
22.0% 19.4% 18.9% 20.0% 




Count 7842 24826 2922 35590 
Within East Central 
Region Last-line-of-
antibiotic-defense 
22.0% 69.8% 8.2% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
70.1% 73.6% 74.8% 72.9% 
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Total 16.1% 50.8% 6.0% 72.9% 
Not Effective 
Antibiotic 
Count 884 2369 247 3500 
Within East Central 
Region Last-line-of-
antibiotic-defense 
25.3% 67.7% 7.1% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
7.9% 7.0% 6.3% 7.2% 
Total 1.8% 4.9% 0.5% 7.2% 
Total Count 11193 33737 3906 48836 
Within East Central 
Region Last-line-of-
antibiotic-defense 
22.9% 69.1% 8.0% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 22.9% 69.1% 8.0% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table 1 
 
Results of Cross Tabulation Comparing Florida as a Whole with the Southwest Region 























13.4% 75.3% 11.3% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
2.8% 3.6% 2.9% 3.4% 
Total 0.5% 2.5% 0.4% 3.4% 









16.7% 70.0% 13.3% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
92.1% 90.2% 90.0% 90.5% 
Total 15.1% 63.3% 12.0% 90.5% 
Not Effective 
Antibiotic 




13.7% 71.0% 15.4% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
5.1% 6.2% 7.1% 6.2% 
Total 0.8% 4.4% 1.0% 6.2% 




16.4% 70.3% 13.3% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 16.4% 70.3% 13.3% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A7 
 
Results of Cross Tabulation Comparing Florida as a Whole with the Southeast Region 
for the Last-line-of-antibiotic-defense  





















14.1% 77.0% 9.0% 100.0% 
182 
 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
3.2% 5.9% 5.1% 5.2% 








23.6% 67.3% 9.2% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
88.6% 84.6% 85.1% 85.6% 
Total 20.2% 57.6% 7.8% 85.6% 
Not Effective 
Antibiotic 




20.2% 69.9% 9.9% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
8.1% 9.4% 9.8% 9.2% 
Total 1.9% 6.4% 0.9% 9.2% 




22.8% 68.0% 9.2% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 22.8% 68.0% 9.2% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 
version 25.  
Table A8 
 





















Did Not Report Count 2561 9228 1369 13158 
Within South Region 
Last-line-of-antibiotic-
defense 
19.5% 70.1% 10.4% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
18.8% 20.6% 24.0% 20.5% 




Count 10415 33050 3996 47461 
Within South Region 
Last-line-of-antibiotic-
defense 
21.9% 69.6% 8.4% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
76.6% 73.7% 70.2% 74.0% 
Total 16.2% 51.6% 6.2% 74.0% 
Not Effective 
Antibiotic 
Count 616 2547 328 3491 
Within South Region 
Last-line-of-antibiotic-
defense 
17.6% 73.0% 9.4% 100.0% 
Within state of Florida 
Last Line of Antibiotic 
Treatment 
4.5% 5.7% 5.8% 5.4% 
Total 1.0% 4.0% 0.5% 5.4% 
Total Count 13592 44825 5693 64110 
Within South Region 
Last-line-of-antibiotic-
defense 
21.2% 69.9% 8.9% 100.0% 
Within state of Florida 




100.0% 100.0% 100.0% 
Total 21.2% 69.9% 8.9% 100.0% 
Note: Table created from data provided by FDOH STARS system and using IBM SPSS 






































All Results of the Multiple Logistic Regression for Florida  
 
Multiple Logistic Regression for the state of Florida 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.114 .005 1 .000 .892 .883 .901 
Age Range .033 .003 1 .000 1.034 1.028 1.039 
Gender -.613 .050 1 .000 .542 .491 .598 
Men Sex with 
Men 
-.030 .025 1 .227 .970 .923 1.019 
Sexual 
Orientation 
.006 .008 1 .430 1.006 .991 1.023 
Pregnant -.391 .013 1 .000 .677 .660 .694 




.031 .052 1 .547 1.032 .932 1.142 
Condom Use 
Always 
-.134 .065 1 .040 .875 .770 .994 
Condom Use 
Sometimes 
-.053 .071 1 .450 .948 .826 1.089 
Condom Use 
Never 












-.013 .061 1 .830 .987 .876 1.112 
Sex with Partner 
Met Via Internet 




Within the Last 
90 Days 
-.036 .077 1 .640 .965 .830 1.122 
Number of Sex 
Partners 
-.013 .008 1 .133 .988 .972 1.004 
Pick Up in Bar .012 .130 1 .929 1.012 .784 1.305 
Pick Up in Bath .035 .122 1 .777 1.035 .814 1.316 
HIV Self-Aware -.085 .013 1 .000 .918 .895 .943 
Paid for Sex -.051 .081 1 .528 .950 .812 1.113 
Was Paid for Sex -.124 .070 1 .079 .883 .769 1.014 
Vaginal or Anal 
Sex with Female 
-.039 .061 1 .526 .962 .853 1.085 
Oral Sex with 
Female 
.200 .081 1 .014 1.221 1.042 1.432 
Unprotected 
Vaginal or Anal 
Sex with Female 
-.098 .073 1 .175 .906 .786 1.045 
Vaginal or Anal 
Sex with Male 
-.005 .049 1 .926 .995 .904 1.096 
Oral Sex with 
Male 
.010 .077 1 .895 1.010 .868 1.176 
Unprotected 
Vaginal or Anal 
Sex with Male 
.154 .070 1 .029 1.166 1.016 1.338 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.061 .061 1 .318 .941 .835 1.060 
History of Prior 
STD 
-.167 .025 1 .000 .846 .806 .888 
History of Prior 
STD Within Last 
12 Months 
-.248 .046 1 .000 .781 .713 .854 
Incarcerated 
Within Last 12 
Months 
-.075 .051 1 .143 .928 .840 1.025 
Victim of Sexual 
Assault 
-.061 .070 1 .385 .941 .819 1.080 
187 
 
Constant -.106 .034 1 .002 .899   
Note: Table created from data provided by FDOH STARS system and using IBM 




All Results of the Multiple Logistic Regression for the Northwest Region  
 
Multiple Logistic Regression for the Northwest Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.010 .020 1 .619 .990 .952 1.030 
Age Range .048 .013 1 .000 1.050 1.023 1.077 
Gender .184 .401 1 .647 1.202 .548 2.635 
Men Sex with 
Men 
-.646 .201 1 .001 .524 .353 .778 
Sexual 
Orientation 
-.510 .051 1 .000 .601 .543 .664 
Pregnant -.444 .054 1 .000 .642 .577 .713 




.187 .220 1 .395 1.206 .784 1.855 
Condom Use 
Always 
-.610 .321 1 .057 .543 .289 1.020 
Condom Use 
Sometimes 
.857 .417 1 .040 2.356 1.041 5.335 
Condom Use 
Never 














.392 .294 1 .183 1.480 .831 2.633 
Sex with Partner 
Met Via Internet 
-.030 .254 1 .906 .970 .590 1.596 
New Partner 
Within the Last 
90 Days 
.025 .292 1 .932 1.025 .578 1.819 
Number of Sex 
Partners 
.064 .039 1 .101 1.066 .988 1.150 
Pick Up in Bar -.583 .345 1 .092 .558 .284 1.099 
Pick Up in Bath .629 .321 1 .050 1.875 1.000 3.516 
HIV Self-Aware -.194 .084 1 .022 .824 .699 .972 
Paid for Sex -.620 .397 1 .119 .538 .247 1.172 
Was Paid for Sex .079 .282 1 .779 1.083 .623 1.883 
Vaginal or Anal 
Sex with Female 
.297 .326 1 .362 1.346 .710 2.551 
Oral Sex with 
Female 
-.319 .491 1 .516 .727 .278 1.902 
Unprotected 
Vaginal or Anal 
Sex with Female 
.343 .464 1 .460 1.410 .568 3.501 
Vaginal or Anal 
Sex with Male 
-.568 .377 1 .132 .567 .271 1.186 
Oral Sex with 
Male 
.499 .446 1 .263 1.647 .687 3.950 
Unprotected 
Vaginal or Anal 
Sex with Male 
.463 .453 1 .307 1.589 .654 3.863 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.390 .277 1 .159 .677 .393 1.165 
History of Prior 
STD 
.224 .092 1 .015 1.251 1.045 1.499 
History of Prior 
STD Within Last 
12 Months 




Within Last 12 
Months 
-.295 .250 1 .239 .745 .456 1.217 
Victim of Sexual 
Assault 
-.364 .232 1 .116 .695 .441 1.094 
Constant -.544 .222 1 .014 .580   
Note: Table created from data provided by FDOH STARS system and using IBM 




All Results of the Multiple Logistic Regression for the Northeast Region 
 
Multiple Logistic Regression for the Northeast Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.028 .015 1 .075 .973 .944 1.003 
 Age Range .060 .008 1 .000 1.062 1.046 1.078 
 Gender -.779 .189 1 .000 .459 .317 .665 
 Men Sex with 
Men 
-.173 .096 1 .070 .841 .697 1.014 
 Sexual 
Orientation 
-.146 .029 1 .000 .864 .816 .915 
 Pregnant -.703 .035 1 .000 .495 .462 .530 




.106 .209 1 .611 1.112 .738 1.675 
Condom Use 
Always 
.245 .398 1 .538 1.278 .586 2.786 
 Condom Use 
Sometimes 
-.536 .266 1 .044 .585 .348 .985 
 Condom Use 
Never 
-.401 .317 1 .206 .669 .359 1.247 
 Condom Use 
with Main 
Partner 










.289 .312 1 .353 1.335 .725 2.460 
Sex with Partner 
Met Via Internet 
-.251 .329 1 .446 .778 .408 1.484 
New Partner 
Within the Last 
90 Days 
-.712 .351 1 .043 .491 .246 .977 
Number of Sex 
Partners 
.223 .047 1 .000 1.250 1.140 1.371 
Pick Up in Bar .161 .504 1 .749 1.175 .438 3.153 
Pick Up in Bath 1.170 .744 1 .116 3.222 .750 13.839 
 HIV Self-Aware -.160 .041 1 .000 .852 .787 .923 
 Paid for Sex -.530 .357 1 .138 .589 .292 1.186 
Was Paid for Sex -.308 .319 1 .335 .735 .393 1.374 
Vaginal or Anal 
Sex with Female 
-.244 .243 1 .316 .783 .486 1.262 
Oral Sex with 
Female 
.914 .355 1 .010 2.494 1.244 4.998 
Unprotected 
Vaginal or Anal 
Sex with Female 
-.373 .237 1 .117 .689 .433 1.097 
Vaginal or Anal 
Sex with Male 
.048 .216 1 .824 1.049 .687 1.602 
Oral Sex with 
Male 
.144 .283 1 .610 1.155 .664 2.010 
Unprotected 
Vaginal or Anal 
Sex with Male 
-.063 .235 1 .788 .939 .592 1.489 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
.404 .387 1 .297 1.497 .701 3.200 
 History of Prior 
STD 
-.079 .079 1 .315 .924 .792 1.078 
191 
 
 History of Prior 
STD Within Last 
12 Months 
.096 .172 1 .576 1.101 .786 1.542 
Incarcerated 
Within Last 12 
Months 
-.655 .245 1 .007 .519 .322 .839 
Victim of Sexual 
Assault 
-.657 .502 1 .190 .518 .194 1.386 
 Constant .317 .112 1 .005 1.373   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B4 
 
All Results of the Multiple Logistic Regression for the North Central Region  
 
Multiple Logistic Regression for the North Central Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.048 .017 1 .005 .953 .922 .985 
 Age Range .017 .010 1 .079 1.017 .998 1.036 
 Gender -.483 .198 1 .015 .617 .418 .909 
 Men Sex with 
Men 
-.410 .099 1 .000 .663 .546 .806 
 Sexual 
Orientation 
-.226 .031 1 .000 .797 .750 .848 
 Pregnant -1.325 .041 1 .000 .266 .245 .288 




.123 .215 1 .567 1.131 .742 1.724 
Condom Use 
Always 
-.042 .241 1 .863 .959 .597 1.539 
 Condom Use 
Sometimes 
.142 .335 1 .671 1.153 .598 2.221 
 Condom Use 
Never 
.511 .278 1 .066 1.667 .966 2.876 
192 
 
 Condom Use 
with Main 
Partner 








.131 .308 1 .670 1.140 .623 2.085 
Sex with Partner 
Met Via Internet 
-.039 .318 1 .903 .962 .516 1.794 
New Partner 
Within the Last 
90 Days 
-.591 .428 1 .167 .554 .239 1.281 
Number of Sex 
Partners 
-.047 .088 1 .595 .954 .804 1.133 
Pick Up in Bar .723 .826 1 .381 2.060 .409 10.390 
Pick Up in Bath -.650 .745 1 .383 .522 .121 2.247 
 HIV Self-Aware -.094 .043 1 .027 .910 .837 .990 
 Paid for Sex .795 .471 1 .092 2.215 .879 5.580 
Was Paid for Sex -.115 .348 1 .741 .892 .451 1.762 
Vaginal or Anal 
Sex with Female 
-.153 .332 1 .644 .858 .447 1.646 
Oral Sex with 
Female 
.205 .379 1 .590 1.227 .583 2.581 
Unprotected 
Vaginal or Anal 
Sex with Female 
-.685 .384 1 .075 .504 .237 1.070 
Vaginal or Anal 
Sex with Male 
-.342 .251 1 .173 .711 .435 1.162 
Oral Sex with 
Male 
-.864 .346 1 .012 .421 .214 .830 
Unprotected 
Vaginal or Anal 
Sex with Male 
.413 .369 1 .262 1.512 .734 3.113 
193 
 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
.390 .327 1 .233 1.478 .778 2.807 
 History of Prior 
STD 
.009 .131 1 .947 1.009 .781 1.304 
 History of Prior 
STD Within Last 
12 Months 
-.266 .216 1 .219 .766 .502 1.171 
Incarcerated 
Within Last 12 
Months 
-.219 .309 1 .479 .804 .439 1.471 
Victim of Sexual 
Assault 
-.494 .402 1 .219 .610 .277 1.341 
 Constant .636 .119 1 .000 1.888   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B5 
 
All Results of the Multiple Logistic Regression for the West Central Region  
 
Multiple Logistic Regression for the West Central Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.062 .011 1 .000 .940 .919 .961 
 Age Range .039 .006 1 .000 1.040 1.028 1.053 
 Gender -.502 .130 1 .000 .605 .470 .781 
 Men Sex with 
Men 
-.380 .065 1 .000 .684 .602 .778 
 Sexual 
Orientation 
-.134 .021 1 .000 .874 .839 .911 
 Pregnant -.835 .029 1 .000 .434 .410 .459 









.024 .140 1 .863 1.024 .779 1.347 
 Condom Use 
Sometimes 
.281 .183 1 .126 1.324 .924 1.896 
 Condom Use 
Never 
.101 .176 1 .566 1.106 .784 1.560 
 Condom Use 
with Main 
Partner 








.007 .134 1 .957 1.007 .774 1.310 
Sex with Partner 
Met Via Internet 
-.025 .166 1 .882 .976 .705 1.351 
New Partner 
Within the Last 
90 Days 
.088 .178 1 .623 1.091 .770 1.547 
Number of Sex 
Partners 
.012 .011 1 .249 1.012 .991 1.034 
Pick Up in Bar -.623 .369 1 .092 .537 .260 1.106 
Pick Up in Bath .810 .433 1 .061 2.249 .962 5.256 
 HIV Self-Aware -.111 .038 1 .003 .895 .832 .964 
 Paid for Sex .260 .226 1 .248 1.298 .834 2.019 
Was Paid for Sex -.223 .195 1 .253 .800 .546 1.173 
Vaginal or Anal 
Sex with Female 
-.375 .155 1 .015 .687 .507 .931 
Oral Sex with 
Female 
.290 .210 1 .168 1.336 .885 2.017 
Unprotected 
Vaginal or Anal 
Sex with Female 
.087 .190 1 .648 1.091 .752 1.582 
Vaginal or Anal 
Sex with Male 
-.108 .122 1 .376 .897 .706 1.141 
Oral Sex with 
Male 




Vaginal or Anal 
Sex with Male 
.160 .170 1 .345 1.174 .842 1.637 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.061 .149 1 .685 .941 .703 1.261 
 History of Prior 
STD 
-.077 .063 1 .224 .926 .818 1.048 
 History of Prior 
STD Within Last 
12 Months 
-.009 .099 1 .930 .991 .817 1.203 
Incarcerated 
Within Last 12 
Months 
-.058 .120 1 .629 .944 .746 1.194 
Victim of Sexual 
Assault 
-.408 .234 1 .081 .665 .421 1.052 
 Constant .159 .080 1 .047 1.172   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B6 
 
All Results of the Multiple Logistic Regression for the East Central Region  
 
Multiple Logistic Regression for the East Central Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.133 .011 1 .000 .875 .857 .894 
 Age Range .046 .006 1 .000 1.047 1.035 1.059 
 Gender -1.520 .107 1 .000 .219 .178 .270 
 Men Sex with 
Men 
-.015 .055 1 .790 .986 .885 1.097 
 Sexual 
Orientation 
.016 .017 1 .369 1.016 .982 1.051 
 Pregnant -1.669 .031 1 .000 .188 .177 .200 






-.037 .133 1 .783 .964 .742 1.252 
Condom Use 
Always 
.575 .200 1 .004 1.776 1.200 2.629 
 Condom Use 
Sometimes 
-.285 .192 1 .139 .752 .516 1.096 
 Condom Use 
Never 
-.094 .229 1 .682 .910 .581 1.427 
 Condom Use 
with Main 
Partner 








.055 .174 1 .752 1.057 .752 1.485 
Sex with Partner 
Met Via Internet 
.100 .190 1 .600 1.105 .761 1.604 
New Partner 
Within the Last 
90 Days 
.380 .220 1 .084 1.462 .950 2.251 
Number of Sex 
Partners 
-.014 .034 1 .682 .986 .923 1.054 
Pick Up in Bar .447 .328 1 .172 1.564 .823 2.973 
Pick Up in Bath -.050 .267 1 .853 .952 .564 1.606 
 HIV Self-Aware -.220 .036 1 .000 .802 .748 .861 
 Paid for Sex -.308 .186 1 .098 .735 .510 1.058 
Was Paid for Sex -.044 .180 1 .807 .957 .673 1.361 
Vaginal or Anal 
Sex with Female 
-.141 .167 1 .399 .869 .626 1.205 
Oral Sex with 
Female 
.146 .228 1 .522 1.157 .740 1.808 
Unprotected 
Vaginal or Anal 
Sex with Female 
.108 .218 1 .622 1.113 .726 1.707 
197 
 
Vaginal or Anal 
Sex with Male 
.058 .139 1 .675 1.060 .808 1.391 
Oral Sex with 
Male 
.141 .217 1 .516 1.152 .752 1.764 
Unprotected 
Vaginal or Anal 
Sex with Male 
-.182 .200 1 .363 .834 .564 1.234 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
.077 .173 1 .659 1.080 .769 1.516 
 History of Prior 
STD 
-.017 .051 1 .741 .983 .890 1.087 
 History of Prior 
STD Within Last 
12 Months 
-.083 .117 1 .479 .921 .732 1.158 
Incarcerated 
Within Last 12 
Months 
.028 .130 1 .828 1.029 .797 1.328 
Victim of Sexual 
Assault 
-.999 .265 1 .000 .368 .219 .619 
 Constant 2.017 .070 1 .000 7.513   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B7 
 
All Results of the Multiple Logistic Regression for the Southeast Region 
 
Multiple Logistic Regression for the Southeast Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity .031 .023 1 .165 1.032 .987 1.078 
 Age Range .078 .011 1 .000 1.081 1.059 1.104 
 Gender .076 .256 1 .766 1.079 .653 1.782 
 Men Sex with 
Men 





-.270 .039 1 .000 .763 .708 .823 
 Pregnant -.161 .074 1 .030 .851 .736 .984 




-.090 .139 1 .519 .914 .696 1.200 
Condom Use 
Always 
-.186 .208 1 .371 .830 .553 1.248 
 Condom Use 
Sometimes 
-.120 .204 1 .559 .887 .594 1.325 
 Condom Use 
Never 
-.291 .232 1 .209 .747 .474 1.178 
 Condom Use 
with Main 
Partner 








-.293 .174 1 .091 .746 .530 1.048 
Sex with Partner 
Met Via Internet 
.136 .175 1 .437 1.146 .813 1.616 
New Partner 
Within the Last 
90 Days 
.258 .221 1 .242 1.295 .840 1.997 
Number of Sex 
Partners 
.013 .010 1 .194 1.013 .993 1.033 
Pick Up in Bar .669 .578 1 .247 1.953 .629 6.061 
Pick Up in Bath .607 .603 1 .315 1.835 .562 5.985 
 HIV Self-Aware -.204 .065 1 .002 .815 .717 .927 
 Paid for Sex .346 .203 1 .089 1.413 .949 2.103 
Was Paid for Sex -.431 .187 1 .021 .650 .450 .938 
Vaginal or Anal 
Sex with Female 
-.049 .193 1 .801 .952 .653 1.390 
Oral Sex with 
Female 




Vaginal or Anal 
Sex with Female 
.410 .232 1 .078 1.506 .956 2.374 
Vaginal or Anal 
Sex with Male 
-.345 .170 1 .042 .708 .508 .988 
Oral Sex with 
Male 
.247 .204 1 .226 1.280 .858 1.910 
Unprotected 
Vaginal or Anal 
Sex with Male 
.092 .200 1 .647 1.096 .740 1.623 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.152 .149 1 .309 .859 .642 1.151 
 History of Prior 
STD 
-.066 .095 1 .486 .936 .777 1.128 
 History of Prior 
STD Within Last 
12 Months 
-.055 .122 1 .654 .947 .745 1.203 
Incarcerated 
Within Last 12 
Months 
.257 .124 1 .038 1.293 1.014 1.648 
Victim of Sexual 
Assault 
-.592 .268 1 .027 .553 .327 .936 
 Constant -1.085 .200 1 .000 .338   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B8 
 
All Results of the Multiple Logistic Regression for the Southwest Region 
 
Multiple Logistic Regression for the Southwest Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity .032 .038 1 .411 1.032 .957 1.113 
 Age Range .048 .020 1 .017 1.049 1.009 1.092 
 Gender -.351 .562 1 .532 .704 .234 2.119 
200 
 
 Men Sex with 
Men 
-.408 .267 1 .126 .665 .394 1.122 
 Sexual 
Orientation 
-.270 .070 1 .000 .763 .665 .875 
 Pregnant -.719 .187 1 .000 .487 .338 .703 




-.021 .222 1 .924 .979 .634 1.512 
Condom Use 
Always 
.456 .272 1 .093 1.578 .927 2.687 
 Condom Use 
Sometimes 
.145 .325 1 .656 1.156 .611 2.184 
 Condom Use 
Never 
-.083 .323 1 .796 .920 .489 1.732 
 Condom Use 
with Main 
Partner 








-.315 .254 1 .214 .730 .444 1.200 
Sex with Partner 
Met Via Internet 
-.119 .296 1 .687 .887 .496 1.586 
New Partner 
Within the Last 
90 Days 
-.104 .285 1 .715 .901 .515 1.575 
Number of Sex 
Partners 
-.105 .116 1 .363 .900 .717 1.129 
Pick Up in Bar .147 .445 1 .741 1.159 .484 2.773 
Pick Up in Bath -.274 .417 1 .511 .760 .335 1.722 
 HIV Self-Aware .007 .098 1 .944 1.007 .831 1.221 
 Paid for Sex -.214 .342 1 .532 .808 .413 1.579 
Was Paid for Sex .313 .296 1 .291 1.367 .765 2.444 
Vaginal or Anal 
Sex with Female 
.043 .259 1 .868 1.044 .628 1.735 
201 
 
Oral Sex with 
Female 
.881 .388 1 .023 2.412 1.128 5.161 
Unprotected 
Vaginal or Anal 
Sex with Female 
-.137 .260 1 .597 .872 .524 1.450 
Vaginal or Anal 
Sex with Male 
-.271 .270 1 .317 .763 .449 1.296 
Oral Sex with 
Male 
.087 .342 1 .800 1.091 .557 2.134 
Unprotected 
Vaginal or Anal 
Sex with Male 
.466 .346 1 .178 1.593 .809 3.138 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.348 .253 1 .169 .706 .430 1.159 
 History of Prior 
STD 
-.149 .159 1 .350 .862 .631 1.177 
 History of Prior 
STD Within Last 
12 Months 
-.484 .244 1 .047 .616 .382 .994 
Incarcerated 
Within Last 12 
Months 
.317 .232 1 .171 1.373 .872 2.163 
Victim of Sexual 
Assault 
.007 .280 1 .981 1.007 .581 1.744 
 Constant -.564 .470 1 .230 .569   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
Table B9 
 
All Results of the Multiple Logistic Regression for the South Region 
 
Multiple Logistic Regression for the South Region 
 B S.E. df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Race/Ethnicity -.140 .011 1 .000 .869 .851 .888 
202 
 
 Age Range .049 .005 1 .000 1.050 1.040 1.060 
 Gender -2.105 .083 1 .000 .122 .103 .143 
 Men Sex with 
Men 
.397 .040 1 .000 1.487 1.375 1.609 
 Sexual 
Orientation 
.149 .014 1 .000 1.160 1.130 1.192 
 Pregnant -1.375 .033 1 .000 .253 .237 .270 




-.072 .124 1 .562 .931 .730 1.186 
Condom Use 
Always 
-.214 .173 1 .217 .807 .575 1.134 
 Condom Use 
Sometimes 
.045 .185 1 .808 1.046 .727 1.505 
 Condom Use 
Never 
.064 .168 1 .703 1.066 .767 1.482 
 Condom Use 
with Main 
Partner 








.038 .144 1 .790 1.039 .784 1.377 
Sex with Partner 
Met Via Internet 
.113 .156 1 .467 1.120 .825 1.519 
New Partner 
Within the Last 
90 Days 
-.019 .172 1 .912 .981 .700 1.375 
Number of Sex 
Partners 
-.003 .007 1 .638 .997 .983 1.010 
Pick Up in Bar -.144 .296 1 .626 .866 .484 1.547 
Pick Up in Bath .389 .300 1 .195 1.476 .819 2.657 
 HIV Self-Aware -.151 .027 1 .000 .860 .815 .907 
 Paid for Sex .333 .184 1 .071 1.395 .973 2.000 
Was Paid for Sex -.433 .157 1 .006 .649 .476 .883 
203 
 
Vaginal or Anal 
Sex with Female 
-.277 .143 1 .052 .758 .573 1.002 
Oral Sex with 
Female 
-.197 .161 1 .222 .822 .599 1.126 
Unprotected 
Vaginal or Anal 
Sex with Female 
.112 .162 1 .490 1.118 .814 1.537 
Vaginal or Anal 
Sex with Male 
.128 .119 1 .283 1.136 .900 1.434 
Oral Sex with 
Male 
.243 .187 1 .192 1.276 .885 1.839 
Unprotected 
Vaginal or Anal 
Sex with Male 
-.224 .161 1 .163 .799 .583 1.095 
Vaginal or Anal 
Sex with Male 
who has Sex 
with Male 
-.148 .132 1 .262 .862 .666 1.117 
 History of Prior 
STD 
-.049 .048 1 .302 .952 .867 1.045 
 History of Prior 
STD Within Last 
12 Months 
-.030 .108 1 .782 .971 .786 1.198 
Incarcerated 
Within Last 12 
Months 
-.072 .116 1 .536 .931 .742 1.168 
Victim of Sexual 
Assault 
.206 .137 1 .132 1.228 .940 1.606 
 Constant 2.017 .070 1 .000 7.514   
Note: Table created from data provided by FDOH STARS system and using IBM 
SPSS version 25.  
 
